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Transposition of the great arteries
Transposition of the great arteries (TGA) is a congenital heart disease characterised by 
atrioventricular concordance and ventriculoarterial discordance: the right atrium is 
connected to the right ventricle from which the entire or most of the aorta originates; the 
left atrium is connected to the left ventricle from which the pulmonary artery arises. This 
results in a circulation in which the pulmonary and systemic circulation are running in 
parallel rather than in series. Postnatally, the blood with high oxygen content, coming from 
the lungs enters the left atrium, passes the left ventricle and is redirected to the lungs again; 
blood with low oxygen content returning from the body enters the right atrium and is 
redirected to the body again via the right ventricle, without passing the lungs. Cyanosis is 
often present directly after birth and survival is dependent on the presence of adequate 
communications between the two circulations (i.e. presence of an atrial septal defect or 
ventricular septal defect (VSD)). When these communications are too small or absent, 
neonates will deteriorate clinically with systemic acidosis, hypoxia and eventually leading 
to death. Neonates can be stabilized hemodynamically in the first days after birth by 
administration of prostaglandin E1, to maintain patency of the arterial duct ensuring 
sufficient pulmonary venous flow for mixing. In addition, a balloon atrial septostomy may 
be necessary to create an unrestrictive interatrial communication allowing adequate mixing 
between the systemic and pulmonary circulation.
Prenatal detection of TGA is of paramount importance as it may prevent hypoxia and 
acidosis early after birth thereby improving preoperative morbidity and mortality rates.1 
Ultimately, children with TGA need corrective cardiac surgery as only option for survival. A 
natural history study performed in California (1957-1964) showed that without intervention 
life expectancy in children with TGA is short and dependent on associated lesions: about 
30% and 52% of the patients die within the first week and first month after birth respectively, 
86% within 6 months and 89% within the first year of life.2
The arterial switch operation – Leiden history
The current surgery of choice is the arterial switch operation (ASO). Before mid-eighties, 
children with TGA were treated by the atrial switch operation (according to dr. W.T. (William) 
Mustard or dr. A. (Åke) Senning). This surgical approach is based on an atrial rerooting of 
the systemic and pulmonary venous blood, by constructing an intraatrial baffle, leaving the 
right ventricle in the position to sustain the systemic circulation and the left ventricle in the 
position to sustain the pulmonary circulation. However, the systemic right ventricle is not 
developed to pump against high systemic arterial vascular resistance for many years and 
will fail sooner or later causing heart failure and ventricular arrhythmias.3, 4 Furthermore, 
the complex intraatrial surgery of the atrial switch procedure is also complicated by sinus 
node dysfunction, atrial arrhythmias, baffle stenosis5 and baffle leakages during early-, 
General introduction
11
1mid- and long-term follow-up.
3, 6 These complications contribute to a high risk of reoperations, 
interventions and a limited life expectancy.3, 4, 6, 7
A significant milestone in congenital cardiac surgery was the introduction of a new 
surgical technique for TGA patients: the arterial switch operation (ASO). In Leiden, the ASO 
for the correction of TGA already started very early, only two years after the first successful 
ASO by dr. A.D. (Adib) Jatene in 1975.8 Leiden’s cardiothoracic surgeon prof. dr. A.G. (Gerard) 
Brom and the South African-born British cardiothoracic surgeon dr. D.N. (Donald) Ross 
performed the first ASO in a patient with TGA and VSD in May 1977 at the Academic Hospital 
Leiden. The ASO restores the ventriculoarterial concordance in such way that after repair 
the left and right ventricle support the systemic and pulmonary circulation respectively. 
During the ASO, the ascending aorta and pulmonary trunk are transected just above the 
commissures and relocated, leaving the semilunar valves and native roots in its original 
position. Consequently, the proximal part of the native pulmonary trunk becomes the neo-
aorta and the native aortic root becomes the neo-pulmonary trunk. The coronary arteries 
are harvested from the native aortic root and are also relocated to the neo-aortic root. In 
the classical ASO as described by dr. Jatene, the reconstruction of the neo-pulmonary trunk 
was performed by a conduit.
  Since the mid-eighties, after most high-volume surgical centers accomplished low 
perioperative mortality, the ASO technique replaced atrial switch operation worldwide. 
Leiden has played a role in this achievement, with its cardiothoracic surgeons prof. dr. Brom 
and prof. dr. J.M. (Jan) Quaegebeur as leading European pioneers and teachers of the ASO 
and other techniques in pediatric congenital heart surgery.9
TGA subtypes and surgical refinements to the ASO
There is a so far unexplained male predominance in TGA patients with a male to female 
ratio of approximately 2:1. TGA is usually an isolated lesion (65% of the cases) but may be 
associated with a ventricular septal defect (VSD), left ventricular outflow tract obstruction, 
and abnormalities related to the pulmonary valve (i.e. bi-leaflet, asymmetrical three-leaflet 
or stenotic valve) or the aortic arch. A slightly different TGA subtype, also amenable for ASO, 
is double outlet right ventricle (DORV) with subpulmonary VSD (i.e. Taussig-Bing anomaly), 
which is frequently associated with an aortic arch abnormality and/or aortic outflow 
obstruction. Moreover, there is a large variation of coronary artery patterns in TGA patients. 
The international nomenclature for the structural description of these variants and its 
course, irrespective of the position of the great arteries, has been simplified by the 
introduction of the Leiden Convention coronary coding system invented by the Leiden 
professor of Anatomy and Embryology dr. A.C. (Adriana) Gittenberger-de Groot.10
Certain coronary variants necessitate different surgical techniques of coronary artery 
transfer. These techniques developed over time, as did other refinements that were 
implemented to optimize ASO. An important improvement was the application of the 
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Lecompte maneuver developed by dr. Y (Yves) Lecompte and his colleagues.11 With this 
maneuver the pulmonary artery bifurcation is transferred to the front of the ascending 
aorta and made a direct reconstruction of the neo-pulmonary artery possible without the 
need of prosthetic conduits.11 As a result, an altered spatial great artery relationship and 
geometry of the thoracic (neo-)aorta remains after ASO with Lecompte maneuver (Figure 
1). Reconstruction of the neo-pulmonary artery after harvesting the coronary arteries is 




Figure 1. Representation of the great artery anatomy of the normal heart and the heart with transposition of 
the great arteries before and after the arterial switch operation.
Drawings by Gabriella Ricciardi - adapted and expanded after Prêtre et al. Lancet 2001;357:1826–30.
Normal heart (A); Transposition of the great arteries (B); Arterial switch operation (C). Note the anterior 
position of the pulmonary artery bifurcation over the ascending aorta after arterial switch operation and the 
translocation of the coronary arteries to the neo-aortic root (C). 1, sinus 1 or right-hand facing sinus; 2, sinus 2 
or left-hand facing sinus (according to the Leiden Convention coronary coding system); Ao, aorta; AoV, aortic 
valve; PA, pulmonary artery; PV, pulmonary valve.
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1Long-term outcome – the neo-aorta
From short- and mid-term follow-up studies after ASO9, 12-14 and mid- and long-term follow-
up studies of the atrial switch cohort,3, 6 we may now conclude that the step towards the 
ASO technique was a good decision. Over the years, early mortality rates decreased 
significantly to current rates less than 5% in large international pediatric cardiac surgical 
centers. The question remains how the long-term cardiovascular status of these patients 
develops, with the first patients now reaching the age of 40 years post-ASO.
Residual problems are recognized during follow-up. The overall surgical and percutaneous 
intervention rates for right-sided lesions varies from 11-28% between different 
studies.15-17 Less is known about the residual lesions and the need for interventions on the 
left side of the heart in the long-term. Neo-aortic root pathology plays a central role in the 
management of patients after ASO. Neo-aortic dilatation has been reported to be present 
in more than two-third of the patients but data on the progression of neo-aortic dilatation 
in adulthood are scarce and controversial.18-21 There are concerns about impairment of 
neo-aortic valve function over time and whether neo-aortic root dilatation may play a key 
role in this. Furthermore, aortic expansion also enhances branch pulmonary artery stenosis22 
and is associated with a more acute angulation of the reimplanted coronary arteries possibly 
increasing the risk of coronary malperfusion, ventricular dysfunction and even sudden 
cardiac death.23, 24
Neo-aortic valve repair with root reconstruction or even valve and/or root replacement 
is required when aortic complications progress. If valve replacement already needs to be 
done at very young age, the use of the autologous neo-pulmonary valve (the former aortic 
valve) is the preferred choice. This procedure for smaller children after ASO was first 
introduced by the Leiden cardiothoracic surgeon prof. dr. M.G. (Mark) Hazekamp and named 
this procedure the switch back Ross operation.25 Together with cardiothoracic surgeon dr. 
D.R. (David) Koolbergen he reported that redo neo-aortic surgery for neo-aortic valve and 
root pathology can be performed with low risk taking into account the specific technical 
difficulties.26 During these reoperations, remarkable thinning of the anterior wall of the 
ascending aorta was observed in many of these patients, located close to the level of the 
pulmonary artery embracement over the aorta after Lecompte maneuver.26
The course of neo-aortic root pathology in the long run is largely unknown and the 
contributors leading to neo-aortic valve and root problems are important to identify. 
In part I of this thesis, the unexplored questions regarding the long-term cardiovascular 
outcome and the fate of the neo-aortic valve and root are investigated. The incidence of 
adverse cardiovascular outcome, such as late death, presence of arrhythmias, coronary 
artery issues and the need for reoperations or catheter interventions are assessed in the 
cohort of the Center for Congenital Heart Disease Amsterdam-Leiden (CAHAL) with current 
43-year experience of ASO. Neo-aortic valve function and the course of neo-aortic root 
dilatation during long-term follow-up for the various morphological subtypes of TGA after 
ASO are studied longitudinally. Furthermore, fetal growth of the semilunar valves is 
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investigated in order to understand the origin of the differences between the  morphological 
subtypes of TGA (and with normal fetal semilunar growth), as starting point for the further 
course of neo-aortic valve and root growth beyond ASO. Finally, questions regarding the 
critical factor(s) for the neo-aortic root dilatation and impairment of neo-aortic valve function 
in the long-term are addressed.
Evaluation of thoracic aorta hemodynamics with 4D flow MRI 
The etiology of neo-aortic root pathology and anterior aortic wall thinning after ASO is not 
clear and the pathophysiological mechanisms leading to neo-aortic root dilatation have not 
been elucidated so far. The pulmonary root in the systemic circulation and the structural 
cell differences in the neo-aortic root wall itself, as described by the Leiden group,27, 28 have 
been reported previously as risk factors for dilatation.
Computational fluid dynamic model studies, simulating patient specific cardiac 
pathologies, have shown in vitro that altered hemodynamics can play a causative role in 
modelling of the heart and large blood vessels.29 The concept that altered blood flow 
patterns with altered local shear stress acting on the vessel wall in a reconstructed neo-aortic 
root after ASO for TGA may contribute to the development of root dilation is of importance. 
However, this has not been investigated so far.
Recently, four-dimensional flow magnetic resonance imaging (4D flow MRI) has been 
introduced as a novel non-invasive imaging tool that can be used for comprehensive in vivo 
assessment of blood flow in the large vessels.30 It provides information about the spatial 
and temporal distribution of vascular blood flow and enables the quantification of flow 
related hemodynamic parameters. Using this technique, it has been shown that altered 
blood flow hemodynamics like blood flow profile and wall shear stress cause remodelling 
of the large vessels and dilation of the aorta in patients with bicuspid aortic valve disease.31, 
32 The application of aortic 4D flow MRI can therefore be of great value for the evaluation 
of aortopathy in patients after ASO for TGA.
Leonardo da Vinci already demonstrated 500 years ago (~1507-1513) the flow patterns 
within the aortic root by his genius sketches (Figure 2A), presumably based on his 
observations from blood flow simulations in glass models with grass seeds suspended in 
water.33, 34 Da Vinci proposed that these observed vortical flow patterns in the aortic root 
aid in closure of the aortic valve and postulated that these secondary vortices do not occur 
more distal in the normal ascending aorta, where the flow is laminar.33 With the use of the 
advanced 4D flow MRI technology, we can now prove that the flow phenomena expressed 
in his sketches show a highly accurate representation of the actual flow patterns in the 
proximal ascending aorta (Figure 2A and 2B).
4D flow MRI enables us to gain new insights in the contribution of flow dynamics on the 
development of aortic disease (i.e. pathophysiology) or disease progression in genetic 




flow MRI technique is used to study on aortic hemodynamics in healthy volunteers and in 
TGA patients after ASO. Furthermore, the application of 4D flow MRI to assess aortopathy 
is explored in patients at risk for aortic problems such as patients with Marfan syndrome. 
Blood flow patterns and 4D flow MRI-derived parameters, regional aortic wall shear stress 
and aortic flow displacement, within the thoracic aorta are investigated to unravel aortic 
flow abnormalities and their relationship with altered aortic geometry which may be 
indicative for vascular wall remodeling and root dilatation. The aortic flow hemodynamics 
are evaluated in rest and during dobutamine-induced stress conditions.
Aim and outline of this thesis
The aim of this thesis is to investigate the prevalence and evolution of neo-aortic root 
pathology and surgical cardiovascular outcomes in patients after ASO for TGA in the long-
term. Secondly, thoracic aortic blood flow hemodynamics are investigated in relation to 
post-ASO geometry and root pathology with advanced non-invasive 4D flow cardiovascular 
MR imaging techniques.
Part I of the thesis focuses on the fate of the neo-aortic valve and the course of neo-aortic 
root dimensions during fetal development and long-term post-ASO with echocardiographic 
imaging. Risk factors for the impairment of the neo-aortic valve function are assessed and 
long-term cardiovascular outcomes such as the prevalence of late mortality and the need 
for reoperations and interventions are investigated.
Figure 2. Vortex patterns in the aortic root and the laminar flow downstream the ascending aorta by a 
schematic sketch from Leonardo da Vinci (A) and by streamline visualization from 4D flow MRI of the proximal 
part of ascending aorta (B).
Figure 2A. Detail of RL19083 verso, Blood flow through the aortic valve. Leonardo da Vinci, c.1512-13. – 
Courtesy by Royal Collection Trust / © Her Majesty Queen Elizabeth II 2020; Figure 2B. 4D flow MRI illustration 
derived from Chapter 9 of this thesis. Altered aortic 3D hemodynamics and geometry in pediatric Marfan 
syndrome patients. J Cardiovasc Magn Reson. 2017;19(1):30.
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Part II of the thesis describes the thoracic aortic blood flow hemodynamics from 4D flow 
MR imaging in relation to post-ASO geometry and its potential role in the contribution to 
neo-aortic root dilatation and aortic wall thinning. Prior to these studies, aortic blood flow 
in healthy volunteers is investigated to test reproducibility of the 4D flow MRI-derived wall 
shear stress parameter. In addition, to further explore the use of aortic 4D flow MR imaging 
in patients with dilative aortopathy, a 4D flow MRI study is performed in patients with Marfan 
syndrome to assess aortic geometry in relation to aortic wall shear stress.
Part I
Chapter 2 reports the long-term surgical outcomes after ASO for TGA performed in the 
Center for Congenital Heart Disease Amsterdam-Leiden (CAHAL), based on 43 years of 
experience and follow-up. Prevalence of reoperations and interventions, arrhythmias and 
late mortality are described and risk factors for reoperation and intervention are identified.
Chapter 3 addresses fetal semilunar valve growth in conjunction with short-term 
postoperative neo-aortic root dilatation.
Chapter 4 shows the neo-aortic growth, neo-aortic valve function and the need for 
reoperations on the neo-aortic valve and/or root during long-term follow-up for the various 
morphological subtypes of TGA after ASO. Moreover, risk factors for neo-aortic root 
dilatation and neo-aortic valve regurgitation are determined.
Chapter 5 demonstrates the effect of changing neo-aortic dimensions over time on the risk 
of neo-aortic valve regurgitation.
Part II 
Chapter 6 describes the scan-rescan validation and reproducibility study on the 
hemodynamic parameter wall shear stress derived from aortic 4D flow MR imaging in 
healthy volunteers. These data serve as reference data for the knowledge about variability 
of the hemodynamic parameter and to judge whether differences between patients and 
healthy volunteers or hemodynamic changes in patients over time or between rest-rest 
examinations represent true (patho)physiological differences.
Chapter 7 shows the altered ascending aorta hemodynamics in patients after ASO for TGA 
and the effect of differences in aortic geometry on hemodynamics.
Chapter 8 further delineates the abnormalities in aorta hemodynamics within the entire 
thoracic aorta after ASO by a rest versus dobutamine-stress comparison.
Chapter 9 describes the altered aorta hemodynamics and geometry in pediatric Marfan 
syndrome patients.
In Chapter 10 the results of all studies from this thesis are summarized and clinical 
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The objective of this study was to assess our 43-year experience with arterial switch 
operation (ASO) for transposition of the great arteries (TGA) by analyzing cardiac outcome 
measures (hospital and late mortality, reoperations and catheter interventions, significant 
coronary artery obstruction) and to identify risk factors for reoperation and catheter 
interventions.
Methods 
A total of 490 patients who underwent ASO for TGA from 1977 to 2020 were included in this 
retrospective, single center study. Data on reoperation and catheter intervention of hospital 
survivors were estimated by the Kaplan-Meier method and compared using a long-rank 
test. Risk factors for reoperation and/or catheter intervention were assessed by multivariate 
Cox regression analysis.
Results
Hospital mortality occurred in 43 patients (8.8%), late death in 12 patients (2.9%) and 43 
patients were lost to follow-up. Median follow-up time of 413 hospital survivors was 15.6 
(interquartile range 7.0-22.4) years. Reoperations were performed in 83 patients (117 
reoperations). Neo-aortic valve regurgitation with root dilatation was the second most 
common indication for reoperation (15/83 patients, 18.1%) after right ventricular outflow 
tract obstruction (50/83 patients, 60.2%). Risk factors for any reoperation on multivariable 
analysis were: TGA morphological subtype [TGA with ventricular septal defect: hazard ratio 
(HR) = 1.99, 95% confidence interval (CI) 1.18-3.36, P = 0.010 and TBA: HR = 2.17, 95% CI 
1.02-4.64, P = 0.045], aortic arch repair associated with ASO (HR = 3.03, 95% CI 1.62-5.69, P 
= 0.001), and a non-usual coronary artery anatomy (HR = 2.41, 95% CI 1.45-4.00, P = 0.001). 
One hundred and one catheter interventions were performed in 54 patients, usually for 
relief of supravalvular pulmonary stenosis (44/54 patients, 81.5%) or arch obstruction (10/54 
patients, 18.5%). Main risk factor for catheter intervention on multivariable analysis was 
aortic arch repair associated with ASO (HR = 2.95, 95% CI 1.37-6.36, P = 0.006). Significant 
coronary artery stenosis was relatively uncommon (9/413 patients, 2.2%) but may be 
underrepresented.
Conclusions
Patients after ASO typically have good long-term clinical outcomes but reoperations and 
interventions remain necessary in some patients. Neo-aortic valve regurgitation with root 
dilatation is the second most common indication for reoperation after right ventricular 
outflow tract obstruction and an increasing need for neo-aortic valve and root redo surgery 
in future is to be expected.




For more than forty years, the arterial switch operation (ASO) is the standard surgical 
treatment for transposition of the great arteries (TGA). Surgical results with low perioperative 
mortality over the last decades have now led to focus on the long-term outcomes. Health 
condition and quality-of-life assessments recently showed that most adult patients perceive 
normal functional health status, similar to healthy peers.1 Cardiovascular outcome and 
survival from mid- and long-term follow-up studies are based on data from 20- up to 30-year 
post-ASO. In these reports residual lesions are reported such as supravalvular pulmonary 
stenosis,2-4 neo-aortic root dilatation, neo-aortic valve insufficiency5, 6 and coronary artery 
problems.7-9 The purpose of this study was to assess our 43-year experience with ASO and 
to determine late mortality and morbidity, including coronary artery stenosis, arrhythmias 
and cardiac device implantations, as well as the need for reoperation and catheter 




Patients who underwent ASO for TGA at the Leiden University Medical Center, Leiden, 
between January 1977 and January 2020 were included in this study. TGA subgroups based 
on anatomic differences included: TGA with intact ventricular septum (TGA-IVS); TGA with 
ventricular septal defect (TGA-VSD) and double outlet right ventricle with subpulmonary 
VSD (i.e. Taussig-Bing anomaly, TBA). Data on demographics, morphologic and surgical 
details, reoperations, catheter interventions, coronary artery problems, atrial or ventricular 
arrhythmias, the need for cardiac devices (pacemaker and implantable cardioverter-
defibrillator) and mortality were collected from hospital and outpatient records. Hospital 
mortality was defined as death occurring before hospital discharge; late mortality was 
defined as death after hospital discharge. Reoperations and catheter interventions were 
subdivided in early (<30 days post-ASO) and late reoperations/interventions (>30 days post-
ASO). Re-explorations for perioperative complications (e.g. for bleeding) were not included. 
Catheter ablations for arrhythmias were not included as catheter intervention but were 
reported separately. Rhythm disorders after hospital discharge were assessed. Left 
ventricular outflow tract obstruction was included as a separate variable; patients with 
TGA-VSD and (sub)pulmonary stenosis were only included when ASO had been performed 
(n = 4) and were classified into the TGA-VSD group. The local Committee for Medical Ethics 
of the Amsterdam and Leiden University Medical Centers approved the study and waived 
the need for informed consent. Data collection was completed in January 2020.
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Surgical procedure
A description of the ASO procedure in our center and indications for two-stage correction 
for TGA have been reported previously:10 coronary artery translocation was performed by 
the button technique whenever feasible or by trap-door technique otherwise. In case of 
posterior common ostium (Yacoub types B and C), the technique as described by Yacoub 
was used.11 The neo-pulmonary artery was reconstructed by using a pantaloon-shaped 
patch of fresh autologous pericardium. The Lecompte maneuver has been applied whenever 
possible since 1981; before that time, a classical Jatene procedure with implantation of a 
conduit between the right ventricle and pulmonary artery (PA) was performed. A Lecompte 
procedure was avoided when a side-to-side relationship of the great arteries was found, as 
this would lead to stretching and narrowing of the left PA. VSDs were closed via the right 
atrium or the aortic valve, and in TBA, the approach to the VSD was often from multiple 
sides sometimes including a limited right ventriculotomy. Arch repair was only by extended 
side-to-side anastomosis when a discrete coarctation was present; in all other cases, the 
arch was repaired with a xenopericardial curved patch which has the additional advantage 
of a better fit to the wider PA base.
Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics 23.0. Clinical characteristics 
were presented as frequency (%) for categorical variables or as median (interquartile range, 
IQR or range). The normality of the distribution was tested using the Shapiro-Wilk test. 
Differences in frequencies of baseline characteristics and outcome parameters between 
TGA subgroups were assessed by the Fisher-Freeman-Halton exact test. A Kruskal-Wallis 
test was performed to test for differences in continuous data between the TGA subgroups. 
Primary outcome parameters were reoperations and catheter interventions. Secondary 
outcome parameters were hospital and late mortality, arrhythmias and coronary artery 
problems.
Kaplan-Meier analyses were performed to estimate overall survival and reoperation and 
catheter intervention-free survival of hospital survivors, and to estimate differences in 
reoperation rate and type based on era. Patients with late mortality, without having had 
reoperation (7/12 patients) or catheter intervention (10/12 patients) before death occurred, 
were censored at the age of death in this analysis (considering late death as competing risk 
resulted in similar percentages of freedom from reoperation/catheter intervention). The 
log-rank test was used to test for differences between intervention-free (reoperation, 
catheter intervention or both) survival curves among morphological TGA subtypes. A Cox 
regression model was used to assess the independent predictive values of different variables 
on primary outcome measures reoperation and/or catheter intervention, resulting in cause-
specific hazard ratios (HRs) for the variables. Risk factors known from literature and potential 
explanatory variables were entered into the equation at the same time. Included risk factors 
from literature were: ‘TGA morphological subtype’; ‘arch abnormality’, for which surgical 
repair was performed; ‘left ventricular outflow tract obstruction’; PA banding prior to ASO, 
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‘prior PA banding’; ‘coronary artery anatomy’, divided in 2 categories: (1) usual coronary 
artery anatomy: 1LCx-2R, 1L-2CxR and 1L-2R,no Cx and (2) non-usual coronary artery anatomy: 
other than (1); ‘weight at ASO’. Potential explanatory variables included in the models were: 
‘sex’; use of ‘Lecompte maneuver’ with the ASO. A P value <0.05 (two-sided) was considered 
statistically significant.
Results
Patient characteristics and hospital mortality
During the study period, 490 patients underwent ASO. Thirty-four overseas patients were 
lost to follow-up. Hospital mortality was 8.8% (43 patients), highest from 1977 to 1987, and 
decreased to 3.3% between 2000 and 2020. Baseline patient characteristics of remaining 
413 hospital survivors with follow-up are shown in Table 1. The morphological TGA subtypes 
were: TGA-IVS in 258 (62.5%), TGA-VSD in 117 (28.4%) and TBA in 38 (9.2%) patients. Arch 
anomalies for which surgical repair before or during ASO was necessary were present in 35 
(8.5%) patients and consisted of hypoplastic aortic arch with (n = 25) or without (n = 2) 
coarctation, interrupted aortic arch (n = 7) and double aortic arch with coarctation (n = 1) 
(Table 1). The majority of the arch abnormalities were present in TBA patients (n = 18, 47.4%), 
in 14 (12.0%) of the TGA-VSD patients and in 3 (1.2%) of the TGA-IVS patients (P = 5.5*10-16). 
Left ventricular outflow tract obstruction was not equally distributed across the TGA 
subgroups and present in 5 (13.2%) of the TBA patients, in 10 (8.5%) of the TGA-VSD patients 
and in 1 (0.4%) of the TGA-IVS patients (P = 3.0*10-6). Median age at ASO was 8 days for the 
patients who underwent one-stage ASO. Forty-two patients had prior surgery before ASO 
(i.e. two-stage ASO). Median follow-up was 15.6 (IQR 7.0-22.4) years post-ASO, with a 
maximum follow-up of 41.1 years.
Late mortality
Twelve patients died late during follow-up (2.9%). Median age of death was 10.6 (IQR 0.9-
21.9) years. TGA morphology in these patients was as follows: TGA-IVS in 3 (1.2%), TGA-VSD 
in 5 (4.3%) and TBA in 4 (10.5%) patients (P = 0.006). In 7 patients, the exact cause of death 
could not be retrieved retrospectively. Causes of mortality of the other patients were: 
recurrent Staphylococcus Aureus endocarditis of a Bentall prosthesis with severe neurological 
complication (n = 1, age 27.9 years); lymphocytic myocarditis with sudden cardiac death (n 
= 1, age 22.8 years); acute cardiac failure after PA embolism from a calcified in-stent 
vegetation by catheter intervention (n = 1, age 19.0 years); cardiac failure after reoperation 
for right ventricular outflow tract (RVOT) obstruction (RVOTO) (n = 1, age 0.4 years); and 
mediastinitis after pacemaker implantation (n = 1, age 0.2 years). The overall survival rate 
of the ASO hospital survivors was 97.9% at 10 years, 97.3% at 20 years and 94.5% at 30 and 
40 years; the survival curve was significantly different between TGA subgroups (P = 0.005) 
(Figure 1).
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Table 1. Demographics and pre-operative anatomy
Study cohort  TGA-IVS   TGA-VSD   TBA   P value
n = 413  n = 258
(62.5%)
  n = 117 
(28.3%)
  n = 38
(9.2%)
Male, n (%) 280 (67.8)  184 (71.3)   72 (61.5)   24 (63.2)   0.133
Age follow-up, yrsa 15.6 (0.1-41.1)  15.7 (0.1-40.1) 15.8 (0.2-41.1) 12.3 (0.1-36.3)   0.661
Age follow-up, yrsb 15.6 (0.1-45.8)  15.7 (0.1-40.6) 15.8 (0.2-45.8) 12.4 (0.1-36.9)   0.706
Coexisting findings, n (%)
Arch abnormality 35 (8.5)  3 (1.2)   14 (12.0)   18 (47.4)   5.5*10-16
Bicuspid pulmonary valve 27 (6.5)  16 (6.2)   10 (8.5)   1 (2.6)   0.337
LVOTO 16 (3.9)  1 (0.4)   10 (8.5)   5 (13.2)   3.0*10-6
Coronary anatomy, n (%)c
Usual (1LCx-2R, 1L-2CxR, 
1L-2R-noCx)
341 (82.6)  224 (86.8)   94 (80.3)   23 (60.5)   3.1*10-4
Other 67 (16.4)  31 (12.0)   21 (17.9)   15 (3.9)
Unknown 5 (1.2)  3 (1.2)   2 (1.7)   0 (0)
Intramural course of LAD 12 (2.9)  8 (3.1)   4 (3.4)   0 (0)   0.812
Pre-operative procedures, n (%)
Balloon atrial septostomy 216 (52.3)  151 (58.5)   57 (48.7)   8 (21.1)   4.0*10-5
Previous PAB 30 (7.2)  11 (4.3)   15 (12.8)   4 (10.5)   0.007
Arterial switch operation
One-stage, n (%) 371 (89.8)  246 (95.3)   94 (80.3)   31 (81.6)   1.0*10-5
   median age (range) 8 d
(0 d-0.9 yrs)
 7 d
(0 d-0.5 yrs) 
  11 d
(1 d-0.9 yrs)
  23 d
(4 d-0.6 yrs)
  9.2*10-13
Two stage, n (%) 42 (10.2)  12 (4.7)   23 (19.7) 7 (18.4)   1.0*10-5




  238 d
 (46 d-12.7 yrs)
286 d
 (32 d-1.7 yrs)
  0.256
Lecompte maneuver, n (%) 376 (91.0)  243 (94.2)   108 (92.3)   25 (65.8)   2.1*10-7
a Median age (range) post-ASO; b Median age (range) post-birth; c Coronary anatomy description according to 
the Leiden Convention coronary coding system. P values based on Fisher-Freeman-Halton exact test for 
frequencies and Kruskal-Wallis test for median values of continue data.  d, days; IVS, intact ventricular septum; 
L or LAD, left anterior descending coronary artery; LVOTO, left ventricular outflow tract obstruction; PAB, 
pulmonary artery banding; R, right coronary artery; TBA, Taussig-Bing anomaly; TGA, transposition of the great 
arteries; VSD, ventricular septal defect; yrs, years.
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Arrhythmias, ablation and cardiac devices
Conduction disorders or late arrhythmias appeared in 26 patients post-ASO (6.3%). Details 
are presented in supplementary Table S1. In short, 8 patients had a complete atrioventricular 
block requiring pacemaker implantation (2 after reoperation). Eight patients presented with 
ventricular tachyarrhythmias at a median follow-up of 15.4 (IQR 12.3-18.5) years post-ASO. 
Supraventricular arrhythmias were diagnosed in 12 patients at a median age of 17.8 (IQR 
8.1-24.1) years.
Reoperations
In total, 117 reoperations (137 procedures) were performed in 83 patients (20.1%) (Table 
2). Twenty-two patients needed 2 or more reoperations (Figure 2). Seven reoperations were 
performed within 30 days post-ASO (1.6%, 7/447 patients). Median age at reoperation was 
2.0 (IQR 0.3-7.1) years post-ASO. Distribution of TGA morphology among patients who 
underwent reoperation was: TGA-IVS in 32 (32/258, 12.4%), TGA-VSD in 32 (32/117, 27.4%) 
and TBA in 19 (19/38, 50.0%) patients and reoperation-free survival differed significantly 
between TGA subgroups (P = 6.5*10-10) (Figure 3A). Overall freedom from reoperation for 
the entire TGA population was 85% at 5 years, decreasing to 81%, 79%, 76%, 75%, 71% and 
71% at 10, 15, 20, 25, 30 and 35 years after ASO, respectively (Figure 3A).
The most common indication for reoperation was RVOTO (n = 50, 68 procedures) (Table 
2). A hybrid procedure with intraoperative stent implantation for relief of PA branch stenosis 
was performed in 7 of 50 patients. Median age at reoperation for RVOTO was 1.3 (IQR 0.3-
4.5) years. Twenty-two of these patients had TGA-IVS (8.5%), 15 TGA-VSD (12.8%) and 13 
TBA (34.2%) (P = 2.2*10-4).





















TGA-IVS 258  211  175  137    90    47     20      6     1
TGA-VSD  117   94    77    64     38    19     12      6     1
Taussig Bing  38    28    23    18     10     7       5       1     0
All
Log-rank test P=0.005
Figure 1. Kaplan-Meier estimates of overall survival of ASO hospital survivors by TGA morphology subgroups
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Table 2. Reoperation and catheter intervention procedures
Reoperation (n = 83) No. procedures (%) 
137 procedures / 117 reoperations
No. patients
RVOTO relief 68 (49.6) 50
Neo-aortic valve & root surgery 21 (15.3) 15 
    Neo-aortic valve plasty 1 
    Neo-aortic valve replacement 3
    Bentall operation 12 
    David operation 2 
    Switchback Ross 1 
    Replacement ascending aorta 2
Coronary revascularisation 8 (5.8) 8
    Ostial plasty 4
    CABG 4
Relief arch obstruction 12 (8.8) 12
LVOTO relief 4 (2.9) 4
Miscellaneous* 24 (17.5) 22
Catheter intervention (n = 54) No. procedures (%)
104 procedures / 101 interventions
No. patients
Relief supravalvular PS 80 (76.9) 44
  Balloon angioplasty**   27
     MPA 5
     RPA 8
     LPA 5
     Bilateral PA       9
  Stent implantation 39
     MPA only     1
     RPA only    13
     LPA only   11
     Bilateral PA 13
     MPA+RPA  1
Relief arch obstruction 15 (14.4) 10
Balloon angioplasty 14 
Stent implantation 1 
Coronary artery intervention 2 (1.9) 2
PTCA 1
Stent implantation 1 
Neo-aortic valve intervention 1 (1.0) 1
TAVI 1
Closure shunts 6 (5.8) 5
Atrial septal defect 5
Aorta-pulmonary collaterals 1
* AV-valve plasty (n = 11), closure residual ASD/VSD (n = 5), relief supravalvular aortic stenosis (n = 1), relief 
MPA aneurysm (n = 3), relief pulmonary vein obstruction (n = 1), pulmonary artery endarterectomy (n = 1). 
** dilatation of native/in-stent PA (branch) stenosis. CABG, coronary artery bypass graft; LPA, left pulmonary 
artery; LVOTO, left ventricular outflow tract obstruction; MPA, main pulmonary artery; PA, pulmonary artery; 
PS, pulmonary stenosis; PTCA, percutaneous transluminal coronary angioplasty; RPA, right pulmonary artery; 
RVOTO, right ventricular outflow tract obstruction; TAVI, transcatheter aortic valve implantation.
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Neo-aortic valve, root or ascending aorta reoperations for neo-aortic valve insufficiency 
and/or root dilatation were performed 15 patients (3.6%) and include 18% of all reoperations 
(21/117 reoperations). Median age at reoperation for these indications was 15.7 (IQR 11.4-
20.0) years post-ASO. Ten patients underwent a Bentall operation, 2 patients had a valve-
sparing root replacement, 1 patient had neo-aortic valve repair followed by later valve 
replacement, 1 patient underwent replacement of the neo-aortic root/ascending aorta by 
a supracoronary tubular prosthesis and in 1 patient, a switch back Ross operation was 
performed. Seven of these patients had TGA-IVS (2.7%), 5 TGA-VSD (4.3%) and 3 TBA (7.9%) 
(P = 0.193).
Aortic arch repair after ASO was necessary in 12 of the 83 reoperated patients (14.5%) 
and consisted of either reoperations for recoarctation (in 7 patients, after ASO with arch 
repair) or reoperations for neo-coarctation (in 5 patients; i.e. aortic coarctation following 
ASO in patients who were not diagnosed with coarctation before or during initial ASO).
Reoperations for coronary artery problems were needed in 8 patients (1.9%) at median 
age of 11.5 (IQR 1.0-24.1) years. Patient-specific and surgical characteristics are summarized 
in supplementary Table S2. Number of coronary artery reoperations differed significantly 
between TGA subgroups: 2 patients had TGA-IVS (0.8%), 2 TGA-VSD (1.7%) and 4 TBA (10.5%) 
(P = 0.004). Usual coronary artery anatomy (1LCx-2R) was present in 4 patients (50%).
Era-specific impact on reoperation rate and common reoperation types could not be 
detected, except for aortic arch repair due to recoarctation (supplementary Figures S1-S3). 
Patients who have been operated on for TGA with arch obstruction in the era ‘1977-1989’ 
were more likely to require an aortic arch reoperation for recoarctation compared to patients 
with ASO and aortic arch repair performed in later eras (P=0.005; supplementary Figure S3).
Univariable Cox regression analysis showed following factors associated with reoperation 
for any indication: TGA morphological subtype (TGA-VSD and TBA), weight at ASO, aortic 
arch repair associated with ASO, not having had a Lecompte maneuver and a non-usual 





















Figure 2. Histogram on the number of reoperations and catheter interventions
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Figure 3. Kaplan-Meier estimates of freedom from reoperation (A), catheter intervention (B) and both 
reoperation and catheter intervention (C) by TGA morphology subgroups. 
IVS, intact ventricular septum; TGA, transposition of the great arteries; VSD, ventricular septal defect.



























TGA-IVS 258   193   153   117     75     33      16      3
TGA-VSD   117    76      55    44      24     13       7       2
Taussig Bing  38     15      12    10       6       6        5       1
All
Log-rank test P=6.5x10-10





























TGA-IVS 258   202  164  128    80    42     20     6      0
TGA-VSD  117    86     71    56    30    15     11      5     1
Taussig Bing  38     23     19    14      9     7       4      1      0
All
Log-rank test P=1.2x10-4
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coronary artery anatomy. On multivariate analysis, TGA morphological subtype (TGA-VSD: 
HR = 1.99, 95% confidence interval (CI) 1.18-3.36, P = 0.010 and TBA: HR = 2.17, 95% CI 1.02-
4.64, P = 0.045), aortic arch repair associated with ASO (HR = 3.03, 95% CI 1.62-5.69, P = 
0.001) and a non-usual coronary artery anatomy (HR = 2.41, 95% CI 1.45-4.00, P = 0.001) 
were identified as independent risk factors for reoperation (supplementary Table S3).
Catheter interventions
In total, 101 interventions were performed in 54 patients (13.1 %) (Table 2). Twenty-eight 
patients needed 2 or more interventions (Figure 2). Median age at first catheter intervention 
was 3.7 (IQR 1.3-12.8) years. Distribution of TGA morphology among patients who underwent 
catheter interventions was: TGA-IVS in 25 (25/258, 9.7%) patients, TGA-VSD in 17 (17/117, 
14.5%) patients, TBA in 12 (12/38, 31.6%) patients and reoperation-free survival differed 
significantly between TGA subgroups (P = 1.2*10-4) (Figure 3B). Overall freedom from catheter 
intervention for the entire TGA population was 92% at 5 years, decreasing to 91%, 88%, 84%, 
83%, 81% and 78% at 10, 15, 20, 25, 30 and 35 years after ASO, respectively (Figure 3B).
 The major indication for catheter intervention was relief of RVOTO (n = 44, 80 
procedures). In 39 patients (9.4%), 1 or more stent implantation(s) in the PA system were 
performed to treat supravalvular pulmonary stenosis (including aforementioned 
intraoperative stent implantations in 7 patients). Distribution of TGA morphology among 
patients with stent implantations was: TGA-IVS in 21 (21/258, 8.1%) patients, TGA-VSD in 13 
(13/117, 11.1%) patients and TBA in 5 (5/38, 13.2%) patients (P = 0.413). One patient received 
a transcatheter pulmonary valve implantation (Melody®) in neo-pulmonary valve position.
Balloon angioplasty for aortic recoarctation was performed in 10 patients. Catheter 
interventions for significant coronary artery stenosis were done in 3 patients. As summarized 
in supplementary Table S2, percutaneous transluminal coronary angioplasty was performed 
in 2 patients (prior to or after coronary revascularization); in 1 patient, a drug-eluding stent 
was implanted for left anterior descending coronary artery ostial stenosis. A transcatheter 
aortic valve implantation (TAVI) was performed in a single TBA patient (with monocoronary 
ostium) for recurrent severe neo-aortic valve regurgitation, 1.5 year after a valve-sparing 
root replacement. Although originally developed for the treatment of aortic stenosis, TAVI 
has emerged as a viable alternative to surgical aortic valve replacement for patients with 
pure aortic regurgitation with a high-risk profile for surgery. Furthermore, this technique 
has proven to be technically feasible and successful for severe aortic regurgitation after 
David valve-sparing root replacement. With the large experience of TAVI for pure aortic 
regurgitation in our center and the patient’s explicit wish to be treated via transcatheter 
procedure, TAVI was chosen over redo surgery.
Univariable Cox regression analysis showed following factors associated with catheter 
intervention: TGA morphological subtype (TBA), aortic arch repair associated with ASO and 
a non-usual coronary artery anatomy. On multivariable analysis, aortic arch repair associated 
with ASO (HR = 2.95, 95% CI 1.37-6.36, P = 0.006) was identified as independent risk factor 
for catheter intervention (supplementary Table S4).
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Risk factors for any intervention - reoperations or catheter interventions
Of the 413 survivors with follow-up, 302 patients did not receive any reoperation or catheter 
intervention (73.1%) during follow-up (Figure 4). One hundred and eleven patients (26.9%) 
underwent at least 1 reoperation or catheter intervention; 26 patients (6.3%) underwent at 
least both a reoperation and catheter intervention. Distribution of the 111 patients over the 
TGA subgroups was: TGA-IVS in 46 (17.8%), TGA-VSD in 41 (35.0%), TBA in 24 (63.2%) patients 
and the combined reoperation/catheter intervention-free survival differed significantly 
between TGA subgroups (P = 2.5*10-12) (Figure 3C). Overall freedom from reoperation or 
catheter intervention for the entire TGA population was 81% at 5 years, decreasing to 76%, 
73%, 65%, 63%, 61% and 61% at 10, 15, 20, 25, 30 and 35 years after ASO, respectively (Figure 
3C).
Risk analysis for the need of any reoperation(s) or catheter intervention(s) is presented 
in Table 3. TGA morphological subtype (TGA-VSD and TBA), aortic arch repair associated 
with ASO, weight at ASO, not having had a Lecompte maneuver, prior PA banding and a 
non-usual coronary artery anatomy were univariable risk factors for the risk of reoperation 
or catheter intervention. Independent risk factors for either reoperation or catheter 
intervention for all indications were TGA morphological subtype (TGA-VSD: HR = 1.84, 95% 
CI 1.18-2.89, P = 0.008), aortic arch repair associated with ASO (HR = 3.72, 95% CI 2.13-6.50, 




















Figure 4. Flow diagram of reoperations and catheter interventions in ASO hospital survivors.
ASO, arterial switch operation
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Discussion
This study evaluated the long-term cardiac outcome in an ASO cohort with one of the longest 
reported follow-up and focussed on late mortality, reoperations and catheter interventions, 
coronary problems and late arrhythmias. During 43-year experience of ASO overall survival 
significantly improved over time, with a late mortality of 2.9% and a decline in hospital 
mortality to 3.3% for the past 2 decades. The need for 1 or more reoperations and 1 or more 
catheter interventions was 20% and 13%, respectively, and most reoperations and 
interventions were performed for RVOT problems. A more complex TGA morphology (TGA-
VSD), aortic arch repair associated with ASO, and the presence of a non-usual coronary 
artery anatomy were found to be independent risk factors for the need for reoperation or 
intervention for any indication.
In 4 decades of ASO, a significant decrease in perioperative mortality to rates below 5% 
in high-volume cardiothoracic surgical centers has been achieved.2, 12, 13 Although survival 
has greatly improved, recurrent and new lesions remain and require reoperations or 
catheter interventions. The reoperation rate in this study was 20% which is relatively high 
compared to other studies. These studies reported reoperation rates between 5% and 20%, 
but with shorter duration of follow-up.12-17 Reoperation rates between studies may vary 
depending on the complexity of the included TGA patients (TGA-VSD and TBA included or 
not). Moreover, our early adoption of ASO (1977) has probably influenced the number of 
reinterventions. With longer follow-up, it is expected that more patients will need a 
reoperation or catheter intervention, confirmed by the 11% reoperation rate beyond 
childhood in a study of adult TGA patients post-ASO.17
Right ventricular outflow tract procedures
RVOT problems are the most common indication for reoperations or catheter interventions 
and often occur in the first years after ASO, as already known from short- and intermediate-
term follow-up studies.2-4 Our data are in line with these reports, with a median age of 1.3 
(IQR 0.3-4.5) years at the time of first RVOT reoperation. The overall surgical and 
percutaneous intervention rates for RVOTO varied from 5 to 28% between the different 
studies with at least 20-year follow-up,2-4, 14-16 which is also similar to the results of this study.
Approximately 75% of the reoperations and all catheter interventions for RVOTO were 
performed for supravalvular obstruction in this study. Anatomical and surgical components 
may play a role in the development of PA stenosis. Patients with concomitant aortic arch 
obstruction (often TBA patients) are at increased risk for RVOTO.18, 19 Moreover, the surgical 
technique and the material used for PA reconstruction, application of Lecompte maneuver, 
extent of mobilization of the PAs, and the age at operation impact the risk of RVOTO.2-4
Balloon angioplasty for supravalvular pulmonary stenosis is the least invasive option but 
usually has limited effect and stent implantation is eventually required in most cases, 
preferably performed at an older age. Although we have not seen complications of branch 
PA stenting after ASO (first procedures 1994), these procedures should be performed with 
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restraint because severe complications such as coronary artery compression and especially 
aortic erosion and aorto-pulmonary fistulas have been reported.20
Neo-aortic reoperations
Twenty-one surgical procedures and 1 catheter intervention for neo-aortic valve regurgitation 
and/or root dilatation were performed in 15 patients (3.6%), approximately 20% of all 
reoperations. It is the second most common indication for reoperation, as has been reported 
in other studies with long follow-up duration.12, 16 The main indication for neo-aortic root 
reoperation in this study was root dilatation with or without significant neo-aortic 
regurgitation.6, 21 In two-thirds of cases, surgery was performed in the last decade (2009-
2020). Although the total amount of reoperations on the neo-aortic valve/root is still low 
and comparable to other surgical centers,15, 16, 22 we expect that with longer follow-up this 
may increase. Longitudinal follow-up studies on the neo-aortic valve function confirm this 
concern as root dilatation progresses over time and proved to be an independent risk factor 
for neo-aortic valve impairment.5, 6 Recently, we showed in a subset of this cohort that 14% 
of patients had developed root diameters ≥40 mm, with moderate neo-aortic regurgitation 
in about 25% of them and one-quarter of these patients being below 18 years of age.6
Thresholds for root replacement in TGA patients after ASO are adapted from international 
guidelines on bicuspid aortic valve and connective-tissue disease-related aortopathy and 
are based on absolute diameters. No aortic dissections or ruptures have been reported 
after ASO to date. In our center root replacement is indicated if the neo-aortic root diameter 
reaches 55 mm according to the guidelines,23 and at smaller sizes if significant neo-aortic 
valve regurgitation is present or if root diameter has rapidly progressed over time. A Bentall 
operation has been performed in most patients,6, 21 but valve-sparing operation should be 
considered whenever possible.
Coronary artery lesions
In our series, coronary artery reoperations or interventions for partial or total occlusion 
were required in only 9 patients (2.2%), suggesting that coronary problems do not frequently 
occur during follow-up so far. Moreover, late mortality was not related to acute coronary 
artery problems in the patients with identified causes of death. One patient had a near-fatal 
ventricular fibrillation due to ischemia based on coronary ostial stenosis. These findings are 
in line with the results of a systematic review on sudden cardiac death due to coronary 
complications late after ASO (at least more than 5 years).24 From that review, sudden cardiac 
death was extremely rare with only a few possible cases and no proven cases of coronary 
artery-related sudden death. In our center, we do not systematically perform coronary 
surveillance imaging during childhood which might have influenced numbers of coronary 
artery problems. In general, children with complex coronary morphology or those with 
intraoperative difficulties of coronary artery transfer receive coronary computed tomography 
angiography (CTA) in the first year after ASO. Furthermore, patients undergo exercise tests 
in childhood and all asymptomatic patients underwent a coronary CTA at least once in early 
adolescence.25
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The detection of coronary artery abnormalities in the patients who underwent 
intervention was based on symptoms, abnormal findings from echocardiography or an 
accidental finding by a surveillance CTA or catheter coronary angiography (all representing 
one-third of the causes of detection). Treatment for partial or total coronary occlusion was 
performed by either ostial plasty or by coronary artery bypass graft. Taussig-Bing anomaly 
patients had the highest prevalence of coronary artery reoperations in this study (4/38 
patients, 10.5%). Remarkably, all coronary reoperations in this subgroup were performed 
during childhood, unlike most coronary procedures in the patients with other TGA subtypes. 
Given the small number of coronary reoperations, it is unclear whether TBA patients are at 
increased risk or whether this is related to the prevalent non-usual coronary artery pattern 
in TBA. Although abnormal coronary artery patterns have been reported as risk factor for 
early coronary artery obstruction,8, 9, 26 it is suggested that the acquired coronary anatomy 
after ASO may be more important as a risk factor for late coronary artery obstruction.27 
Correspondingly, half of the patients necessitating coronary reoperation from this study 
had a usual coronary artery pattern without problems during coronary artery transfer. 
Acquired abnormal coronary anatomy may result from the surgically created pattern after 
reimplantation and changes by growth, arterial distortion or root dilatation.25, 27
Risk factors for reoperation, intervention or combined
Independent risk factors for reoperation in this study were: TGA morphological subtype 
(TGA-VSD), aortic arch repair associated with ASO and a non-usual coronary artery anatomy. 
More complex TGA anatomy have been reported to be a risk factor for reoperation in 
previous studies.12-14 Not surprisingly, aortic arch repair associated with ASO was reported 
as independent risk factor for surgical or catheter reintervention. A higher rate of 
reinterventions was previously described in TGA patients with arch obstruction by our 
group18 and in other large series as well,12, 19, 22 particularly indicated for right-sided 
obstructions next to residual arch obstruction. A non-usual coronary artery anatomy showed 
to be an independent risk factor for both reoperation and any reoperation or intervention 
for any indication in this study. Vargo et al.28 hypothesized that this could be related to the 
fact that an abnormal coronary artery anatomy sometimes requires an unusual 
reconstructive technique to avoid compression of the coronary artery button. However, we 
were not able to prove this in our series. Differences in reoperation rate or type based on 
era of ASO could not be detected in this series, except for aortic arch reoperation due to 
recoarctation. Although these are relatively small numbers, patients operated on for TGA 
with arch obstruction in the early years after start of the ASO program (era ‘1977-1989’) 
were more likely to require an aortic arch reoperation for recoarctation compared to patients 
operated on in later eras.
Rhythm disorders 
Arrhythmias requiring ablative therapy or device implantation are fairly uncommon after 
ASO in this study, which is in concordance with other studies.12, 14 Most sustained ventricular 
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arrhythmias are related to coronary ischemia or post myocardial infarction necessitating 
preventive ventricular tachycardia ablation or implantable cardioverter-defibrillator 
implantation and, if present, relief of coronary artery obstruction. Supraventricular 
tachycardia episodes are usually more prevalent in the newborn period and directly after 
ASO and only very rarely occur later, as was also shown in this study. Pacemaker need for 
atrioventricular block was low and related to VSD closure (in TGA-VSD and TBA) from early 
surgical eras (before 2000).
Limitations
Limitations of this study are related to the retrospective design from a single center. The 
prevalence of coronary artery stenosis or occlusion identified in this study may be 
underestimated because coronary surveillance imaging by CTA or coronary angiogram was 
not performed routinely in all cases.
Conclusion
Patients after ASO typically have good clinical outcomes in the long term but reoperations 
and interventions remain necessary in some patients. Right ventricular outflow tract 
problems are the main indication for surgical and percutaneous interventions with neo-
aortic valve or root reoperations as second most common reoperation indication. More 
complex TGA anatomy (TGA-VSD and TBA), aortic arch repair associated with ASO and non-
usual coronary artery anatomy were independent risk factors for any reoperations or 
interventions of any indication. Reoperations for neo-aortic valve insufficiency and/or root 
dilatation are relatively low but revealed an increased incidence over the last decade. With 
the reported ongoing neo-aortic root dilatation in adulthood, this observation is of major 
concern for the future, as this implicate an expected increased need for neo-aortic valve or 
root redo surgery.
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Total AV-block 8  Pacemaker (n = 8)
    Post-ASO (n = 5 before year 2000) 6
    After reoperation** 2 15.2 and 32.1
Ventricular tachyarrhythmia 8 15.4 (12.3-18.5) ICD (n = 5), catheter ablation (n = 5)
    Ventricular tachycardia 7 
    Ventricular fibrillation - aborted sudden 1
     cardiac death
Supraventricular tachyarrhythmia 12*** 17.8 (8.1-24.1) Catheter ablation (n = 4; redo in n = 1)
    AV(N)RT 3
    Atrial flutter 8
    Atrial fibrillation 1
AV(N)RT, AV(nodal) reentrant tachycardia; ICD, implantable cardioverter defibrillator; n, number of patients. 
* age post-ASO.
** reoperation: mitral valve replacement (n = 1, age 15.2 years), Bentall procedure (n = 1, age 31.1 years).
*** 2/12 patients also suffered from ventricular tachyarrhythmia.
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1977-1989  55     44     39     39      37     35      28      6
1990-1999 118    98     91     89      57     17       0
2000-2009 131   110    90     43       0






























1977-1989  55     51     50     49      45     41      34     10
1990-1999 118   114   111   107      83     25       0
2000-2009 131   126   107    51       0






1st reoperation (n = 83)
2nd reoperation (n = 22)
Supplementary Figure S1. Differences in reoperation rate by era.
Differences in reoperation rates of 1st reoperation (A) and 2nd reoperation (B) post-ASO between eras.
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1977-1989  55     47     46    46    44    42    35    11     2
1990-1999 118   114   113  113    88    28     0
2000-2009 131   127   109   53      0

































1977-1989  55     51     50    50    48    45    37    13     2
1990-1999 118   115   114  114    89    28     0
2000-2009 131   124   106   51      0




A Arch repair for recoarctation (n = 7)
B Arch repair for neo-coarctation (n = 5)
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Transposition of the great arteries: 








Documentation of semilunar valve growth in fetal transposition of the great arteries (TGA) 
and the relationship between neo-aortic root dilatation, a cause for postoperative 
reinterventions after the arterial switch operation (ASO), and pulmonary valve (PV) annulus 
dimensions prenatally.
Methods
This retrospective multicenter observational study included TGA fetuses suitable for ASO. 
Semilunar valve annuli pre-ASO and neo-aortic root diameters (post-ASO) were measured. 
Trends in annulus diameters were analyzed using a linear mixed-effects model and 
compared with normal values. Prenatal semilunar valve Z-scores were correlated with neo-
aortic root diameters post-ASO. 
Results
We included 137 TGA fetuses (35.8% with significant ventricluar septal defects (VSDs)). One 
hundred twenty-one underwent ASO. Fetal TGA-PV diameters were significantly larger than 
control aortic valve (AoV) and PV annuli from 23 and 27 weeks, respectively, especially when 
a VSD was present. Fetal TGA-AoV annuli were significantly larger than control AoV and PV 
annuli from 26 and 30 weeks, respectively. Z-scores of fetal TGA-PV and neo-aortic root 
diameter at last follow-up correlated significantly, (P < 0.001 at 26-30 weeks). 
Conclusion
Fetal TGA semilunar valve annuli are larger than control annuli, especially when there is a 
significant VSD. Factors besides postoperative hemodynamics, including fetal anatomy, PV 
Z-score, prenatal flow, connective tissue properties and genetics may influence the risk for 
late reintervention in these fetuses. 




Transposition of the great arteries (TGA) is a frequently seen cyanotic cardiac anomaly, 
occurring in 1 in 3.500 to 5.000 live births per year.1 The pulmonary and systemic circulations 
are in parallel not series, and blood with a higher saturation is ejected into the pulmonary 
circulation instead of the systemic circulation.2, 3  Historically, low prenatal TGA detection 
rates have contributed to a relatively limited knowledge of fetal TGA pathophysiology.4 With 
the inclusion of additional views in prenatal screening protocols, the prenatal detection rate 
of TGA is improving.5 Fetal cardiologists are required to discuss long-term postoperative 
outcomes of TGA more frequently.
Currently, the arterial switch operation (ASO) is the preferred intervention for TGA and 
Taussig-Bing anomaly (TBA) worldwide with an operative mortality less than 5%.6-8 Despite 
this encouraging figure, some troubling complications do occur.8 Problems with coronary 
perfusion and peripheral pulmonary artery stenosis may occur in the short term. The growth 
of the anastomoses of the great arteries and the competence of the native pulmonary valve 
(PV) and root, now functioning as the neo-aortic valve and root in the systemic circulation, 
are important in the long term.6-8 Neo-aortic root dilatation has been reported,8-17 even in 
the first year post-ASO,9-11 and the root continues to grow excessively,15-17 at a rate ≥4 times 
normal.9 The resulting neo-aortic valve regurgitation and aneurysm formation may require 
a reintervention.15-17 The 25-year reintervention-free survival for the neo-aortic valve or root 
after ASO is reported to be 95%.15
The underlying etiology of neo-aortic root dilatation is not completely understood and 
is probably multifactorial. Prior pulmonary artery banding, presence of a ventricular septal 
defect (VSD), TBA, gender, the technique used for the transfer of the coronary buttons and 
the length of follow-up have been implicated.11-20 The study aim was to document the natural 
growth of the semilunar valves in fetuses with TGA and to compare it to normal semilunar 
valve growth. We also wished to determine if neo-aortic root dilatation post-ASO is related 
to the prenatal semilunar valve growth. This knowledge could be important to understand 
the pathophysiology of fetal TGA and the long-term post-ASO complications.
Methods
Study population
All fetuses diagnosed between 2000 and 2017 with TGA or TBA (TGA without pulmonary 
stenosis with a large VSD and overriding of the PV ≤50%) suitable for ASO at four academic 
centers in the Netherlands (Amsterdam University Medical Centers [Academic Medical 
Center and VU Medical Center], Leiden University Medical Center, and the University Medical 
Center Groningen), were included in this observational study. The patients were divided 
into two subgroups: (1) TGA with a hemodynamically significant VSD and (2) TGA with an 
intact interventricular septum (IVS). The study was approved by the Medical Ethics Committee 
of the Academic Medical Center, Amsterdam University Medical Centers, Amsterdam.
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Clinical data
The collected clinical data included sex, gestational age at prenatal follow-ups, prenatal and 
final diagnosis after birth, gestational age at birth, birth weight, surgical procedures 
performed, and outcome (alive or dead). The age, weight, and height of the patients at 1-year 
post-ASO and/or last follow-up moment were also collected.
Echocardiographic measurements
The diameters of the semilunar valve annuli at each prenatal follow-up visit and on the first 
postnatal day were measured in millimeters. The prenatal and pre-ASO measurements were 
made with the valves open using outflow tract views and compared with the normal data 
of Vigneswaran et al.21 and Schneider et al.22 as Vigneswaran et al. measured the annuli with 
the valve closed and Schneider et al. with the valves open. Fetal and pre-ASO Z-scores for 
the PV and aortic valve (AoV) annular diameters were calculated from Vigneswaran et al.21 
and Schneider et al.22 
Measurements post-ASO included the neo-aortic annulus, neo-aortic root at the level of 
the sinuses, and sinotubular (ST) junction at the follow-up closest to 1-year post-ASO and 
at the last follow-up visit. The measurements were made with the valves open from inner-
edge to inner-edge (Figure 1). The Haycock formula was used to calculate the body surface 
area,23 and the Z-scores were determined according to a pediatric reference dataset.24 
Measurements were performed by two observers (SAC and RvdP) using stored images. The 
prenatal images were recorded using Voluson E8 and E10 ultrasound machines (General 
Electric). The postnatal echo images were recorded on Vivid 7 echomachines (General 
Electric) and measured using the EchoPac workstation.
Figure 1. Echocardiographic measurements prenatally and post arterial switch.
Prenatal measurements at the level of the semilunar valve annulus with the valve open (A). Post arterial switch 
measurements of the neo-aortic root from the parasternal long-axis view with the neo-aortic valve open (B).
Dimensions: 1 = annulus, 2 = neo-aortic root and 3 = sinotubular junction.
Ao, aorta; LV, left ventricle; PA, pulmonary artery; RV, right ventricle.





Statistical analysis was performed using IBM SPSS Statistics 23.0 (SPSS Inc., Chicago, IL, USA) 
and R version 3.3.2.25 Clinical characteristics and echocardiographic parameters were 
presented as a number (percentage) for categorical variables, mean (standard deviation) 
for continuous variables with an approximately symmetric distribution, and median 
(interquartile range, IQR) for continuous data with a skewed distribution. Comparisons 
between baseline characteristics for TGA fetuses with IVS and VSD were performed using 
the chi-square test for categorical variables and for continuous variables, the Welch 
approximate t-test or the Mann Whitney test, as appropriate.
Prenatal trends in PV and AoV annular diameters
A repeated measurements analysis with a linear mixed-effects model was used to assess 
average age trends in PV and AoV annular diameters, using all available prenatal 
echocardiograms per fetus and the first postnatal echocardiogram. This was also done for 
the Z-scores of the PV and AoV annular diameters, using only the fetal data. A mixed-effects 
model takes account of repeated measurements per fetus over time during which the 
number and timing of the measurements may vary per fetus. Natural cubic splines were 
modeled to evaluate the variations in time. Knots were placed at five fixed quintiles of the 
predictor’s distribution as suggested by Stone and Koo.26 The intercept was allowed to differ 
per fetus and was assumed to follow a multivariate normal distribution (random effect). 
Since the slope and the intercept of both semilunar valve models had a correlation of 1.0, 
no random effect for the slope was used. Control lines for PV and AoV annular diameters 
were plotted on the basis of regression equations described by Vigneswaran et al.21 and 
Schneider et al.22
Several comparisons were performed for the PV and AoV annular diameters: (1) the 
average trend in PV annular diameters of the TGA fetuses compared with the trend in PV 
annular diameters of controls and (2) with the AoV annulus of the controls. Further, (3) the 
average trend in AoV annulus of the TGA fetuses was compared with the trend in PV annulus 
of the controls and (4) the AoV annulus of controls. The average trends in (5) the PV and 
AoV annuli of the TGA fetuses were additionally allowed to differ by the presence or absence 
of a VSD as well as (6) by the presence of TBA. A sensitivity analysis was also performed for 
the TGA-PV annulus trend where only measurements made during fetal life were included. 
For the Z-scores of the PV and AoV annular diameters, the average trend was analyzed and 
the trends were allowed to differ by the presence or absence of a VSD. Sampling uncertainty 
was quantified via 95% confidence intervals and P values. A P value <0.05 was considered 
statistically significant.
Correlation between prenatal and postnatal measurements
Correlations between the Z-scores of the prenatal semilunar valve annuli and the neo-aortic 
dimensions 1-year post-ASO and last outpatient follow-up were performed, stratified for 
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gestational age: 18 to 22, 26 to 30, and 32 to 36 weeks’ gestation. Each group included only 
one measurement of PV and AoV annulus per fetus. Correlation between prenatal and 
postnatal measurements was tested by the Spearman correlation coefficient (r).
Prediction of neo-aortic root dilatation post-ASO
Receiver-operating characteristic (ROC) analyses were performed, and the area under the 
curves (AUCs) were determined for neo-aortic root dilatation (defined as Z-score ≥2.0) at 
1-year post-ASO or the last post-ASO follow-up visit for all gestational age groups (i.e. 8-22, 
26-30, and 32-36 weeks’ gestation), based on the fetal PV and AoV Z-score of one 
measurement per age group. An AUC >0.700 was considered to be of a good predictive 
value, and of these values, an optimal cut-off value was defined (Youden’s index). A logistic 
regression analysis was additionally performed to stratify the predictive value for sex.
Results
Population characteristics
One hundred forty-nine fetuses were identified with a prenatal diagnosis of TGA suitable 
for ASO. There were no fetal echocardiograms available for revision in 12 (8.1%). One 
hundred thirty-seven fetuses were included in the analyses of whom 90 (65.7%) were male 
and 46 were female. The gender of one fetus, where the pregnancy was interrupted, was 
not recorded. Eighty-eight fetuses (64.2%) had an IVS and 49 (35.8%) a significant VSD of 
which 12 (8.8%) had a TBA. In total, 15 fetuses (11%) died (Figure 2). One hundred twenty-
one underwent an ASO. There were three post-ASO deaths related to coronary perfusion 
problems giving an operative mortality of 2.5%. Table 1 shows the baseline characteristics 
of the included fetuses. There were 384 fetal and 119 postnatal echocardiograms analyzed 
giving pre-ASO data from 503 echocardiograms. The median number of included 
echocardiograms was 5 (range 1-10) per patient. Follow-up data post-ASO was available 
from 118 fetuses. The median follow-up was 2.9 years (range 1 month - 14.3 years).
Trends in PV annular diameters
A statistically significant trend in PV annular diameter (P < 0.0001) was seen in the TGA 
fetuses through gestation. The average trend in PV annular diameter in TGA fetuses 
compared with controls was different from 27 weeks’ gestation, with the PV-annuli being 
larger in the TGA fetuses (Figure 3A and supplementary Figure S1). In late gestation, the PV 
annular growth rate reduced (change in slope of curve). The sensitivity analysis with the 
exclusion of the first postnatal measurements showed a subtler reduction in PV annular 
growth rate in late gestation (supplementary Figure S2).
When compared with the AoV annular diameter of the controls (Figure 3B and 
supplementary Figure S1), TGA fetuses had a larger PV annular diameter from 23 weeks’ 
gestation onwards. There was a statistically significant difference in the PV annular diameter 
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of TGA-fetuses with and without a VSD (P = 0.005) (Figure 3C). TGA fetuses with VSD had, on 
average, larger PV annular dimensions. When the TGA-VSD fetuses were further stratified 
on the basis of a TBA or non-TBA anatomy, there was a statistically significant difference in 
the trend in PV annular diameter between the subgroups (P < 0.0001) (Figure 3D).
Figure 2. Flow diagram of included patients.
ASO, arterial switch operation; IUD, intra-uterine death; IVS, intact interventricular septum; TBA, Taussig-Bing 
anomaly; TGA, transposition of the great arteries; TOP, termination of pregnancy; VSD, ventricular septal 
defect.
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Trends in AoV annular diameters
A statistically significant trend was seen in the AoV annular diameter in the TGA fetuses (P 
< 0.0001). There was a significant difference between the average trend in AoV annulus in 
TGA fetuses compared with the PV annular diameter of the controls from 30 weeks’ gestation 
(Figure 3E). TGA fetuses had a significantly larger AoV annular diameter compared with the 
AoV annular diameter of the controls from 26 weeks’ gestation onwards (Figure 3F).
Prenatal trends in Z-score of PV and AoV annular diameters
A statistically significant trend was seen in the semilunar valve Z-scores in the TGA fetuses 
(P < 0.0001 for both valves). The trends in the Z-scores of the PV and AoV annular diameters 
were not different for the presence or absence of a VSD (P = 0.052 and P = 0.078, respectively) 
(Figure 4 and supplementary Figure S3).
Correlation between prenatal and postnatal measurements
All correlations are documented in Table 2. Most importantly, at 26 to 30 weeks gestation, 
Z-scores of the PV and AoV annular diameters correlated with the Z-score of the neo-aortic 
root measurement at the last follow up visit (r = -0.49, P < 0.001 and r = -0.35, P = 0.003, 
respectively).
Prediction of neo-aortic root dilatation post-ASO
Only the PV annulus Z-score at 26 to 30 weeks’ gestation was considered to be of a predictive 
value for neo-aortic root dilatation at the last follow-up visit (AUC = 0.761) (supplementary 
Table S1). The optimal cutoff value to predict neo-aortic root dilatation at the last follow-up 
visit post-ASO was a PV annulus Z-score of -0.04 at 26 to 30 weeks’ gestation (sensitivity 








TGA- IVS vs 
TGA-VSD
Malea 90 (65.7%) 63 (71.6%) 27 (55.1%) 0.0001
Femalea 46 (33.6%) 25 (28.4%) 21 (42.9%) 0.55
Number of echocardiograms* 5 (4-7) 6 (4-7) 5 (4-6) 0.007




39.0 ± 1.5 
(n = 43)
0.43




3.320 ± 0.454 
(n = 43)
0.47







Deaths 15 (10.9%) 6 (6.8%) 9 (18.4%) 0.07
a The gender of one fetus, where the pregnancy was interrupted, was not recorded and is therefore missing 
from these numbers. * Median (IQR), ** Mean ± standard deviation. IVS, intact interventricular septum; VSD, 
ventricular septal defect.
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Figure 3. Average trends in semilunar valve diameters in TGA fetuses versus controls (Vigneswaran et al.). 
Average trends in PV annular diameters in TGA fetuses (TGA-PV) (A) versus trends in controls PV annular 
diameter (Control-PV); (B) versus AoV annular diameter (Control-AoV); (C) TGA with an IVS (TGA with IVS-PV) 
and a VSD (TGA with VSD-PV); and (D) with the TGA-VSD fetuses further stratified on the basis of a TBA or non-
TBA anatomy (TGA with TBA-PV). Average trend in AoV annular diameters in TGA fetuses (TGA-AoV): (E) versus 
trends in controls of PV annular diameter (Control-PV); and (F) AoV annular diameter (Control-AoV). Trends in 
PV and AoV annular diameters in controls are shown (Control-PV and Control-AoV). Grey dots are individual 
measurements, and grey lines are individual trends. The 95% confidence intervals for both the fitted model 
and the control line as described by Vigneswaran et al.21 are shown in blue (pulmonary valve) and red (aortic 
valve). Note that the 95% confidence intervals for the controls are smaller than the thickness of the line.
AoV, aortic valve; IVS, intact interventricular septum; PV, pulmonary valve; TBA, Taussig-Bing anomaly; TGA, 
transposition of the great arteries; VSD, ventricular septal defect.
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73%, specificity 69%) (supplementary Figure S4). There was no statistically significant 
difference between males and females in the prediction of neo-aortic root dilatation at last 
follow-up visit post-ASO based on the PV annulus Z-score at 26 to 30 weeks’ gestation (P = 
0.395).
Table 2. Comparisons between Z-scores of semilunar valve annulus and left ventricular outflow tract 
measurements at 1 year and last follow-up
Comparisons r P value Comparisons r P value
18-22 weeks
1 year FU Last FU
Z-fPV vs Z-AoV -0.18 0.142 Z-fPV vs Z-AoV -0.10 0.370
Z-fPV vs Z-Root -0.27 0.027 Z-fPV vs Z-Root -0.29 0.009
Z-fPV vs Z-STjunction -0.09 0.491 Z-fPV vs Z-STjunction 0.01 0.949
Z-fAoV vs Z-AoV -0.35 0.002 Z-fAoV vs Z-AoV -0.21 0.062
Z-fAoV vs Z-Root -0.16 0.171 Z-fAoV vs Z-Root -0.12 0.338
Z-fAoV vs Z-STjunction -0.09 0.501 Z-fAoV vs Z-STjunction -0.03 0.794
26-30 weeks
1 year  FU Last FU
Z-fPV vs Z-AoV -0.31 0.020 Z-fPV vs Z-AoV -0.32 0.008
Z-fPV vs Z-Root -0.28 0.035 Z-fPV vs Z-Root -0.49 <0.001
Z-fPV vs Z-STjunction -0.20 0.150 Z-fPV vs Z-STjunction -0.39 0.019
Z-fAoV vs Z-AoV -0.31 0.019 Z-fAoV vs Z-AoV -0.29 0.016
Z-fAoV vs Z-Root -0.13 0.333 Z-fAoV vs Z-Root -0.35 0.003
Z-fAoV vs Z-STjunction -0.08 0.574 Z-fAoV vs Z-STjunction -0.10 0.441
32-36 weeks
1 year FU Last FU
Z-fPV vs Z-AoV -0.24 0.054 Z-fPV vs Z-AoV -0.27 0.024
Z-fPV vs Z-Root -0.24 0.063 Z-fPV vs Z-Root -0.28 0.019
Z-fPV vs Z-STjunction -0.06 0.658 Z-fPV vs Z-STjunction -0.11 0.394
Z-fAoV vs Z-AoV -0.11 0.410 Z-fAoV vs Z-AoV -0.24 0.056
Z-fAoV vs Z-Root -0.21 0.112 Z-fAoV vs Z-Root -0.17 0.164
Z-fAoV vs Z-STjunction -0.17 0.228 Z-fAoV vs Z-STjunction -0.02 0.877
Significant results are shown in bold (P < 0.05). Fetal Z-scores based on Vigneswaran et al.21 
FU, follow-up; Z-AoV, Z-score of neo-aortic valve annulus diameter post arterial switch operation; Z-fAoV, Z-score 
of the fetal aortic valve annulus diameter; Z-fPV, Z-score of the fetal pulmonary valve annulus diameter; Z-Root, 
Z-score of the neo-aortic root; Z-STjunction, Z-score of the sinotubular junction. 
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Figure 4. Average trend in semilunar valve Z-scores in TGA fetuses (based on Vigneswaran et al.).
Average trend in TGA fetal (A) PV annular diameter Z-score (TGA-PV Z-score) and (B) AoV annular diameter 
Z-score (TGA-AoV Z-score). Fetal Z-scores based on data from Vigneswaran et al.21 Grey dots are individual 
measurements and grey lines are individual trends. Both trends were stratified on the basis of the presence 
(TGA with VSD) or absence (TGA with IVS) of a VSD (C and D). 
AoV, aortic valve; IVS, intact interventricular septum; PV, pulmonary valve; TGA, transposition of the great 
arteries; VSD, ventricular septal defect.
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Discussion
This study has shown that the semilunar valves are larger in TGA fetuses compared with 
fetuses with normal hearts. PV annular diameters in the TGA fetuses were significantly larger 
than controls from 27 weeks’ gestation, especially when a VSD was present. They were also 
significantly larger than control AoV annular diameters from 23 weeks’ gestation. The 
Z-scores of the PV-annulus and neo-aortic root diameter at last follow-up post-ASO 
correlated significantly, but only the PV annulus Z-score at 26 to 30 weeks’ gestation was 
considered to be of a predictive value for neo-aortic root dilatation at the last follow-up visit 
(AUC = 0.761). Additionally, the AoV annular diameters were significantly larger in TGA 
fetuses than controls from 26 weeks’ gestation and larger than control PV annular 
measurements from 30 weeks’ gestation.
Flow and growth of the semilunar valves
The size of a vessel can be related to the flow through it,27, 28 growing larger with more flow. 
The PV annulus is usually larger than the AoV annulus in a normal fetal heart. This correlates 
with the larger proportion of the combined cardiac output (CCO) ejected by the right ventricle 
compared with the left ventricle, which increases with gestation to about 66% for the right 
ventricle.3, 29-31 In the fetus, oxygenated blood from the venous duct is preferentially streamed 
across the oval fossa into the left atrium and left ventricle. In TGA, this blood, with a higher 
oxygen saturation, is ejected into the pulmonary artery and may cause pulmonary 
vasodilatation and potential ductal constriction. Increased pulmonary blood flow, pulmonary 
venous return to the left atrium and left ventricular filling then follows.2, 3, 5 The percentage 
of the CCO ejected by the left ventricle increases as a consequence to about 50%.2, 3, 5
So, if only flow determines growth, the PV annular diameter in fetal TGA hearts should 
be smaller than control PV annuli but larger than control AoV annuli. However, we found 
the diameters of fetal TGA-PV annuli to be significantly larger than controls from 27 weeks 
and also larger than the control AoV annuli from 23 weeks onwards. A previous study has 
also shown PV Z-scores smaller than the AoV Z-scores (-0.65 vs 1.13), in TGA-fetuses with 
IVS,4 in concordance with our findings. Furthermore, the fetal TGA-AoV annuli were not 
smaller than control PV annuli as may be expected if only flow determines annular growth. 
Our findings suggest that other factors besides flow also play a role in the growth of the 
semilunar valve annuli in fetal TGA. Lalezari et al. have shown that the amount of collagen 
was diminished in unoperated neonatal TGA hearts and the anchorage and embedding of 
both arterial roots in the myocardium was less extensive.32 This deficiency in support for 
the great vessels possibly contributes to the increased size of the semilunar valves. 
Furthermore, the pulmonary artery in unoperated TGA hearts showed a clear trend in loss 
of actin-positive smooth muscle cells with age,33 which may further contribute to neo-aortic 
root dilatation post-ASO.
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Effect of a VSD
The enlargement of the PV annulus was especially marked when there was a significant VSD 
from about 30 weeks’ gestation. In TBA, the PV annular diameter is larger than the AoV 
annulus as the subpulmonary VSD allows a proportion of the right ventricular output, in 
addition to the left ventricular output, to cross the PV, encouraging growth. Larger PV annular 
diameters in non-TBA TGA hearts with a significant VSD were also found, suggesting a net 
right to left shunt across the fetal VSD and increased flow over the PV, coinciding with the 
fall in pulmonary resistance that is seen in the fetus around 28 weeks’ gestation.30, 31
Late gestational changes in PV annular growth
We found a reduced growth rate in the PV annulus at the end of gestation. A corresponding 
leveling in the prenatal PV Z-score was seen from 35 weeks onwards. Godfrey et al. have 
also described a significant reduction in the PV annular Z-score in fetal TGA between the 
second and third trimesters.4 The reason for this is not entirely clear. After 30 weeks, the 
proportion of the CCO passing through the lungs and oval fossa is stable in normal fetal 
hearts, but the pulmonary vascular resistance increases.31 In TGA fetuses, the pulmonary 
venous return may be increased elevating left atrial pressure and encouraging restriction 
of the oval foramen,2 reducing right to left shunting at atrial level, left ventricular filling and 
flow over the PV in later gestation with possible reduced growth of the PV as a result. When 
the postnatal measurements were not included in our model, the late gestational trend for 
reduction in PV annular growth was less evident.
Neo-aortic root
The long-term prognosis of the ASO depends on the adequate growth of the repaired 
arteries and the adaption of the neo-aortic valve.6, 8, 9 We have shown that the size of the 
PV-annulus at 26 to 30 weeks correlated with the size of the neo-aortic root at last follow-up 
visit post-ASO and that the PV annulus in fetal TGA is already larger than a normal AoV 
annulus. However, this correlation was not strong enough to be clinically useful for a 
prenatal prediction of neo-aortic root dilatation post-ASO. Measuring the PV annulus at 28 
weeks’ gestation will not influence the immediate postnatal management of the baby. In 
countries where there are constraints on prenatal echo facilities, the emphasis should rather 
lie on the initial diagnosis of the transposition of the great arteries around 20 weeks of 
gestation with the use of the outflow tract views. A follow-up echo in the last two weeks of 
pregnancy is also important to evaluate the oval fossa size and risk for a postnatal Rashkind 
procedure and pulmonary hypertension.34
Hourihan et al. also observed that the neo-aortic root and PV annulus are already larger 
than in normal infants before the ASO.8 An increased risk of neo-aortic root dilation in TBA 
and TGA with VSD has previously been recognized,13, 16, 18 highlighting the role of a significant 
VSD in the pathophysiology of neo-aortic root dilatation. This is clinically relevant as the 
reintervention rate is higher in TGA patients with a VSD compared to those with an IVS.14, 17 
Furthermore, the neo-aortic root growth rate post-ASO is ≥4 times the normal rate.9 The 
resultant valve regurgitation may require reintervention.7, 15-17
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Strengths and limitations
This was a multicenter study of one of the largest cohorts of fetal TGA reported to date and 
presents serial data. As with all retrospective studies, it has limitations. Not all cases had 
stored data that could be analyzed. The fetal echocardiograms were made by different 
observers, and there was no predetermined protocol, which may have biased the results. 
However, two researchers performed all the measurements. We did not have our own 
control group and used the normal data of Vigneswaran et al. based on a cohort of more 
than 7000 fetuses.21 As the semilunar valves were measured in closed position by 
Vigneswaran et al.21 and they had no measurement data after 36 weeks’ gestation, we also 
plotted our cohort against the normal data of Schneider et al.22 where the semilunar valves 
were measured in the open position in 130 fetuses. The trends and our conclusions using 
the different control data were similar.
Conclusions
In conclusion, fetal TGA semilunar valve annuli are larger than normal, especially when there 
is a significant VSD. This research adds to our understanding of the pathophysiology of fetal 
TGA and the long-term complications post-ASO.
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Figure S1. Average trends in semilunar valve diameters in TGA fetuses versus controls (Schneider et al.).
Average trends in PV annular diameters in TGA fetuses (TGA-PV): (A) versus trends in controls PV annular 
diameter (Control-PV); (B) versus AoV annular diameter (Control-AoV); (C) TGA with an IVS (TGA with IVS-PV) 
and a VSD (TGA with VSD-PV); and (D) with the TGA-VSD fetuses further stratified on the basis of a TBA or non-
TBA anatomy (TGA with TBA-PV). Average trend in AoV annular diameters in TGA fetuses (TGA-AoV): (E) versus 
trends in controls of PV annular diameter (Control-PV); and (F) AoV annular diameter (Control-AoV). Trends in 
PV and AoV annular diameters in controls are shown (Control-PV and Control-AoV). Grey dots are individual 
measurements, and grey lines are individual trends. The 95% confidence intervals for both the fitted model 
and the control line as described by Schneider et al.22 are shown in blue (pulmonary valve) and red (aortic 
valve). Note that the 95% confidence intervals for the controls are smaller than the thickness of the line. 
AoV, aortic valve; IVS, intact interventricular septum; PV, pulmonary valve; TBA, Taussig-Bing anomaly; TGA, 
transposition of the great arteries; VSD, ventricular septal defect.
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Figure S2. Sensitivity analysis.
Average trend in PV annular diameters in TGA fetuses (A) including first postnatal measurements and (B) 
including fetal measurements only. Grey dots are individual measurements and grey lines are individual 
trends. The 95% confidence intervals for both of the fitted models are shown in dark grey. 
PV, pulmonary valve; TGA, transposition of the great arteries.
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Figure S3. Average trend in semilunar valve Z-scores in TGA fetuses (based on Schneider et al.).
Average trend in TGA fetal (A) PV annular diameter Z-score (TGA-PV Z-score) and (B) AoV annular diameter 
Z-score (TGA-AoV Z-score). Fetal Z-scores based on data from Schneider et al.22 Grey dots are individual 
measurements and grey lines are individual trends. Both trends were stratified based on the presence (TGA 
with VSD) or absence (TGA with IVS) of a VSD (C and D).
AoV, aortic valve; IVS, intact interventricular septum; PV, pulmonary valve; TGA, transposition of the great 
arteries; VSD, ventricular septal defect. 
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Figure S4. ROC for the prediction of neo-aortic root dilatation post-ASO at the last follow-up visit postnatally 
based on the PV-annular Z-score at 26-30 weeks gestation.
Fetal Z-scores based on Vigneswaran et al.21 
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To study neo-aortic growth and the evolution of neo-aortic valve regurgitation (AR) in 
patients with transposition of the great arteries (TGA) after arterial switch operation (ASO) 
from newborn to adulthood and to identify patients at risk.
Methods
Neo-aortic dimensions (annulus/root/sinotubular junction) and neo-aortic valve regurgitation 
were assessed serially in 345 TGA patients that underwent ASO between 1977-2015. Linear 
mixed-effect models were used to assess increase of neo-aortic dimensions over time and 
to identify risk factors for dilatation. Risk factor analysis for AR by using time-dependent 
Cox regression models.
Results
After a rapid increase in the first year after ASO and proportional growth in childhood, neo-
aortic dimensions continue to increase in adulthood without stabilization. Annual diameter 
increase in adulthood was 0.39 ± 0.06, 0.63 ± 0.09 and 0.54 ± 0.11 mm for respectively neo-
aortic annulus, root and sinotubular junction, all significantly exceeding normal growth. AR 
continues to develop over time: freedom from AR ≥moderate during the first 25 years 
post-ASO was 69%. Risk factors for root dilatation were complex TGA anatomy (TGA-VSD, 
double outlet right ventricle with subpulmonary ventricular septal defect (DORV-SP-VSD)) 
and male gender. Risk factors for AR ≥moderate were: complex TGA anatomy and neo-aortic 
growth. Per mm increase in aortic root dimension there was a 9% increase in the hazard of 
AR ≥moderate. Bicuspid pulmonary valve did not relate to the presence of root dilatation 
or AR.
Conclusion
After ASO, neo-aortic dilatation proceeds beyond childhood and is associated with an 
increase in AR incidence over time. Careful follow-up of the neo-aortic valve and root 
function is mandatory, especially in males and in patients with complex TGA anatomy.




The arterial switch operation (ASO) has been a significant milestone in the evolution of 
surgery for transposition of the great arteries (TGA) and after its introduction in 19751 has 
gradually replaced the atrial switch procedure worldwide. Despite excellent late survival 
with good functional ability, residual problems are increasingly recognized during long-term 
follow-up and include dilatation of the neo-aortic root and neo-aortic valve regurgitation 
(AR) that may result in neo-aortic root replacement.2-4 It has been reported that the neo-
aortic root dilates in more than two-thirds of patients after ASO.5, 6 However, data on 
progression of neo-aortic dilatation in adulthood are scarce and controversial.4, 7 Similar to 
root dilatation, concerns have risen about the neo-aortic valve function over time and AR 
has been described as an important cause for reoperation.8 The purpose of this study was 
to assess neo-aortic growth, neo-aortic valve function and the need for reoperations on 
neo-aortic valve and/or root during long-term follow-up for the various morphological 




All patients who underwent ASO for TGA with intact ventricular septum (TGA-IVS), TGA with 
ventricular septal defect (TGA-VSD) or double outlet right ventricle with subpulmonary 
ventricular septal defect (DORV-SP-VSD) at the Center for Congenital Heart Disease 
Amsterdam-Leiden, The Netherlands, between 1977 and 2015 with two or more 
echocardiographic follow-up examinations were included in the study. Hospital and 
outpatient records were reviewed to obtain information on demographics, anthropometrics, 
morphologic and surgical details, aortic re-interventions and mortality. The local Committee 
for Medical Ethics of the academic centers approved the study and waived the need for 
informed consent.
Echocardiographic measurements
Retrospective measurements were performed on images derived from transthoracic 
echocardiograms by two observers. Echocardiographic images were analysed from 
videocassette tapes (before 2006) and from digital recordings (after 2006) using an offline 
workstation (EchoPac v11.1.8., GE Vingmed Ultrasound AS, Norway). Available and good 
quality images were assessed at the following intervals after ASO: 3, 6, 9 and 12 months, at 
2, 3 and 5 years and thereafter with 5-year intervals up to the last available follow-up 
recordings. End of follow-up was defined as the date of the last available echocardiogram 
or the last echocardiogram before root and/or aortic valve reoperation. Neo-aortic diameters 
were measured from two-dimensional mid-systolic parasternal long-axis views at three 
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levels: 1. neo-aortic valve annulus, from hinge-point to hinge-point; 2. neo-aortic root, at 
mid-sinus level from internal edge to internal edge; 3. neo-aortic sinotubular junction (STJ), 
from internal edge to internal edge (Figure 1). To account for the range in body size for 
neo-aortic measurements during childhood (0-18 years), Z-scores were calculated for each 
patient by using pediatric reference values and BSA (DuBois method).9 Dilatation was defined 
as Z-score ≥2.0.
Neo-aortic regurgitation (AR) severity was assessed semi-quantitatively by one pediatric 
cardiologist based on the width of the color Doppler regurgitation jet at the level of neo-
aortic valve on the parasternal long-axis view.10 The regurgitation jet width was graded as 
follows: 0-1 mm (none-trivial), 1-4 mm (mild), 5-6 mm (moderate), >6 mm (severe). 
Additionally, left ventricular end-diastolic diameter as well as the presence of diastolic flow 
reversal in the proximal descending aorta was verified to distinguish moderate from severe 
AR. This method is used in clinical practice and has been described and applied in previous 
echocardiographic studies on follow-up of AR.11-13
Figure 1. Measurement of neo-aortic dimensions from parasternal long-axis view.
Dimensions: 1 = neo-aortic valve annulus, 2 = neo-aortic root and 3 = sinotubular junction.




Statistical analysis was performed using IBM SPSS Statistics 23.0 and R versions 3.4.0/3.4.2. 
Clinical characteristics were presented as number (%) for categorical variables, mean ± 
standard deviation for continuous variables or as median (range) where appropriate. To 
analyse the progression of neo-aortic dimensions at three neo-aortic levels over time, linear 
mixed-effects models were used. To adequately capture non-linear progression over time 
and the between subject variability, natural cubic splines both in the fixed and random-
effects term with 3 knots located at the sample quantiles were used. Potential risk factors 
known from literature for neo-aortic dilatation were incorporated in the models for the 
different neo-aortic levels (see details on risk factor inclusion in supplementary material). 
The likelihood ratio test including Bonferroni correction was used to test for differences in 
mean neo-aortic profiles over time between TGA subtypes.
Kaplan-Meier analysis was performed to assess the probability of freedom from AR ≥mild 
and AR ≥moderate. The log-rank test was used to test for differences of event-free survival 
curves among morphological TGA subtypes. To assess the independent predictive value of 
different covariates (from Table 1) on the occurrence of AR, Cox regression models were 
used. A time-dependent Cox model was used to evaluate the effect of the changing aortic 
dimensions over time on risk of AR (see details on inclusion of variables in Supplementary 
section 1). All P values were 2 sided with a significance threshold <0.05.
Results
During the study period, 452 patients underwent ASO. Fifty-two patients (11.5%) died during 
follow-up. Mortality in the first postoperative month was 9.3% (42 patients) and late deaths 
(>30 days post-ASO) occurred in 10 patients. Early-mortality was highest from 1977-1987 
after start of the ASO program and early-mortality incidence decreased to 3.3% between 
1995 and 2015. Fifty overseas patients were lost to follow-up directly post-surgery and in 
five patients echocardiographic examinations were either lacking (n = 3) or of poor image 
quality (n = 2), leaving 345 patients for the analysis. Baseline patient characteristics are 
shown in Table 1. The morphological TGA subtypes were: TGA-IVS in 230 (66.7%) patients, 
TGA-VSD in 89 (25.8%) patients and DORV-SP-VSD in 26 (7.5%) patients. Baseline 
characteristics did not significantly differ between the study population and patients lost to 
follow-up or those who did not survive. Median number of repeated neo-aortic 
measurements and AR grading was 4 (range 2-9) per patient.
Neo-aortic growth from neonate to adult
Averaged time-related evolution of the neo-aortic dimensions for all TGA patients are 
depicted in Figure 2A-C. The neo-aortic annulus, neo-aortic root and the STJ all showed 
similar growth patterns: a rapid increase in the first year after ASO, followed by a nearly 
linear increase of neo-aortic dimensions in childhood with an ongoing increased growth 
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Table 1. Demographics and pre-operative anatomy
 Study cohort (n = 345), no. (%)
Male 228 (66.1)
Age at 1st assessment, median (range) 1.9 (0.04-31.5) years






Arch abnormality 24 (7.0)
Bicuspid pulmonary valve 21 (6.1)
Left ventricular OTO 12 (3.5)
Coronary anatomya
Usual (1LCx-2R, 1L-2CxR) 275 (79.7)
Other 60 (17.4)
Intramural course of LAD 4 (1.2)
Unknown 6 (1.7)
Pre-operative procedures
Balloon atrial septostomy 182 (52.8)
Previous PAB 18 (5.2)
Arterial switch operation
One-stage 319 (92.5)
     Median age (range) 8 days (0 days-0.6 years)
Two stage 26 (7.5)
     Median age (range) 143 days (36 days-5.1 years) 
Coronary artery transfer technique
Double button 197 (57.1)
Single trapdoor, single button 96 (27.9)
Double trapdoor 31 (9.0)
Aortic sinus pouch technique 4 (1.2)
Unknown 17 (4.9)
Lecompte maneuver 320 (92.8)
a Coronary anatomy description according to the Leiden Convention coronary coding system.
Cx, circumflex artery; DORV-SP-VSD, double outlet right ventricle with subpulmonary ventricular septal defect; 
IVS, intact ventricular septum; L or LAD, left anterior descending coronary artery; OTO, outflow tract obstruction; 
PAB, pulmonary artery banding; R, right coronary artery; TGA, transposition of the great arteries; VSD, ventricular 
septal defect.
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rate in adulthood. The average diameter progression in adulthood (18-30 years post-ASO) 
for all TGA patients was 0.39 mm/year for the neo-aortic annulus (95% CI: 0.33-0.46 mm/
year), 0.63 mm/year for the neo-aortic root (95% CI: 0.54-0.71 mm/year), and 0.54 mm/year 
for the STJ (95% CI: 0.43-0.65 mm/year).
Figure 2. Mean progression of neo-aortic dimensions over time for all patients with TGA.
Absolute neo-aortic diameters (A-C); neo-aortic Z-scores (D-F). Mean profiles are plotted with the described 
risk factors set to the reference level; dashed lines represent 95% confidence interval. Annulus, neo-aortic 
valve annulus; Root, neo-aortic root; STJ, sinotubular junction; TGA, transposition of the great arteries.
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For the childhood period, neo-aortic diameters were indexed to body size and depicted 
as Z-scores (Figure 2D-F). A rapid increase in neo-aortic Z-scores was observed for all neo-
aortic dimensions in the first year after ASO (average Z-score >2.5 for neo-aortic annulus 
and neo-aortic root and average Z-score of 2.0 for STJ), followed by stabilization at these 
high Z-score levels during childhood. From 2-18 years, no Z-score increase was observed 
for neo-aortic annulus (P = 0.53) and neo-aortic root (P = 0.79). The Z-score for STJ slightly 
increased within this period (P = 0.005), between 15-18 years post-ASO (Figure 2D-F).
Neo-aortic progression between TGA subtypes
Figure 3A-C depicts the time-related evolution of the neo-aortic dimensions at three aortic 
levels for the different TGA subtypes (CI in supplementary Figure S1A-C). The mean profiles 
for neo-aortic annulus and neo-aortic root diameters showed significant differences between 
the three TGA subtypes (P = 3.7x10-4 and P = 7.6x10-6 respectively). No difference in mean 
profiles between TGA subgroups for STJ was found (P = 0.37).
Mean increase of the neo-aortic dimensions beyond childhood for the TGA subtypes is 
depicted in supplementary Table S1. The growth rate slightly decreases after 18 years post-
ASO but remained high for the different neo-aortic dimensions in all subtypes. The smallest 
neo-aortic diameter increase was observed in the TGA-IVS patients and the largest increase 
in the DORV-SP-VSD patients.
Risk factors for neo-aortic dilatation
Morphological TGA subtype and gender were independent risk factors for root dilatation 
(Figure 3A-F). Male TGA patients tend to have larger neo-aortic roots compared to female 
TGA patients (Annulus P = 3.0x10-6; Root P = 8.5x10-6; STJ P = 0.008), of which the effect starts 
13 years after ASO (Figure 3D-F; CI in supplementary Figure S1D-F). Explorative risk factor 
analysis showed that none of the other anatomical and surgical variables from Table 1 were 
associated with progression of neo-aortic root dimensions (supplementary Table S2).
Neo-aortic valve regurgitation
Neo-aortic valve regurgitation was assessed serially. At last follow-up or just before 
reoperation for neo-aortic root pathology, thirty-three of the 345 TGA patients (9.6%) had 
at least moderate AR (AR ≥moderate). Moderate or more AR was present in 7.4% (n = 17) of 
the TGA-IVS, in 11.2% (n = 10) of the TGA-VSD and in 23.1% (n=6) of the DORV-SP-VSD 
patients. Mild or more AR was present in 28.2% (n = 65) of the TGA-IVS, in 36.0% (n = 32) of 
TGA-VSD and in 53.8% (n = 14) of the DORV-SP-VSD patients. The Kaplan-Meier curves for 
AR ≥mild and AR ≥moderate are shown in Figure 4. The overall probability of freedom from 
AR ≥moderate was 96% at 5 years, which decreased to 95%, 88%, 78% and 69% at 10, 15, 
20 and 25 years after ASO, respectively. The overall freedom from AR ≥mild was 79% at 5 
years, which decreased to 64%, 50%, 39% and 33% at 10, 15, 20 and 25 years after ASO, 
respectively. Log-rank test showed significant differences between the TGA subtypes (P = 
0.037 and P = 0.013 for AR ≥moderate and AR ≥mild respectively).
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Results from Cox regression and time-dependent Cox regression analysis for the 
development of AR are depicted in Table 2. TGA morphological subtype was a univariable 
risk factor for the occurrence of both AR ≥mild and AR ≥moderate (P = 0.009 and P = 0.02 
respectively). Furthermore, late ASO (ASO ≥6 months of age) was significantly associated 
with the occurrence of AR ≥mild. Aortic diameter increase over time (for neo-aortic annulus 
Figure 3. Mean progression of neo-aortic dimensions over time for different TGA subtypes (A-C) and gender 
(D-F).
Mean profiles are plotted with the described risk factors set to the reference level. For confidence intervals 
(supplementary Figure S1). Annulus, neo-aortic valve annulus; DORV-SP-VSD, double outlet right ventricle with 
subpulmonary ventricular septal defect; IVS, intact ventricular septum; Root, neo-aortic root; STJ, sinotubular 
junction; TGA, transposition of the great arteries; VSD, ventricular septal defect.
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and root) were risk factors for development of AR ≥moderate in the univariable time-
dependent Cox analysis. Multivariable models for the diameters showed a 9% (95% CI 1-17%) 
increase in the hazard of AR ≥moderate per mm increase in aortic root diameter dimension 
(Table 2).
























TGA-IVS       230   169    114     67     34     13      5       1
TGA-VSD          89     59      40      16      8       4       1       0
DORV-SP-VSD  26     17       9        7       4       2       0       0
Log-rank P-value=0.013




























TGA-IVS        230   178    129     88     44     18      7       1
TGA-VSD          89    67      52      25     11      5       1       0




Figure 4. Freedom from at least mild (A) and at least moderate (B) neo-aortic valve regurgitation after ASO.
AR, neo-aortic valve regurgitation; ASO, arterial switch operation; DORV-SP-VSD, double outlet right ventricle 
with subpulmonary ventricular septal defect; IVS, intact ventricular septum; TGA, transposition of the great 
arteries; VSD, ventricular septal defect.
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Neo-aortic reoperation
Ten patients (2.9%) from the study cohort underwent reoperation on the neo-aortic valve 
and/or root (Table 3). Median age at reoperation was 17.4 (range 7.9-29.0) years. Original 
diagnoses were TGA-IVS in 3 (1.3%), TGA-VSD in 5 (5.6%) and DORV-SP-VSD in 2 patients 
(7.7%). Primary indications for neo-aortic reoperations were root dilatation (n = 4) or root 
dilatation with AR (n = 6). Surgical procedures performed were: Bentall operation (n = 6), 
neo-aortic valve replacement (n = 2), supracoronary tubular prosthesis for repair of root/
STJ (n = 1) and switch back operation (n = 1). Additional details on neo-aortic diameters, 
patient and surgical characteristics are depicted in Table 3.
Discussion
This is the first study that investigated long-term neo-aortic growth and neo-aortic valve 
function in TGA patients by analysing serial measurements using a linear mixed model 
approach from birth up to 39 years post-ASO. This study demonstrates that neo-aortic root 
dilatation is progressive and does not stabilize in adulthood and that AR progresses over 
time. Dilatation did not only involve the neo-aortic root but also the neo-aortic valve annulus 
and STJ. Morphological TGA subtype (TGA-VSD and DORV-SP-VSD) and male gender were 
found to be independent risk factors for aortic root dilatation. Furthermore, the progression 
of root dilatation was a critical factor for impairment of neo-aortic valve function: per mm 
increase in aortic root dimension over time there is an average 9% increase in the hazard 
of AR ≥moderate.
Neo-aortic root dilatation
Discussion about the neo-aortic growth pattern after ASO in childhood is still ongoing. In 
the present study we show that a disproportional increase of neo-aortic sizes occurs in the 
first year after ASO, followed by a neo-aortic growth rate comparable to normal somatic 
growth from 2 till 18 years of age albeit at a higher Z-score level. Similar findings were 
reported by smaller mid-term follow-up studies.14, 15 In contrast, other studies reported 
ongoing disproportional neo-aortic root growth during the entire childhood period13 or 
disproportionate growth till the age of 10 years followed by stabilization until 18 years of 
age.16 This study extends the current knowledge on aortic growth patterns by its unique 
serial evaluation of neo-aorta dimensions in these patients from birth till adulthood. A major 
finding of this study and a concern for the future is the ongoing growth of the neo-aortic 
root beyond childhood, after somatic growth stops. Our findings are in agreement with 
those of a cardiac MRI study using longitudinal data from two consecutive MRI examinations 
in patients between 0-29 years post-ASO.17
The rate of progression of the aortic root in healthy adult individuals is estimated 0.08 
mm/year18 whereas in TGA patients the growth rate, depending on its exact morphological 
subtype, is on average 0.63 mm/year as shown by this study. This growth rate is similar to 
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the yearly aortic root growth rate in patients with other diseases associated with aortopathy: 
for Marfan disease average aortic root growth is reported 0.41 up to 0.49 ± 0.5 mm/year 
before the era of preventive beta-blocker and losartan therapies,19, 20 in bicuspid aortic valve 
related aortopathy 0.42 ± 0.6 up to 0.5 mm/year for the ascending aorta20 and after Ross 
operation in adulthood 0.43 mm/year for the neo-aortic root.21 The annual growth of the 
neo-aortic annulus and STJ in adult patients after Ross operation is estimated between 
0.33-0.40 mm and 0.49-0.51 mm respectively.21, 22 Likewise, after Ross operation there is 
also an initial rapid increase in neo-aortic root dimension followed by a slower ongoing 
progression.
In this study, we demonstrated complex TGA anatomy (TGA-VSD and DORV-SP-VSD) and 
male gender to be independent risk factors for neo-aortic root dilatation. Complex TGA 
anatomy is more often reported as risk factor in smaller studies with shorter follow-up 
duration.5, 14, 15, 23 Other reported risk factors could not be found in this study, including 
pulmonary artery banding (PAB) prior to ASO5, 16, 23 and presence of an aortic arch anomaly.15 
Remarkably, male gender appeared to be an independent risk factor for larger neo-aortic 
root growth after ASO. The onset of the differences in aortic diameters between TGA males 
and females coincides with the age of puberty onset which suggests a possible relation with 
hormonal changes. Although male gender is known to be related with larger aortic diameters 
from population studies on aortic sizes in healthy adults,18, 24 this association has only been 
reported in one cross-sectional study in complex TGA patients after ASO.8
The etiology of ongoing root dilatation most likely has a multifactorial origin. From a 
post-mortem specimen study it is known that the arterial roots in unoperated TGA patients 
have a diminished amount and altered distribution of collagen and that the root and neo-
aortic valve are less firmly embedded in the myocardium.25 Furthermore, the neo-aortic 
root and pulmonary valve annulus already start larger in TGA patients immediately after 
birth (pre-ASO) compared to healthy infants.23 This finding is more pronounced in TGA-VSD 
and DORV-SP-VSD patients as compared to TGA-IVS patients. The role of hemodynamic 
factors in aortic dilatation is unknown. Important geometric alterations in the ascending 
neo-aorta after ASO with Lecompte maneuver may have hemodynamic consequences which 
potentially impacts on the root diameter. Four-dimensional flow MR imaging in pediatric 
post-ASO patients has already shown abnormal systolic flow patterns in the ascending aorta 
in two-thirds of the TGA patients26 but a causal relation still has to be demonstrated.
Neo-aortic valve regurgitation and reoperation
The occurrence of AR becomes increasingly evident long-term after ASO. Several factors 
are reported to be associated with AR in literature. These include neo-aortic root dilatation 
(certain Z-scores: ≥2.5 or ≥3.0),11, 14, 16 TGA subtype,5, 11, 14, 16, 27, 28 older age at ASO,16, 27, 29 previous 
PAB16, 27, 28 and left ventricular outflow tract obstruction.11, 16, 29 In this study we could only 
confirm morphological TGA subtype and ASO ≥6 months as risk factors for the development 
of AR by univariable  analysis. More importantly, this study is the first to show an increase 
in neo-aortic valve annulus and root diameter over time (i.e. annulus and root growth) as 
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independent risk factors for moderate or more AR. Every mm increase in neo-aortic root 
size significantly increases the hazard of at least moderate AR. These data suggest that in 
this group of patients an important underlying mechanism for AR is impaired leaflet 
coaptation due to progression of the neo-aortic root and valve-annulus dimensions. In 
addition, the anatomical pulmonary valve itself may be more at risk for valvar incompetence 
due to differences in histology and anchoring compared to a native aortic valve.25 
Nevertheless, bicuspid native pulmonary valve morphology was not associated with AR in 
this study which endorses that a pre-operative competent bicuspid valve itself is not a 
contraindication for ASO when it comes to long-term valve function.
To date, no cases have been reported with aortic rupture or dissection after ASO but in 
several re-operated patients the anterior wall of the aneurysmatic aorta was observed to 
be paper-thin and fragile.3, 30 Indications for reoperation for aortic root dilatation after ASO 
to prevent rupture, dissection or progressive aortic regurgitation are unclear. The threshold 
and timing for aortic root repair are mainly based on absolute diameters rather than indexed 
aortic diameters (Z-scores) and are adapted from guidelines for aortopathy due to bicuspid 
aortic valve or connective tissue disease. The current incidence of neo-aortic reoperations 
in this study and in a recent multicenter study is low.30 However, in the present study already 
47 patients (14%) developed a root diameter ≥40 mm, and moderate AR was present in 26% 
of them. One quarter of these patients have not even reached adulthood. The ongoing 
neo-aortic dilatation, AR progression and its mutual relationship beyond childhood as shown 
is this study may predict an increased number of root and valve reoperations in the future.
Limitations
This is a retrospective study and is therefore subject to limitations inherent to the design. 
A complete series of measurements from birth to adulthood was not available in all patients, 
with an average of 4 measurements per patient. In general, in the oldest group of patients 
fewer images at young ages after ASO were available. Therefore, the aortic measurements 
at young age after ASO (<5 years) mainly consisted of data from patients operated in the 
last two decades. However, as long as those that were followed for a period can be seen as 
representative for the whole population of similar age, our linear mixed-effect models will 
provide an unbiased estimate of aortic diameter trends over time. Echocardiographic 
imaging systems have improved the last decades that might affect accuracy of the 
measurements. However, only good quality images were used for analysis. Finally, AR 
grading remains a semi-quantitative estimation and may therefore be subject to observer 
variability that needs to be taken into account.




After ASO, neo-aortic root dilatation is progressive over time and does not stabilize in 
adulthood with male gender and complex TGA morphology as risk factors. The progressive 
root dilatation is a critical factor for the impairment of AR long-term after ASO. Based on 
this data, concerns exist for the neo-aortic root function and the expected increasing need 
for neo-aortic root and/or neo-aortic valve reoperations in this aging group of patients of 
which the firsts have now reached the age of 40 years.
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Supplementary material
Detailed description of Statistical analysis
To analyse the progression of neo-aortic dimensions at three neo-aortic levels over time, 
linear mixed-effects models were used. To adequately capture non-linear progression over 
time and the between subject variability, natural cubic splines both in the fixed and random-
effects term with 3 knots located at the sample quantiles were used. Potential risk factors 
known from literature for neo-aortic dilatation were incorporated in the models for the 
different neo-aortic levels. For all models, risk factors ‘morphological TGA subtype’ (i.e. TGA-
IVS, TGA-VSD and DORV-SP-VSD) and ‘gender’ were included as main effects and in interaction 
with time. Additional risk factors were included as main effects in the models for the 
following neo-aortic levels: for the neo-aortic valve model, ‘presence of aortic arch 
abnormality’; for the neo-aortic root model, ‘previous pulmonary artery banding’ (PAB) and 
‘method of coronary artery transfer’; for the STJ model, none. Normality was tested on the 
model residuals. To assess whether additional candidate risk factors (covariates from Table 
1) are associated with neo-aortic diameter progression, these factors were included 
simultaneously as main effects in the models. 
To assess the independent predictive value of different covariates (from Table 1) on the 
occurrence of AR, Cox regression models were used. A time-dependent Cox model was used 
to evaluate the effect of the changing aortic dimensions over time on risk of AR. For the 
multivariable time-dependent Cox model regarding the effect of aortic diameter on AR 
certain factors were included; for AR ≥mild: ‘morphological subtype’, ‘gender’, ‘presence of 
pulmonary valve abnormality’, ‘previous PAB’ and ‘ASO performed ≥6 months post birth’. 
For AR ≥moderate, the lower number of events only allowed inclusion of the two strongest 
univariable risk factors: ‘morphological TGA subtype’ and ‘gender’. All P values were 2 sided 
with a significance threshold <0.05.
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Figure S1. Mean progression of neo-aortic dimensions over time for different TGA subtypes (A-C) and gender 
(D-F), including confidence intervals.
Mean profiles are plotted with the described risk factors set to the reference level; dashed lines represent 
95% confidence interval. Annulus, neo-aortic valve annulus; DORV-SP-VSD, double outlet right ventricle with 
subpulmonary ventricular septal defect; IVS, intact ventricular septum; Root, neo-aortic root; STJ, sinotubular 
junction; TGA, transposition of the great arteries; VSD, ventricular septal defect.
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TGA-IVS (18-26 yrs) 0.40 (0.34-0.46) 0.61 (0.53-0.70) 0.56 (0.44-0.68)
     18-20 yrs 0.45 (0.40-0.51) 0.67 (0.61-0.75) 0.60 (0.50-0.70)
     20-22 yrs 0.42 (0.36-0.48) 0.63 (0.55-0.71) 0.57 (0.46-0.68)
     22-24 yrs 0.38 (0.31-0.45) 0.59 (0.50-0.68) 0.54 (0.42-0.67)
     24-26 yrs 0.35 (0.27-0.43) 0.55 (0.45-0.66) 0.52 (0.38-0.66)
TGA-VSD (18-26 yrs) 0.47 (0.36-0.57) 0.75 (0.60-0.90) 0.57 (0.37-0.77)
     18-20 yrs 0.52 (0.44-0.61) 0.80 (0.68-0.92) 0.63 (0.47-0.79)
     20-22 yrs 0.48 (0.38-0.58) 0.76 (0.62-0.90) 0.59 (0.40-0.77)
     22-24 yrs 0.44 (0.33-0.56) 0.73 (0.57-0.89) 0.55 (0.34-0.76)
     24-26 yrs 0.41 (0.28-0.54) 0.70 (0.52-0.87) 0.52 (0.28-0.75)
DORV-SP-VSD (18-26 yrs) 0.51 (0.36-0.66) 0.78 (0.58-0.97) 0.58 (0.27-0.89)
     18-20 yrs 0.56 (0.44-0.68) 0.84 (0.68-1.00) 0.61 (0.37-0.86)
     20-22 yrs 0.52 (0.38-0.67) 0.80 (0.61-0.98) 0.59 (0.30-0.88)
     22-24 yrs 0.49 (0.33-0.65) 0.75 (0.55-0.96) 0.56 (0.23-0.90)
     24-26 yrs 0.46 (0.28-0.64) 0.72 (0.49-0.95) 0.54 (0.16-0.92)
Data represent average annual growth over the depicted time-interval. Annulus, neo-aortic valve annulus; CI, 
confidence interval; DORV-SP-VSD, double outlet right ventricle with subpulmonary ventricular septal defect; 
IVS, intact ventricular septum; Root, neo-aortic root; STJ, sinotubular junction; TGA, transposition of the great 
arteries; VSD, ventricular septal defect; yrs, years.
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Table S2. Additional determinants of neo-aortic diameter progression
Annulus Root STJ
Coefficient P value Coefficient P value Coefficient P value
Previous PAB
   No ref (1) ref (1) ref (1)
   Yes -0.213 0.681 0.026 0.967 0.111 0.876
Arch abnormalitya - No
   DORV-SP-VSD ref (1) ref (1) ref (1)
   TGA-IVS -0.935 0.487 -2.022 0.229 -0.181 0.940
   TGA-VSD -0.950 0.402 -0.896 0.527 1.659 0.405
Pulmonary valve
   Tricuspid ref (1) ref (1) ref (1)
   Bicuspid 0.028 0.949 0.211 0.696 0.002 0.997
Balloon atrial septostomya - No
   DORV-SP-VSD ref (1) ref (1) ref (1)
   TGA-IVS 0.363 0.654 0.542 0.608 1.417 0.311
   TGA-VSD 1.207 0.159 1.600 0.138 2.234 0.124
Lecompte maneuver
   No ref (1) ref (1) ref (1)
   Yes -0.797 0.145 -0.078 0.913 -0.026 0.976
Coronary artery transfer
(sinus 1, sinus 2)
   2 buttons N/A N/A ref (1) ref (1)
   2 trapdoor OR 
   1 button, 1 trapdoor
N/A N/A 0.251 0.368 0.515 0.091
a Arch abnormality and need for balloon atrial septostomy have been modelled in interaction with the three 
morphological TGA subtypes. Annulus, neo-aortic valve annulus; DORV-SP-VSD, double outlet right ventricle 
with subpulmonary ventricular septal defect; IVS, intact ventricular septum; N/A, not applicable; PAB, pulmonary 
artery banding; Root, neo-aortic root; STJ, sinotubular junction; TGA, transposition of the great arteries; VSD, 
ventricular septal defect.
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To the Editor 
Patients after arterial switch operation (ASO) for transposition of the great arteries (TGA) 
usually have excellent late survival with good quality of life. However, residual sequelae may 
develop post-ASO of which neo-aortic root dilatation and neo-aortic valve regurgitation (AR) 
are common and require longitudinal monitoring on severity and progression. Although 
current reoperation rates for neo-aortic root dilatation or AR are relatively low,1, 2 it is 
reported to be the second most common cause for reoperation in the long-term follow-up.3
In our recently published paper4 we reported on the ongoing progression of neo-aortic 
root dilatation beyond childhood (Figure, panels A and B) and identified TGA morphological 
subtype and male sex as risk factors for neo-aortic root dilatation. In that paper, neo-aortic 
dimensions and neo-aortic valve function derived from echocardiographic imaging were 
longitudinally assessed from birth till adulthood in 345 TGA patients after ASO. Thirty-three 
Figure. The great arteries after arterial switch operation and mean progression of neo-aortic dimensions.
Neo-pulmonary artery and pulmonary artery branches (neo-PA) running in front and embracing the neo-aorta 
with its dilated neo-aortic root (dashed arrow). Panels A and B derived from van der Palen et al.4 represent 
mean progression of neo-aortic dimensions over time for all patients after arterial switch operation for 
transposition of the great arteries: neo-aortic annulus (A), neo-aortic root (B). Mean profiles are plotted with 
the described risk factors set to the reference level; dashed lines represent 95% confidence intervals.
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of the 345 patients (9.6%) developed at least moderate AR (AR ≥moderate) and mild or more 
AR (AR ≥mild) was present in one hundred and eleven patients (32.2%). From these data, 
the mutual relationship between the neo-aortic root dilatation and the development of 
neo-aortic valve regurgitation was demonstrated. Univariate time-dependent Cox-regression 
(TD-Cox) analysis to assess the effect of changing aortic dimensions over time on the risk 
of AR ≥moderate showed a clear relationship between neo-aortic annulus and root 
dimensions and AR ≥moderate. However, with the multivariate TD-Cox analysis only neo-
aortic root dimensions were independently associated with the development of AR 
≥moderate (HR = 1.09 (1.01-1.17), P = 0.040). No significant association could be established 
for the development of AR ≥mild, neither in the univariate nor in the multivariate analysis.
Recent developments in biostatistics allow a more comprehensive statistical approach 
for the evaluation of the association between longitudinal markers and time-to-event 
outcomes by means of joint modeling.5 A major advantage of the joint model compared to 
the TD-Cox analysis is that the joint model reconstructs the complete trajectory of the 
longitudinal marker instead of assuming it to remain constant between two measurement 
points. This assumption of the TD-Cox model might have had an effect on the results and 
conclusions from our series. The joint model method combines a mixed effect submodel 
for the longitudinal marker with a time-to-event submodel for the risk of the event. The 
mixed effect submodel estimates the trajectory of a marker (i.e. neo-aortic diameter in our 
dataset), and the estimated marker value at the time of the event (i.e. reaching certain 
degree of neo-aortic valve regurgitation) is used to estimate the hazard of the event. Non-
linear terms, such as quadratic terms or splines, can be included in the mixed effect 
submodel to obtain a modelled trajectory of the marker that follows the natural evolution 
over time. Since the event of neo-aortic regurgitation is only diagnosed at a visit, the exact 
time point of the event is unknown, but takes place somewhere between the last two 
measurements. This interval-censored nature of the data can be taken into account by the 
joint model. Another advantage of joint modeling over TD-Cox analysis is that it additionally 
easily allows for modeling of different associations between the marker and the event. For 
example, the slope of the marker can be additionally included. Therefore, analysis of the 
valve function over time in relation to neo-aortic dimensions with the joint modeling 
statistical approach is preferable to the TD-Cox model for the analysis of our dataset and 
the dataset was therefore re-analyzed.
In accordance with the previous analysis,4 cubic splines with knots at 2 and 10 years were 
used in the mixed effect model to capture non-linear evolutions over time. The mixed effect 
models were estimated for both neo-aortic annulus and root dimensions over time, and 
the event data were classified as either AR ≥mild or AR ≥moderate. In addition to the 
estimated neo-aortic dimensions, the slope of this marker was added to the survival 
submodel, representing the estimated growth rate at each point in time. Additional risk 
factors measured at baseline were included in the risk submodel, which was estimated 
taking the interval censoring into account. Statistical analysis was performed with the 
JMbayes software package in R.6, 7
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From the multivariable analysis using the joint modeling approach, it was confirmed that 
the neo-aortic root dimensions showed a positive significant association with AR ≥moderate, 
but the association was much stronger than was determined by the previous TD-Cox analysis 
(Joint modeling: HR = 1.25 (1.13-1.39), P < 0.001 vs TD-Cox: HR = 1.09 (1.01-1.17), P = 0.040 
(Table). Furthermore, with joint modeling the neo-aortic root dimension was also shown to 
be an independent risk factor for the development of AR ≥mild (HR = 1.15 (1.08-1.22), P < 
0.001), where previously no association was found. Moreover, the neo-aortic annulus 
dimension was an independent risk factor for the development of AR ≥mild and AR 
≥moderate (AR ≥mild: HR = 1.18 (1.10-1.27), P < 0.001; AR ≥moderate: HR = 1.22 (1.08-1.38), 
P < 0.001). Apart from this, we identified that the neo-aortic annular growth rate as well as 
the neo-aortic root growth rate were independently associated with the development of at 
least mild neo-aortic regurgitation (Table). This means that a faster growth of the neo-aortic 
annulus and neo-aortic root, in addition to the neo-aortic dimensions itself, was associated 
with a higher risk of AR ≥mild. For AR ≥moderate, growth rate of the neo-aortic annulus and 
Table. Time-dependent Cox models and Joint models for the risk on neo-aortic valve regurgitation
TD Cox model $ AR ≥moderate* AR ≥mild**
Diameter increase Hazard ratio  
(95% CI)
P value Hazard ratio  
(95% CI)
P value
Annulus (per mm) 1.09 (0.99 – 1.21) 0.09 1.03 (0.97– 1.09) 0.31
Root (per mm) 1.09 (1.01 – 1.17) 0.04 1.04 (0.99 – 1.09) 0.10
Joint model AR ≥moderate* AR ≥mild**
Diameter increase Hazard ratio  
(95% CI)
P value Hazard ratio 
(95% CI)
P value
Annulus (per mm) - 
dimension dimension 1.22 (1.08 – 1.38) <0.001 1.18 (1.10 – 1.27) <0.001
Annulus (per mm) -  
dimension and slope
dimension 1.20 (1.07 – 1.37) 0.006 1.11 (1.03 – 1.20) 0.008
slope 1.75 (0.44 – 6.24) 0.376 3.06 (1.40 – 6.45) 0.004
Root (per mm) - 
dimension dimension 1.25 (1.13 – 1.39) <0.001 1.15 (1.08 – 1.22) <0.001
Root (per mm)  -  
dimension and slope
dimension 1.25 (1.13 – 1.38) <0.001 1.10 (1.04 – 1.18) 0.006
slope 1.26 (0.36 – 3.72) 0.647 2.28 (1.28 – 4.02) 0.008
$ Results from time-dependent Cox model as reported by van der Palen et al.4
* Multivariable analysis adjusted for morphological subtype and gender. n = 31/323 (annulus); n = 32/323 (root).
** Multivariable analysis adjusted for morphological subtype, gender, pulmonary valve, previous pulmonary 
artery banding and age ASO ≥6 months of age. n = 105/323 (annulus and root).
AR, neo-aortic valve regurgitation.
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root did not show such an association next to its absolute neo-aortic dimensions. This could 
be related to a lack of power as less than 10% of the patients developed AR ≥moderate.
Data on the evaluation of the neo-aortic growth rate next to neo-aortic dimensions is 
new in the clinical risk factor assessment on the development of neo-aortic valve 
regurgitation in patients after congenital heart surgery. This report is the first to show the 
effect of neo-aortic growth rate in addition to neo-aortic dimensions as critical factors for 
the impairment of neo-aortic valve function. These results, with stronger and additional 
effect measures compared to the previously reported outcomes by traditional TD-Cox 
regression analysis,4 support the knowledge and concept of AR mechanisms by root 
dilatation as presented previously by Grande et al. using computational modeling.8 From 
that study, progressive root dilatation has been shown to reveal a significant increase in 
stress and strain on the aortic valve leaflets, leading to significantly reduced leaflet coaptation 
and valve regurgitation.8
The advantages of multimarker analysis from joint modeling on large population data 
ultimately might help in tailoring surgical decision making for neo-aortic valve and/or root 
reinterventions after ASO. Furthermore, extensions to this joint model approach can also 
help for individual prediction of the occurrence of a defined event in future (i.e. reaching 
certain degree of AR), by the use of dynamic predictions of the repeated measures in the 
joint model. With this technique, for each individual patient the probability of a certain 
degree of valve regurgitation over time can be estimated. Each time new information on 
the patient’s aortic dimensions is available, the probabilities can be updated.
In conclusion, based on the joint model analysis, both annulus and root dimensions are 
independently associated with AR and, additionally, growth rate of the former native 
pulmonary valve annulus and adjacent root is associated with AR as well. The fact that neo-
aortic dilatation after ASO is progressive over time without stabilization in adulthood, 
predicts an increasing incidence of neo-aortic regurgitation in future with an expected 
growing need for surgical reinterventions on the neo-aortic valve and/or root.
PART I  |  Chapter 5
104
References
1. Koolbergen DR, Manshanden JS, Yazdanbakhsh AP, Bouma BJ, Blom NA, de Mol BA, Mulder BJ, Hazekamp 
MG. Reoperation for neoaortic root pathology after the arterial switch operation. Eur J Cardiothorac Surg. 
2014;46(3):474-9.
2. Vida VL, Zanotto L, Zanotto L, Stellin G, European Congenital Heart Surgeons Association Study G, 
Padalino M, Sarris G, Protopapas E, Prospero C, Pizarro C, et al. Left-Sided Reoperations After Arterial 
Switch Operation: A European Multicenter Study. Ann Thorac Surg. 2017;104(3):899-906.
3. Kempny A, Wustmann K, Borgia F, Dimopoulos K, Uebing A, Li W, Chen SS, Piorkowski A, Radley-Smith R, 
Yacoub MH, et al. Outcome in adult patients after arterial switch operation for transposition of the great 
arteries. Int J Cardiol. 2013;167(6):2588-93.
4. van der Palen RLF, van der Bom T, Dekker A, Tsonaka R, van Geloven N, Kuipers IM, Konings TC, 
Rammeloo LAJ, Ten Harkel ADJ, Jongbloed MRM, et al. Progression of aortic root dilatation and aortic 
valve regurgitation after the arterial switch operation. Heart. 2019;105(22):1732-40.
5. Rizopoulos D. Joint Models for longitudinal and Time-to-Event Data with Applications in R2012.
6. R Core Team (2017). R: A language and environment for statistical computing.  R Foundation for Statistical 
Computing, Vienna, Austria. URL https://www.R-project.org/.
7. Rizopoulos D. The R Package JMbayes for Fitting Joint Models for Longitudinal and Time-to-Event Data 
Using MCMC. J Stat Softw. 2016(72):1-46.
8. Grande KJ, Cochran RP, Reinhall PG, Kunzelman KS. Mechanisms of aortic valve incompetence: finite 




Aortic 4D flow MR imaging
The arterial switch operation for TGA and beyond
PART II

Roel L.F. van der Palen
Arno A.W. Roest




Scan-rescan reproducibility of segmental aortic 
wall shear stress as assessed by phase-specific 
segmentation with 4D flow MRI in healthy 
volunteers
Magnetic Resonance Materials in Physics, Biology and Medicine. 2018;31:653-63
CHAPTER 6




The aim was to investigate scan-rescan reproducibility and observer variability of segmental 
aortic 3D systolic wall shear stress (WSS) by phase-specific segmentation with 4D flow MRI 
in healthy volunteers.
Materials and Methods
Ten healthy volunteers (age 26.5 ± 2.6 years) underwent aortic 4D flow MRI twice. Maximum 
3D systolic WSS (WSSmax) and mean 3D systolic WSS (WSSmean) for 5 thoracic aortic 
segments over 5 systolic cardiac phases by phase-specific segmentations were calculated. 
Scan-rescan analysis and observer reproducibility analysis were performed.
Results
Scan-rescan data showed overall good reproducibility for WSSmean (coefficient of variation, 
COV 10-15%) with moderate-to-strong intraclass correlation coefficient (ICC 0.63-0.89). The 
variability in WSSmax was high (COV 16-31%) with moderate-to-good ICC (0.55-0.79) for 
different aortic segments. Intra- and interobserver reproducibility was good-to-excellent 
for regional aortic WSSmax (ICC ≥0.78; COV ≤17%) and strong-to-excellent for WSSmean 
(ICC ≥0.86; COV ≤11%). In general, ascending aortic segments showed more WSSmax/
WSSmean variability compared to aortic arch or descending aortic segments for scan-rescan, 
intraobserver and interobserver comparison.
Conclusions
Scan-rescan reproducibility was good for WSSmean and moderate for WSSmax for all 
thoracic aortic segments over multiple systolic phases in healthy volunteers. Intra/
interobserver reproducibility for segmental WSS assessment was good-to-excellent. 
Variability of WSSmax is higher and should be taken into account in case of individual follow-
up or in comparative rest-stress studies to avoid misinterpretation.




Four-dimensional flow magnetic resonance imaging (4D flow MRI) is a non-invasive imaging 
method to investigate in-vivo cardiovascular flow and is used to better understand 
cardiovascular physiology and pathophysiology. Besides simple measures of flow,1-3 this 
technique allows for quantification of more comprehensive hemodynamic parameters, such 
as wall shear stress (WSS).4, 5 WSS is defined as the viscous shear force of flowing blood 
acting tangentially to the vessel wall and can be estimated in both small and large vessels. 
Alterations in WSS within the aorta have been associated with vascular wall remodelling 
and dysfunction6 and this hemodynamic parameter is therefore of interest in patients with 
aortopathy.
Aortic WSS can be calculated from 4D flow MRI data based on 2D cross-sectional planes 
at specific locations along the vessel wall7 or by volumetric 3D WSS computational 
algorithms.8 It is known that several acquisition and post-processing factors may influence 
the estimation of WSS, e.g. spatial resolution, settings of encoding velocity (VENC parameter), 
signal-to-noise ratio and segmentation inaccuracies.9, 10 Estimation of WSS from 4D flow MRI 
data necessitates analysis of velocity data within a geometric representation of the 3D 
vascular structure of interest through segmentation (i.e. creating a cast of the vessel of 
interest).11 Currently, thoracic aorta segmentations in most studies are based on phase 
contrast MR angiograms averaged over all cardiac time frames or manually drawn for every 
cardiac time frame in 2D planes. Using these approaches, accurate WSS reproducibility has 
been proven in healthy volunteers.7, 12 However, due to movement of the aorta during the 
cardiac cycle, aortic compliance and peak systolic time-differences of the propagating blood 
flow wave front along the thoracic aorta, calculations of WSS throughout the systolic cardiac 
cycle from a time frame averaged aortic cast could lead to an incorrect assessment of true 
aortic border velocities for aortic segments along the thoracic aorta.
Therefore, the aim of the study was to assess scan-rescan reproducibility and observer 
variability of segmental aortic 3D WSS based on semi-automatic, systolic phase-specific 3D 
aortic segmentation from 4D flow MRI in healthy volunteers. To put the reproducibility 
analysis of segmental WSS approach into clinical perspective, aortic WSS analyses of two 
patient cases with congenital aortic abnormalities were compared to the healthy volunteers.
Materials and methods
Study population
The study protocol was approved by the Medical Ethics Committee of the Leiden University 
Medical Center and informed consent was obtained from all participants. Ten healthy 
volunteers (age 26.5 ± 2.6 yrs) without history of cardiovascular disease were included. All 
subjects underwent a cardiovascular MR examination including aortic 4D flow MRI. The 
same scanning protocol was performed twice (i.e. scan and rescan) in the same session with 
a 10-minute break between the scans and repositioning and replanning for every volunteer.
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Cardiovascular MR imaging acquisition and 4D flow data processing
Cardiovascular MR imaging, including aortic 4D flow imaging, was performed on a 3.0 Tesla 
scanner (Ingenia, Philips Medical Systems, the Netherlands with Software Stream 4.1.3.0) 
with FlexCoverage Posterior coil in the table top with a dStream Torso coil, providing up to 
32 coil elements for signal reception. Aortic 4D flow MRI was acquired during free breathing 
using respiratory navigator gating based on hemidiaphragm excursion and retrospective 
ECG gating with full 3D coverage of the thoracic aorta in an oblique sagittal orientation. 4D 
flow MRI sequence parameters were as follows: velocity-encoding of 200 cm/s in three 
directions, acquired spatial resolution: 2.5 x 2.5 x 2.5 mm, temporal resolution: 35.1-36.5 
ms, echo time/repetition time: 2.5-2.7 ms/4.4-4.6 ms, flip angle: 10°, field of view: 350 x 250 
x 75 mm, TFE factor: 2, Sensitivity encoding (SENSE) factor 2.5 in anterior-posterior direction. 
Concomitant gradient correction and local phase correction was performed from standard 
available scanner software. Acquisition time was on average 12 minutes.
4D flow MRI data was imported into the commercially available software program CAAS 
MR 4D flow v1.1 (Pie Medical Imaging BV, Maastricht, the Netherlands). Additional phase 
offset correction and anti-aliasing was performed in the CAAS MR software package.
The peak systolic cardiac phase was automatically detected by the CAAS MR Flow software 
program by identification of the cardiac phase with the highest variance in the 3D velocity 
dataset. For this phase, the segmentation was initialized by manual placing two delimiter 
points (start and endpoint): one in the subaortic region of the left ventricular outflow tract 
(start point) and one in the descending aorta (end point), at the same level as the start point. 
A phase-specific 3D aortic volume was automatically segmented for this peak systolic phase 
plus two consecutive phases before and two phases after this peak systolic phase (i.e. peak 
systolic phase-2, peak systolic phase-1, peak systolic phase, peak systolic phase+1 and peak 
systolic phase+2). The 3D segmentation uses a deformable model algorithm13 that recursively 
optimizes the location of the surface towards the vessel luminal boundary based on image 
gradients, extracted from the appropriate phase within the 4D flow MRI data, while 
simultaneously maintaining local smoothness of the 3D segmented surface. Manual 
delineation of the vessel lumen boundary was applied with the available adaptation tool 
from the software in case of segmentation incorrectness.
Segmental WSS assessment
The surface of the 3D segmented aorta consisted of wall points and for each wall point the 
3D systolic WSS vector was calculated based on a quadratic approximation of the axial 
velocity profile perpendicular to the surface of the 3D segmented aorta. For the regional 
assessment of maximum aortic 3D systolic WSS (WSSmax) and mean 3D systolic WSS 
(WSSmean) the thoracic aorta was manually divided into 5 aortic segments based on 
anatomic landmarks (Figure 1). This aortic subdivision was applied to each of the five phase-
specific segmentations. Segment 1: proximal ascending aorta (pAAo, from the sinotubular 
junction to the mid-ascending aorta); segment 2: distal ascending aorta (dAAo, from mid-
ascending aorta to the origin of the innominate artery); segment 3: aortic arch (Arch, from 
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origin innominate artery until left subclavian artery); segment 4: proximal descending aorta 
(pDAo, beyond the left subclavian artery to the mid-descending thoracic aorta); and segment 
5: distal descending aorta (dDAo, from mid-descending thoracic aorta to the descending 
aorta at the level of the aortic valve). Of note, supra-aortic arch branches were excluded 
from segmental WSS measurements. WSSmax was defined as the maximum WSS vector of 
all wall points within the defined aortic segment. WSSmean was defined as the average of 
all WSS vectors of all wall points within the defined aortic segment.
To assess scan-rescan reproducibility, the two consecutively acquired 4D flow MRI scans 
for each healthy volunteer were analyzed and compared: segmental aortic WSS analysis 
(i.e. including segmentation and adaptation, and subsequent division of the aorta into 5 
segments) for 5 systolic cardiac phases (peak systolic phase ± 2 phases) was performed for 
the first and second 4D flow MRI scan data (i.e. scan and rescan) by a single observer (RvdP) 
in all volunteers. All data was presented blinded to the observers who analyzed the data in 
a random order. To assess intraobserver variability, segmental aortic WSS analysis was 
performed twice for 5 systolic cardiac phases (peak systolic phase ± 2 phases) from the first 
acquired 4D flow MRI scan by a single observer (RvdP) in all volunteers. To assess 
interobserver variability, segmental aortic WSS analysis was performed for 5 systolic cardiac 
phases (peak systolic phase ± 2 phases) from the first acquired 4D flow MRI scan by two 
observers (RvdP and PvdB) in all volunteers. The analysis took approximately 18 minutes 
per systolic phase per volunteer.
To put the reproducibility analysis of segmental WSS approach into clinical perspective, 
two patient cases with congenital aortic abnormalities were included: Case 1. A 13-year-old 
male patient with non-stenotic residual narrow proximal descending aortic segment after 
surgical correction for aortic coarctation at the age of 1 month; and Case 2. A 17-year-old 
Figure 1. Aortic 4D flow MRI processing and analysis.
4D flow MRI raw data including anatomical and flow data (A). Automatic segmentation of 3D aortic volume 
after manually defining start and endpoint of the thoracic aorta and aortic segment definition (B). 3D color-
coded aortic segmentation representing WSSmax distribution for one systolic cardiac phase (C).
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male patient with ascending aortic dilation after arterial switch operation for transposition 
of the great arteries prior to replacement of the proximal ascending aorta. Cardiovascular 
MR imaging, including 4D flow MRI and post-processing, was performed in these cases 
according to above described methods. An aortic segmentation was made and WSS 
calculations (WSSmax and WSSmean) were performed for the peak systolic cardiac phase 
for the aortic segments of interest for the two patients. For patient case 1 this included the 
pDAo segment, for patient case 2 the ascending aortic segments (pAAo and dAAo).
Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics 20.0 (SPSS Inc., Chicago, IL, USA). 
Normality assumptions for all variables were assessed using a Shapiro-Wilk test. All 
continuous parameters were expressed as mean ± standard deviation (SD). Paired t-test 
was used to determine heart rate differences and differences in time-points of the systolic 
cardiac phases between the scan and rescan data. To assess the degree of agreement for 
scan-rescan and intra- and interobserver comparison, mean differences and limits of 
agreement (± 2SD of mean difference) of WSSmean and WSSmax for the different aortic 
segments from 5 consecutive cardiac systolic phases were calculated by Bland-Altman 
analysis.14 Correlation between measurements of the scan and rescan as well as for intra- 
and interobserver comparison was tested by the Spearman correlation coefficient (r). To 
evaluate the extent of variability in relation to the mean, the coefficient of variation (COV) 
was calculated as: standard deviation of mean difference for the WSS parameter (WSSmean 
or WSSmax) between scan-rescan divided by the group average of that WSS parameter for 
each aortic segment. Reliability between two scans was assessed by the intra-class 
correlation (ICC) coefficient. Correlation and agreement were classified as follows: r or ICC 
≥0.95: excellent, 0.94-0.85: strong, 0.84-0.70: good, 0.69-0.50: moderate, <0.50: poor. The 
COV was classified as: low (≤10%), intermediate (11-20%), high (21-30%) and very high (≥31%). 
A P value <0.05 was considered statistically significant.
Results
Baseline characteristics of the volunteers are shown in Table 1. Average heart rate (HR) was 
similar in the volunteers for the scan and rescan (60.8 ± 7.7 vs 61.6 ± 6.0 bpm, P = 0.65). 
Average time-points of the 5 systolic phases (ms) throughout the cardiac cycle were not 
significant different between the scan and rescan data from the volunteers (Table 1).
Scan-rescan reproducibility
Figure 2 shows the group averaged WSS measurements over 5 systolic cardiac phases (peak 
systolic phase ± 2 phases) across the 5 thoracic aortic segments for all volunteers for the 
scan and rescan. The average WSSmean shows very similar values for scan and rescan and 
both average WSSmean and average WSSmax closely follow similar trend during the 5 
systolic cardiac phases.
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Results from the scan-rescan reproducibility analysis for regional aortic WSSmean and 
WSSmax are presented in Table 2. For all thoracic aortic segments, moderate to good ICCs 
and Spearman correlations were found for WSSmax and overall good to strong ICCs with 
good to strong correlation for WSSmean. COV of segmental systolic WSS measurements 
between the scan and rescan were 16-31% for WSSmax and 10-15% for WSSmean. For the 
WSSmax, this degree of variation was higher for the ascending aortic segments compared 
to the descending aortic segments, on average 26-31% versus 16-18% respectively. Bland-
Altman plots and correlation diagrams for scan-rescan analysis for WSSmax and WSSmean 
of all aortic segments during 5 systolic cardiac phases were depicted in Figure 3.
Intraobserver analysis
Table 3 and supplementary Tables S1-S4 show the results of the intraobserver reproducibility 
analysis. Both WSSmax and WSSmean showed overall good to excellent correlation for the 
different aortic segments (WSSmax:  r = 0.66-0.99, P < 0.001-0.038); WSSmean: r = 0.82-1.00, 
P < 0.001-0.004) with overall strong to excellent ICC and low COV indicating excellent 
reproducibility (range COV WSSmax 1-14%; range COV WSSmean 1-7%) (supplementary 
Tables S1-S4). Larger variability for WSS measurements of the ascending aortic segments 
was shown compared to the measurements of the aortic arch and descending aortic 
segments, more pronounced for the WSSmax than for WSSmean.
Table 1. Baseline characteristics
Volunteers Scan Rescan P value*
n 10
Male (%) 5 (50%)
Age, years 26.5 ± 2.6
Height, cm 175.6 ± 6.6
Weight, kg 68.3 ± 12.7
BSA, m2 1.8 ± 0.2
Heart rate, bpm 61 ± 8 62 ± 6 0.65
Time-points throughout cardiac cycle (ms)
Peak systolic phase-2 104.1 ± 19.2 103.4 ± 19.0 0.91
Peak systolic phase -1 136.8 ± 18.4 135.4 ± 18.1 0.86
Peak systolic phase 169.0 ± 17.5 167.5 ± 17.6 0.85
Peak systolic phase +1 201.5 ± 17.6 199.9 ± 17.2 0.83
Peak systolic phase +2 233.6 ± 17.6 232.0 ± 17.1 0.83
Data presented as mean ± standard deviation. * paired sample t-test.
BSA, body surface area; bpm, beats per minute; ms, milliseconds.
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Interobserver analysis
Results from the interobserver reproducibility analysis are depicted in Table 4 and 
supplementary Tables S5-S8. WSSmax between the two observers shows overall good to 
excellent correlation (r = 0.77-0.99, P < 0.001-0.009) with strong to excellent ICC and low to 
intermediate COV (2-17%), indicating good reproducibility. WSSmean between the two 
observers shows good to excellent correlation (r = 0.76-1.00, P < 0.001-0.011) with overall 
excellent ICC and low COV (1-11%), indicating excellent reproducibility (supplementary Tables 
S5-S8). Least variability in WSS parameters is seen in the aortic arch and descending aortic 
segments.
Clinical application of segmental WSS assessment - patient cases
Figure 4 shows two examples of aortic WSS assessment by 4D flow MRI in patients with 
congenital heart disease involving the aorta. Panel 4A shows the color-coded aortic model 
of the WSSmax distribution from a 13-year-old patient after neonatal aortic coarctation 
repair with a residual non-stenotic narrow proximal descending aortic segment (patient 1). 
Peak systolic WSSmax and WSSmean in the post-coarctation region were 7023 mPa and 
3444 mPa, respectively. These WSS values are high and far above the upper 95% confidence 
Figure 2. Mean and max systolic WSS over 5 systolic cardiac phases around peak systole (peak systolic phase 
± 2 phases) across the 5 thoracic aortic segments for all volunteers.
Error bars represent standard error of the mean (SEM).
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limit compared to the average WSS measures in the proximal descending aortic segment 
of the 10 healthy volunteers (scan/rescan: WSSmax 2492 ± 497/ 2466 ± 431mPa; WSSmean 
1418 ± 199/ 1386 ± 180 mPa) (Figure 2).
Panel 4B shows the color-coded aortic model of WSSmax distribution from a 17-year-old 
male patient after neonatal arterial switch operation for transposition of the great arteries 
(TGA) with severely dilated proximal ascending aortic segment (52 mm) prior to ascending 
aorta replacement (patient 2). Regional peak systolic WSS values in this TGA patient: WSSmax 
2564 mPa; WSSmean 842 mPa. These WSS values were lower compared to the average WSS 
measures found in the proximal ascending aortic segment in the 10 healthy volunteers 
(scan/rescan: WSSmax 3106 ± 479/ 3385 ± 1553 mPa and WSSmean 1432 ± 273/ 1340 ± 335 
mPa) (Figure 2).
Figure 3. Bland-Altman and correlation plots for scan-rescan analysis for the WSSmax (A-B) and WSSmean 
(C-D) for 5 systolic cardiac phases (peak systolic phase ± 2 phases)
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Discussion
The results of this study demonstrate reproducibility of segmental aortic systolic 3D WSS 
measures in the thoracic aorta of healthy volunteers, by phase-specific 4D flow MRI 
segmentation. Scan-rescan reproducibility was good for WSSmean for all thoracic aortic 
regions but scan-rescan reproducibility for WSSmax was moderate with higher variability 
up to 31% in the proximal ascending aorta. The intraobserver and interobserver 
reproducibility for segmental systolic WSS analysis of WSSmax and WSSmean was good to 
excellent. In general, the ascending aortic segments showed more variability in WSSmax 
and WSSmean measurements compared to aortic arch or descending aortic segments for 
scan-rescan, intraobserver and interobserver comparison.
Deriving accurate WSS from 4D flow MR velocity data remains challenging and delineation 
of the aortic wall influences the accuracy of this WSS estimation.9, 10 Most of the previously 
reported studies on 3D WSS assessment make use of segmentations based on phase 
contrast MR angiograms averaged over all cardiac time frames to assess aortic WSS over 
the entire systolic cardiac cycle.12, 15-17 In this study, we used a phase-specific segmentation 
approach for 3D WSS calculations from velocity data for 5 consecutive systolic cardiac 
phases. A major advantage of this phase-specific segmentation approach is that it will 
Figure 4. Color-coded aortic model representing WSSmax distribution from two patients with congenital heart 
disease involving the aorta.
Aortic model from a 13-year-old male patient with non-stenotic residual narrow proximal descending aortic 
segment after surgical correction for aortic coarctation (A). Aortic model from a 17-year-old male patient with 
severe dilation of the proximal ascending aorta after neonatal arterial switch operation for transposition of 
the great arteries (B).
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approximate the aortic wall of the thoracic aorta more accurate in order to better estimate 
true border WSS. Due to the aortic compliance and movement of the aorta, calculations 
from a segmentation from averaged phase contrast MR angiograms over all cardiac time 
frames could lead to an incorrect assessment of WSS along the thoracic aortic wall. 
Furthermore, the phase-specific segmentations enable identification of peak systolic WSS 
for each aortic segment along the thoracic aorta, which for every aortic segment is reached 
at a different time frame throughout systole.
The ability to measure advanced aortic hemodynamic parameters make 4D flow MRI 
potentially valuable for patients with different entities of aortopathy: to assess disease 
severity, to better anticipate disease progression and potentially stratify patients at risk for 
adverse events. However, knowledge of scan-rescan variability for regional WSS measures 
is essential to study interactions between hemodynamic parameters and aortic geometry 
and to judge whether hemodynamic changes in patients over time represent true (patho)
physiological changes.
Few studies have investigated scan-rescan reproducibility and/or observer variability of 
aortic WSS measurements in vivo.7, 12, 18 Similar to our findings, these studies reported good 
scan-rescan reproducibility for WSSmean measures with relatively higher scan-rescan 
variability for WSSmax measures. However, these WSS reproducibility studies used different 
approaches for WSS estimation varying from a time-resolved 2D planar WSS quantification 
method with manual 2D aortic segmentation7 to a volumetric 3D WSS assessment from an 
aortic segmentation from phase contrast MRAs averaged over all cardiac time frames.12 
Furthermore, different time intervals between first and second scan in these studies were 
chosen compared to this study and varied from 2-4 weeks12 to 1 year.7 Moreover, in the 
study by van Ooij et al.12 anisotropic voxels of different sizes for different subjects were 
used, that might have resulted in accuracy problems of WSS estimations between subjects. 
Our study extends the WSS reproducibility knowledge with its phase-specific, semi-
automated 3D WSS segmentation approach with segmental aortic WSS assessment from a 
non-contrast enhanced 4D flow MRI data acquisition. The good to excellent intra- and 
interobserver reproducibility from this study is in accordance with these reported studies7, 
12 and a study by Bieging et al.,18 in which observer reproducibility was evaluated by a time-
resolved volumetric 3D aortic WSS approach for contrast-enhanced 4D flow MRI.
In general, ascending aortic segments showed more variability in WSSmax and WSSmean 
compared to aortic arch or descending aortic segments for scan-rescan, intra- and 
interobserver comparison. Operator and subject dependent factors may have contributed 
to the differences found in WSS reproducibility for different aortic segments. First, the sub-
optimal anatomic information within the 4D flow dataset hampers the exact manual 
determination of the aortic segments based on anatomic landmarks; especially identifying 
the sinotubular junction to determine the proximal ascending aortic segment proved to be 
challenging. Second, variability due to movement and systolic longitudinal stretch of the 
ascending aorta cannot entirely been ruled out as an influencing factor, despite the phase-
specific segmentation has been applied. Heart-beat related motion and longitudinal stretch 
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during systole has been reported to be more present in the ascending aorta compared to 
the aortic arch and descending aorta.19, 20 Third, small individual variations in heart rate 
might have affected WSS differences between scan and rescan, although the averaged heart 
rate of each individual volunteer was not significantly different between the consecutive 
scans. Greater variability was found in WSSmax for both scan-rescan, but in general WSSmax 
values are more subject to noise than WSSmean values. Furthermore, the VENC setting 
affects the velocity-to-noise ratio and therefore may have influence on the WSS calculations 
in low velocity range near the aortic wall. In this study, VENC was 200 cm/s, which was chosen 
with respect to the anticipated peak velocity in the full aorta, in order to avoid phase 
wrapping. However, the VENC setting was identical between both scan and rescan and 
therefore differences due to the velocity sensitivity between both scans are unlikely.
In patients with aortopathy, the aorta can be regionally affected or being entirely involved 
in the disease, depending on its expression. Aortic WSS disturbances have been shown to 
strongly correlate with molecular and architectural medial aortic wall alterations6 or show 
a direct relation with its regional aortic geometry.16, 21 The regional WSS analysis by phase-
specific segmentation models in the presented patient cases provides its clinical applicability 
in locally diseased aortas, as the WSS values in patient 1 fall far beyond the confidence these 
intervals of the healthy controls and the WSS values in patient 2 are considerably lower than 
of the healthy controls with this WSS approach. Using this method, it shows that segment-
specific aortic WSS estimation is discriminative and emphasizes the importance of accurate 
knowledge of WSS reproducibility and consistency across different aortic segments for each 
applied WSS method.
A limitation of this study is that the study consisted of only 10 healthy volunteers with a 
relatively small age range. A larger number of volunteers with a larger variation of age could 
have provided more information about the robustness of this method over ages. The study 
did not include patients with aortopathy for a scan-rescan comparison which could have 
provided more insight in the reproducibility of this method for clinical use in patients with 
aortic disease. The spatial and temporal resolution was similar for the scan-and rescan and 
both were performed without use of contrast agents. The latter could be considered as a 
limitation as the use of contrast agents might have increased our signal-to-noise ratio and 
therefore our reproducibility. However, in the light of the recent discussions on the use of 
contrast agents in cardiovascular MR we tested the robustness of the WSS assessment 
method with 4D flow MRI without contrast.22 The scan and rescan for every volunteer in this 
study was performed on the same day, which is the most ideal circumstance for a 
reproducibility analysis, as the volunteers were in the same cardiovascular, neurohormonal 
and mental status, at the same scanner, the similar moment of the day. Repeated scans on 
separate days would have been more comparable with clinical practice and may have 
resulted in a more realistic estimation of reproducibility. However, these assessments have 
already been performed in other WSS reproducibility studies with time intervals between 
first and second scan varying from 2-4 weeks12 to 1 year.7
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In conclusion, reproducibility of phase-specific WSS assessment in this scan-rescan study 
in healthy volunteers was good for mean 3D systolic WSS for all thoracic aortic segments 
over multiple systolic phases. Maximum 3D systolic WSS showed more variability, up to 31% 
for the proximal ascending aortic region. Although intra- and interobserver reproducibility 
is good to excellent, these scan-rescan WSS variations should be considered to avoid 
misinterpretation by investigators in case of individual follow-up or in comparative rest-
stress studies.
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CHAPTER 7




Patients with transposition of the great arteries (TGA) have an altered aortic geometry after 
an arterial switch operation (ASO), with neo-aortic root dilatation as an important 
complication. Geometry-related aortic hemodynamics have been assumed to contribute to 
pathology of the ascending aorta (AAo). 
Purpose
To evaluate aortic flow displacement (FD) and regional wall shear stress (WSS) in relation 




Twenty-eight TGA patients after ASO and ten healthy volunteers. 
Field Strength/Sequence
3.0T/4D flow (segmented fast-spoiled echo pulse), non-contrast enhanced MR angiography 
(Dixon), and anatomic images (SSFP).
Assessment
Aortic diameters and body surface area-indexed aortic dimensions (Z-scores), normalized 
FD and planar ascending aortic WSS.
Statistical tests
Mann Whitney and chi-square tests for differences in FD magnitude, WSS, and FD 
directionality between groups, respectively. Spearman rank correlation to assess the degree 
of association between aortic geometry, FD and WSS parameters. Shapiro-Wilk test to 
evaluate distribution normality on the absolute differences in octant location between FD 
and WSS.
Results
TGA patients showed a significantly dilated proximal AAo and relatively small mid-AAo 
dimensions at the level of the pulmonary arteries (Z-scores neo-aortic root: 4.38 ± 1.96 vs 
1.52 ± 0.70, P < 0.001; sinotubular junction: 3.48 ± 2.67 vs 1.38 ± 1.30, P = 0.010; mid-AAo: 
0.32 ± 3.06 vs 1.69 ± 1.24, P = 0.001). FD magnitude was higher in TGA patients (neo-aortic 
root: 0.048 ± 0.027 vs 0.021 ± 0.006, P < 0.001; sinotubular junction: 0.054 ± 0.037 vs 0.029 
± 0.013, P < 0.05) and was related to the neo-aortic Z-score. Clear areas of higher WSS at 
the right and anterior aortic wall regions along the distal AAo were detected in TGA patients, 
most pronounced in those with relatively smaller mid-AAo diameters.




TGA-specific geometry related to the ASO, evidenced by neo-aortic root dilatation and a 
sudden change in vessel diameter at mid-AAo level, leads to more aortic flow asymmetry 
in the proximal AAo and WSS distribution with higher WSS at the right and anterior aortic 
wall regions along the distal AAo.
Introduction
The arterial switch operation (ASO) is currently the operation of choice for patients with 
transposition of the great arteries (TGA).1 The ASO replaced the atrial switch operation with 
excellent early and long-term survival and good function outcome in most of the patients. 
However, studies on large cohorts of patients show progressive neo-aortic root dilatation 
over time with an associated increased incidence of neo-aortic regurgitation and the need 
for root and/or valve re-operation.2, 3 Factors involved in the pathophysiological mechanisms 
for neo-aortic root dilatation are largely unknown.
The ASO with the Lecompte maneuver restores ventriculo-arterial concordance; however, 
the spatial relation between the aorta and pulmonary artery is still abnormal, with the 
pulmonary trunk situated anterior to the ascending aorta and the two pulmonary arteries 
embracing the ascending aorta. During the ASO, the aorta and pulmonary trunk are 
transected just above the commissures and relocated, leaving the semilunar valves and 
native root in its original position. Subsequently, the proximal part of the native pulmonary 
trunk becomes the proximal neo-aorta and the native aortic root becomes the neo-
pulmonary root. The arterial relocation leads to an abnormal angulation between the neo-
aortic valve and the newly formed sinotubular junction (STJ) in TGA patients compared with 
healthy subjects, and geometric alterations in the ascending neo-aorta after ASO have 
hemodynamic consequences.4, 5
Currently, 4D flow magnetic resonance imaging (4D flow MRI) allows visualization and 
quantification of abnormal hemodynamics within the ascending aorta6 which has led to 
better knowledge of cardiovascular hemodynamics and disease progression in patients 
with congenital heart disease-related aortopathy.7-11 Different studies have shown that aortic 
flow eccentricity, defined as the displacement of peak systolic flow from the aortic center, 
is related to aortic morphology in bicuspid valve-related dilated aortopathy.11, 12 Another 
comprehensive hemodynamic parameter that can be derived from 4D flow MRI is wall shear 
stress (WSS). WSS is defined as the viscous shear force of flowing blood acting tangentially 
to the vessel wall. Areas of high WSS have been associated with marked histological changes 
in the ascending aortic vessel wall in patients with bicuspid aortic valves.13 In addition, 
abnormal WSS has been suggested to have potentially contributing effects on vessel 
dilatation and aneurysm formation; for example, on the thoracic aorta and on intracranial 
aneurysms.14, 15 In TGA patients after ASO, abnormal flow patterns in the ascending aorta 
are present in the majority of patients.4 Assessment of aortic flow displacement and 
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detection of areas of high WSS may be helpful in unravelling flow alterations and their 
relationship with altered arterial geometry and aortic dilatation. We hypothesized that the 
specific geometry of the ascending neo-aorta after ASO including the Lecompte maneuver 
is related to altered ascending aortic flow hemodynamics. Therefore, the aim of this study 
was to evaluate aortic flow displacement and regional WSS in relation to ascending neo-
aortic geometry in patients after ASO for TGA.
Materials and methods
Study population
All patients or their legal guardians and all healthy subjects gave written informed consent 
for the study. The study protocol was approved by the institutional Medical Ethical 
Committee. Twenty-eight patients with simple TGA or TGA with ventricular septal defect 
(VSD) were included in this study between December 2015 and March 2018. TGA patients 
(simple TGA or TGA with VSD) aged 10-25 years that underwent regular MRI examinations 
of the heart and large vessels as part of the standardized clinical follow-up protocol for early 
detection of well-known sequelae after ASO (typically performed shortly after birth) were 
asked for participation in the study. Aortic 4D flow acquisitions were performed additionally 
to a standard-of-care cardiac MRI. To ensure morphologic homogeneity, patients with 
complex TGA including Taussig-Bing anomaly, prior left ventricular outflow tract obstruction, 
bicuspid neo-aortic valve, aortic arch obstruction, moderate-to-severe neo-aortic 
insufficiency, or prior neo-aortic valve or root re-operations were not included in the study. 
All patients underwent 4D flow MRI in addition to the clinically indicated standard-of-care 
MRI assessment of the heart and large vessels. Ten healthy subjects with a tricuspid aortic 
valve and without history of cardiovascular disease were included as a healthy reference 
group. All healthy subjects underwent the same MRI assessment of the heart and great 
vessels including 4D flow aortic imaging as part of a validation study.16 
MRI acquisition
MRI examinations including aortic 4D flow imaging of all patients and healthy subjects were 
performed at the same 3T scanner (Ingenia, Philips Medical Systems, the Netherlands; 
Software Stream 4.1.3.0) using a combination of FlexCoverage Posterior coil in the table top 
with a dStream Torso coil, providing up to 32 coil elements for signal reception. The standard-
of-care MRI exam of the heart and large vessels included dynamic ECG gated two-dimensional 
(2D) cine steady state free precession (SSFP) imaging for the evaluation of cardiac anatomy 
and function, as well as a non-contrast enhanced three-dimensional (3D) free-breathing 
navigator-gated MR angiography (NCE-MRA) images for the assessment of thoracic aorta 
diameters.17 For the NCE-MRA imaging, a Dixon sequence with prospective triggering and 
gated to end diastole, respiratory navigator gating was used with following sequence 
parameters: spatial resolution = 1.6 x 1.6 x 3.2 mm, echo time/repetition time = 2.3/3.6-3.9 
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msec, field of view = 300 x 300 x 99 mm; reconstructed voxel size = 0.8 x 0.8 x 1.6 mm. 4D 
flow MRI was a segmented fast spoiled-gradient echo technique with standard 4-point 
velocity encoding in all three directions. The 4D flow MRI was acquired during free breathing 
using a hemidiaphragm respiratory navigator and retrospective ECG gating. Scan parameters 
were as follows: velocity-encoding of 200-300 cm/s in three directions, acquired spatial 
resolution = 2.5 x 2.5 x 2.5 mm, temporal resolution = 33.6-36.8 msec, echo time/repetition 
time = 2.4-2.7/4.2-4.6 msec, flip angle = 10°, field of view = 350 x 250 x 75 mm, segmentation 
factor = 2, sensitivity encoding (SENSE) was used with SENSE factor 2.5 in anterior-posterior 
direction. Acquisition time was on average 12 minutes. Concomitant gradient correction 
and initial phase offset correction was performed from standard available scanner software.
Data analysis
Aortic dimensions and cardiac function
Left ventricular ejection fraction was measured from short-axis SSFP images by a radiologist 
with over 20 years of experience in MR imaging (L.K.). From NCE-MRA, ascending aortic 
diameters were measured at five standardized anatomic landmarks according to 
international guidelines,18 consisting of the neo-aortic valve (AoV), neo-aortic root (Root), 
STJ, for TGA patients defined as the aortic level 5-7 mm below the pulmonary artery 
bifurcation; mid-ascending aorta at the level of the pulmonary artery bifurcation (mid-AAo) 
and the distal ascending aorta, just proximal to the origin of the brachiocephalic trunk (AAo-
BCT) (Figure 1). All diameters were measured from edge to edge and obtained from a 
sagittal-axis orientation. The mean neo-aortic root diameters (i.e. average of three cusp-to-
commissure diameters) were measured perpendicular to the aortic axis on NCE-MRA double 
oblique transversal angulated multiplanar reconstructions. A second observer (independent 
radiologist with 10 years of experience in cardiovascular MR imaging) remeasured all 
ascending aortic diameters in a random subset of healthy volunteers (n = 5) and patients 
(n = 10) to assess interobserver reproducibility. To take into account differences in age and 
body size between individuals, aortic Z-scores were determined for each individual using 
MRI-derived normative data of aortic diameters in children and adolescents.19 Body surface 
area was calculated using the Mosteller formula. The Z-score represents the deviation of a 
given measurement to the body size or age-specific population mean. A Z-score between 
-2 and +2 is considered normal. Aortic diameter ratio between the neo-aortic root diameter 




4D Flow - Aortic flow displacement & WSS assessment
4D flow MRI data were imported into the software program CAAS MR 4D flow v2.0 (Pie 
Medical Imaging BV, Maastricht, the Netherlands). Additional phase offset correction and 
antialiasing was performed in the CAAS MR software package. The 4D flow segmentation 
was performed as previously described.16 In short, from the 4D flow raw data (Figure 1A) 
the peak systolic phase was automatically detected by the CAAS MR Flow software program 
by identification of the cardiac phase with the highest variance in the 3D velocity dataset. 
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For this phase (Figure 1B), the segmentation was initialized by manually placing two points 
(start and endpoint): one in the left ventricular outflow tract and one in the descending 
aorta, at the same level as the start point (Figure 1B). A centerline was automatically created 
(Figure 1B) and a phase-specific 3D aortic volume was automatically segmented for this 
peak systolic phase (Figure 1C) plus two consecutive phases before and two phases after 
this peak systolic phase. For the ascending aorta, the peak systolic 3D aortic segmentation 
was selected, visually checked and manually adapted when necessary in case of segmentation 
incorrectness. Eight cross-sectional planes were manually positioned along the ascending 
aorta perpendicular to the centerline (Figure 1D). The 2D analysis planes were placed from 
the LVOT to the origin of the brachiocephalic trunk at anatomic locations: 1. left ventricular 
outflow tract (LVOT), 0.5 cm beneath the neo-aortic valve (AoV) level; 2. AoV; 3. neo-aortic 
root (Root); 4. STJ, for TGA patients defined as the aortic level 5-7 mm below the pulmonary 
artery bifurcation; 5. mid-AAo, at the level of the pulmonary artery bifurcation; 6. distal 
ascending aorta-1 (dAAo-1), at 1/3 distance between plane 5 and plane 8, calculated from 
plane 5; 7. distal ascending aorta-2 (dAAo-2), at 2/3 distance between plane 5 and plane 8, 
calculated from plane 5; 8. proximal to the origin of the brachiocephalic trunk (AAo-BCT) 
(Figure 1D).
Normalized systolic flow displacement (FD) was calculated in each of the cross-sectional 
planes according to a method previously described by Sigovan et al.20 (Figure 1E). Briefly, 
FD is defined as the distance between the anatomical center of the vessel and the center 
velocity (Cvel) of the flow at peak systole, normalized to the vessel lumen diameter. The 
vessel lumen diameter was automatically identified on 2D analysis planes by the CAAS MR 
software and manual delineation of the vessel lumen boundary was performed with the 
available adaptation tool from the software in case of incorrectness. To determine the center 




	 , 𝑖𝑖 = 𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙	𝑝𝑝𝑖𝑖𝑝𝑝𝑙𝑙𝑙𝑙𝑝𝑝; 𝑗𝑗 = 𝑝𝑝, 𝑦𝑦, 𝑧𝑧	𝑝𝑝𝑝𝑝𝑝𝑝𝑖𝑖𝑝𝑝𝑖𝑖𝑝𝑝𝑙𝑙𝑝𝑝; 𝑣𝑣' = 𝑣𝑣𝑙𝑙𝑙𝑙𝑝𝑝𝑣𝑣𝑖𝑖𝑝𝑝𝑦𝑦 
The vessel circumference was divided into eight equally-sized segments (octants) and for 
each patient the direction of FD in each cross-sectional plane was qualitatively assessed (A 
= anterior, LA = left-anterior, L = left, LP = left-posterior, P = posterior, RP = right-posterior, 
R = right, RA = right-anterior) (Figure 1E).
Peak systolic WSS was calculated for eight aortic wall segments from the cross-sectional 
planes 3-8 (i.e. from the neo-aortic root to the origin of the brachiocephalic trunk) (Figure 
1F). The systolic WSS was calculated based on the extracted velocity profile perpendicular 
to the phase-specific 3D aortic surface. After factorizing the velocity profile into its component 
parallel to the aortic lumen wall, the systolic WSS was computed by the first derivative of a 
quadratic approximation of that velocity profile at the location of the aortic lumen wall.16
Similarities between the location of FD and the location of the highest systolic WSS were 
evaluated by determining the absolute difference between these locations. The number of 
octant positions clockwise or counterclockwise away from the position of the FD location 
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was calculated and categorized as follow: 0 = no difference in location; 1 = difference of 1 
octant position; 2 = difference of 2 octant positions; 3 = difference of 3 octant positions; 4 
= difference of 4 octant positions. A difference ≤1 octant position was defined as good to 
excellent. In case of no relationship, a Gaussian (nonskewed) distribution of the absolute 
differences is expected, with a nonsignificant result from the normality test.
Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics version 23 (IBM, Chicago, IL, 
USA). Variables are presented as mean ± standard deviation or median [interquartile range, 
IQR] if not normally distributed. A Shapiro-Wilk test was used to test variables for normal 
distribution. A chi-square test was performed to investigate differences in gender distribution 
between TGA patients and healthy subjects. To compare normally distributed parameters 
between TGA patients and healthy subjects an unpaired t-test was used. An interobserver 
reproducibility analysis was performed for the aortic diameter measurements. For 
comparison of differences in magnitude of FD and regional aortic WSS between the TGA 
patients and healthy subjects a Mann Whitney test was used. A chi-square test was 
performed to investigate differences in FD directionality between TGA patients and healthy 
subjects and within the TGA patients based on the preoperative spatial position of the great 
arteries. The relationship between aortic Z-score and FD was investigated using correlation 
analysis based on linear regression (Spearman’s correlation). Correlation analysis based on 
linear regression (Spearman’s correlation) was also performed to assess the effect of aortic 
geometry (aortic diameter ratio between neo-aortic root and mid-AAo) and WSS parameters. 
To evaluate distribution normality on the absolute differences in octant location between 
flow displacement in root, STJ and mid-AAo and location of highest peak systolic WSS at 
mid-AAo level, a Shapiro-Wilk test was performed and skewness and kurtosis markers were 
calculated. P < 0.05 was considered significant for all statistical tests. A Bonferroni correction 
was performed to adjust for the multiple comparisons for the planar WSS analysis along 
the AAo and differences between groups were considered significant for P < 0.00104.
Results
Baseline and surgical characteristics are presented in Table 1. No significant differences 
between TGA patients and healthy subjects were observed except for age. All patients and 
healthy subjects had a normal systolic left ventricular function. The proximal ascending 
aorta in TGA patients, including the indexed neo-aortic valve annulus, neo-aortic root and 
STJ, was significantly larger and dilated compared with healthy subjects. Using a Z-score 
>2.0 to define aortic dilatation, 25 patients (89%) had neo-aortic root dilatation and 19 of 
the TGA patients (68%) had dilatation of the STJ. In contrast, the diameter of the mid-AAo, 
the location where the pulmonary arteries embrace the ascending aorta from anterior in 
TGA patients, was significantly smaller in TGA patients compared with healthy subjects 
(mid-AAo: 17.0 [16.0-18.3] vs 20.5 [18.0-21.6] mm/m2, P = 0.001; mid-AAo Z-score 0.32 ± 3.06 
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Patient and surgical characteristics
Male, n (%) 18 (64.3) 5 (50.0) 0.473
Age, years 16.0 ± 3.3 27.3 [24.9-28.4] <0.001
Weight, kg 60.5 ± 14.0 68.3 ± 12.7 0.129
Height, cm 170.8 ± 12.2 175.6 ± 6.6 0.250
Body surface area, m2 1.7 ± 0.2 1.8 ± 0.2 0.137
LV ejection fraction, % 59.1 ± 5.7 62.0 ± 2.5 0.155
Surgical variables
Age at ASO, days 6.0 [4.0-10.0]
Weight at ASO, kg 3.5 ± 0.5
Lecompte maneuver, n (%) 28 (100)
Transposition type, n (%)
TGA-IVS 21 (75.0)
TGA-VSD 7 (25.0)
Great artery position, n (%)
Aorta right anterior to PA 15 (53.6)
Aorta right side to PA 3 (10.7)
Aorta anterior to PA 7 (25.0)
Aorta left anterior to PA 3 (10.7)
Aortic diameters (mm/ BSA0.5)a
Neo-aortic valve annulus 18.8 [17.4-20.1] 15.2 [13.9-17.4] <0.001
Neo-aortic root sagittal 28.0 [25.7-29.7] 23.1 [21.0-24.2] <0.001
Neo-aortic root short-axis, mean 27.2 [26.3-30.6] 22.4 [21.5-22.9] <0.001
Sinotubular junction 20.6 [19.7-24.0] 19.2 [17.2-20.2] 0.008
Mid ascending aorta 17.0 [16.0-18.3] 20.5 [18.0-21.6] 0.001
Origin of BCT 17.2 [15.5-18.1] 18.0 [16.3-18.9] 0.142
Aortic Z-scoresb
Neo-aortic root short-axis, mean 4.38 ± 1.96 1.52 ± 0.70 <0.001
Sinotubular junction 3.48 ± 2.67 1.38 ± 1.30 0.010
Mid ascending aorta 0.32 ± 3.06 1.69 ± 1.24 0.001
Origin of BCT -0.52 ± 1.21 0.20 ± 1.29 0.122
a Data are presented as median [interquartile range]. b Data are presented as mean ± SD.
ASO, arterial switch operation; BCT, brachiocephalic trunk; BSA, body surface area; IVS, intact ventricular septum; 
LV, left ventricular; PA, pulmonary artery; TGA, transposition of the great arteries; VSD, ventricular septal defect.
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vs 1.69 ± 1.24, P = 0.001). The interobserver reproducibility analysis showed an excellent 
agreement between the aortic measurements of the observers: mean difference 0.18 mm, 
limits of agreement (±2 SD) of 3.9 mm; coefficient of variation 3.2%; intraclass correlation 
coefficient: 0.979 (95% confidence interval [CI] 0.969-0.986); correlation: r = 0.96, P < 0.001.
Aortic flow displacement
The group-averaged magnitude of FD along the entire ascending aorta for both TGA patients 
and healthy subjects is illustrated in Figure 2. Flow displacement magnitude was significantly 
higher in TGA patients compared with the healthy subjects at the level of the neo-aortic root 
(FD 0.048 ± 0.027 vs 0.021 ± 0.006, P < 0.001) and STJ (FD 0.054 ± 0.037 vs 0.029 ± 0.013, P 
< 0.05). No differences in FD magnitude were found at the mid-AAo level (TGA vs healthy 
subjects: FD 0.050 ± 0.034 vs 0.033 ± 0.021, P = 0.083).
Flow displacement direction and magnitude for all individual patients and healthy 
subjects were depicted for three adjacent aortic planes (root, STJ, and mid-AAo) in Figure 
3. The FD direction in the ascending neo-aorta in TGA patients (root and mid-AAo) was 
different compared with healthy subjects (Figure 3; Root P = 0.024, mid-AAo P = 0.002). 
Figure 2. Flow displacement along the ascending aorta.
Group averaged flow displacement along the ascending aorta (mean, 95% CI) at aortic levels as stated in Figure 
1D. * P < 0.05.
AoV, neo-aortic valve; BCT, distal ascending aorta proximal to the origin of the brachiocephalic trunk; dAAo-1, 
distal ascending aorta at 1/3 distance between ‘mid-AAo plane’ and ‘BCT plane’; dAAo-2, distal ascending aorta 
at 2/3 distance between ‘mid-AAo plane’ and ‘BCT plane’; LVOT, left ventricular outflow tract; mid-AAo, mid 
ascending aorta; Root, neo-aortic root; STJ, sinotubular junction.
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Figure 3. Flow displacement magnitude and direction profiles.
Each dot represents the peak systolic flow displacement direction (i.e. octant location) and magnitude per 
subject (i.e. FD magnitude increasing from inner (0) to outer circle (0.20)): TGA patients (blue dots), healthy 
subjects (red dots) (A). Flow displacement direction per octant in TGA patients (n = 28) vs healthy subjects (n = 
10) (B). Of note, FD direction analysis for the mid-AAo plane is presented for 27 TGA patients and nine healthy 
subjects because of no FD in two subjects, one in each group. 
FD, normalized flow displacement; mid-AAo, mid-ascending aorta; STJ, sinotubular junction; TGA, transposition 
of the great arteries.
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Healthy subjects showed a primarily central and central-left orientated (left-anterior, left 
or left-posterior) aortic flow at the root, STJ and mid-AAo levels, whereas the TGA patients 
showed a more heterogeneous flow direction, both left- and rightward orientated in the 
root that shifted more to anterior and right side from root to the mid-AAo (Figure 3). 
Differences in FD direction between TGA patient subgroups based on preoperative great 
artery position were observed in the neo-aortic root (Figure 4). TGA patients with a right-
anterior or right-sided position of the aorta related to the pulmonary artery (n = 18) showed 
more FD to the right-side of the AAo, whereas a left-anterior or anterior position of the 
aorta (n = 10) resulted in more FD to the left-side of the aortic wall at the level of the neo-
aortic root (P = 0.025) (Figure 4). At the level of the STJ and mid-AAo this difference in FD 
direction could not be statistically detected (STJ, P = 0.148; mid-AAo, P = 0.738).
Ascending aortic WSS assessment
The systolic WSS distribution along the ascending aorta showed distinct differences between 
the TGA patients and the healthy subjects. In the proximal ascending aortic segment (plane 
3-4: root and STJ) the systolic WSS in the TGA patients was evenly distributed along the 
circumference of the aortic wall and WSS was low. In specific regions at these levels (root 
and STJ) significantly lower WSS was found compared with the healthy subjects (Figure 5, 
plane 3-4: root and STJ).
Figure 4. Flow displacement direction per octant in TGA subgroups.
TGA patients are divided into subgroups based on great artery position before arterial switch operation (aorta 
related to pulmonary trunk). Group 1 (TGA RA + RS) consists of TGA patients with the aorta right-anterior (RA) 
or right-sided (RS) to the pulmonary trunk (n = 18). Group 2 (TGA LA + A) consists of TGA patients with the aorta 
anterior (A) or left-anterior (LA) to the pulmonary trunk (n = 10). Of note, FD direction for the mid-AAo plane is 
presented in nine TGA LA+A patients because of no FD in 1 TGA LA+A patient.
A, anterior; LA, left-anterior; RA, right anterior; RS, right-sided; TGA, transposition of the great arteries.
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In TGA patients, significantly higher and highly asymmetric peak systolic WSS was detected 
in the distal ascending aortic segments, at and beyond the level of the embracement of the 
ascending aorta by the pulmonary artery branches (plane 6-8: dAAo-1, dAAo-2, and AAo-BCT) 
(Figure 5). At these distal AAo planes, the distribution of the systolic WSS in the TGA patients 
was uneven, with the most pronounced significantly increased peak systolic WSS in the 
anterior regions (right-anterior, anterior and left-anterior, P ≤ 0.001). In healthy subjects 
there was no increase in systolic WSS in the distal part of the ascending aorta (Figure 5).
Figure 5. Planar aortic WSS assessment along the ascending aorta in TGA patients and healthy subjects.
Wall shear stress in mPa. Mann Whitney test for comparison of differences in regional aortic WSS between 
the TGA patients and healthy subjects. Differences between the groups were considered significant for P < 
0.00104 (Bonferroni correction for multiple comparisons).
AAo-BCT, distal ascending aorta proximal to the origin of the brachiocephalic trunk; dAAo-1, distal ascending 
aorta at 1/3 distance between plane 5 ‘mid-AAo’ and plane 8 ‘AAo-BCT’; dAAo-2, distal ascending aorta at 2/3 
distance between plane 5 ‘mid-AAo’ and plane 8 ‘AAo-BCT’; mid-AAo, mid ascending aorta; Root, neo-aortic 
root; STJ, sinotubular junction; TGA, transposition of the great arteries.
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Flow displacement, WSS and correlations with aortic geometry
In the entire study cohort (TGA patients and healthy subjects), FD magnitude showed a 
moderate positive linear relationship with the neo-aortic Z-score at the level of the neo-aortic 
root and STJ (r = 0.54, P < 0.001 and r = 0.54, P < 0.001, respectively; Figure 6). 
The octant location of FD in the root, STJ, and mid-AAo matched the location of maximum 
systolic WSS at mid-AAo level. The distribution of absolute differences in FD location (root, 
STJ, and mid-AAo) vs WSS location at mid-AAo level was skewed. In approximately 60% of 
the TGA patients, absolute differences in location between FD and WSS were 0 or 1 octant, 
representing no differences (Figure 7). TGA patients showed a predominant FD direction in 
the anterior and rightward orientation (right, right-anterior, anterior) from root to mid-AAo 
plane levels with elevated maximum systolic WSS in the anterior to right anterior locations 
from the mid- to distal AAo planes (Figure 3 and 7A). Wall shear stress magnitude in the 
distal ascending aortic planes showed a moderate positive linear relationship with the 
change in aortic dimension between the root and mid-AAo in TGA patients (Figure 8). A more 
pronounced increase in peak systolic WSS in those regions was detected in the patients 
with relatively small mid-AAo diameter compared with the neo-aortic root. The association 
between WSS magnitude and vessel diameter change was found for the right, right-anterior 
and anterior regions from the distal AAo planes (dAAo-1 and dAAo-2) (Figure 8), which 
corresponds with the regions where TGA patients showed highly asymmetric and elevated 
peak systolic WSS.
Figure 6. Relationship between aortic Z-score and normalized flow displacement in the proximal ascending 
aorta.
Aortic root: Z-score vs FD (A). STJ: Z-score vs FD (B).
STJ, sinotubular junction; TGA, transposition of the great arteries.
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Figure 7. Location of peak systolic WSS (mid-AAo) and the relation with flow displacement direction in the 
proximal ascending aorta.
Location of peak systolic WSS at mid-AAo level in TGA patients and healthy subjects (A). Frequency histograms 
on the distribution of the absolute differences in octant location between FD (root, STJ, and mid-AAo) and 
the location peak systolic WSS (mid-AAo) in TGA patients (B). Normality tested by Shapiro-Wilk test. Of note, 
absolute differences in octant location between FD and WSS at the mid-AAo are presented for 27 TGA patients 
because of no FD in one TGA patient.
FD, normalized flow displacement; mid-AAo, mid-ascending aorta; Root, neo-aortic root; STJ, sinotubular 
junction; TGA, transposition of the great arteries; WSS, wall shear stress.
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Discussion
The results of this study demonstrate a more eccentric aortic flow in the proximal ascending 
aorta in TGA patients compared with healthy subjects. TGA-specific preoperative position 
of the great arteries showed different directionality of the eccentric flow profiles and the 
magnitude of the eccentric flow was linearly related with the local aortic Z-scores. The ASO-
specific geometry consisted of neo-aortic root dilatation and a sudden change in vessel 
diameter at mid-ascending aortic level, the level of anterior aortic compression by the 
pulmonary trunk. This sudden change in aortic diameter was associated with increased and 
asymmetric peak systolic WSS distribution along the distal ascending aorta, most pronounced 
in the right and anterior aortic wall regions (right, right-anterior and anterior regions). The 
flow displacement direction from root to mid-AAo also corresponded to the peak systolic 
WSS distribution in the mid-AAo, but the contribution of FD on WSS distribution more 
upstream in the distal AAo was less compared with the effect of vessel tapering. The regions 
of abnormal increased WSS in the distal AAo clinically correlates with the location of the 
paper-thin and fragile anterior wall of the AAo that has been found in ASO patients during 
root reoperations.21, 22
Neo-aortic root dilatation is a key problem in long-term follow-up in patients after ASO 
for TGA because of its ongoing progression beyond the age of 18 years.2, 3, 23 The neo-aortic 
root after ASO dilates and elongates and the STJ becomes more distally-displaced over 
time.24 Similar to previous findings,2, 5 the geometric alterations in the proximal ascending 
Figure 8. Relationship between aortic diameter change and wall shear stress along the distal ascending aorta.
Diameter change between neo-aortic root and mid-ascending aorta represented as Root/mid-AAo ratio. Peak 
systolic wall shear stress (WSSmax) for the right, right-anterior and anterior regions along the distal ascending 
aorta (cross-sectional plane 6: dAAo-1 and plane 7: dAAo-2, as illustrated in Figure 1D).
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aorta with neo-aortic root dilatation were accompanied by the relatively narrow mid-
ascending aortic segments in this study, due to the anterior impression of the ascending 
aorta by the pulmonary trunk following Lecompte maneuver.
Mechanisms leading to progressive dilatation and elongation are not fully understood. 
Based on unoperated heart specimen with TGA, it is suggested that the arterial root in TGA 
patients has a diminished amount and altered distribution of collagen and that the root and 
left-sided semilunar valve are less firmly embedded in the myocardium,25 which potentially 
makes the arterial root of these patients more susceptible for aortic dilatation after ASO. 
Semilunar valve diameters in TGA fetus are proven to be larger than in normal fetal hearts 
and the prenatal pulmonary valve size has been associated with neo-aortic root dilatation 
in the first years post-ASO.26 Furthermore, it is known that abnormal blood flow may affect 
vessel wall tissue and may impact neo-aortic root dilatation as well.13 Hemodynamic factors 
derived from 4D flow MRI, including flow eccentricity and WSS, have been associated with 
aortic diameter progression and vascular wall remodeling in patients with bicuspid aortic 
valve related aortopathy respectively.12, 13 This study shows that children and adolescent TGA 
patients after ASO have an eccentric systolic flow in the ascending aorta: regions of most 
prominent flow eccentricity were detected at the level of the neo-aortic root and STJ. 
Consistent with the results of studies in patients with a bicuspid aortic valve,12, 27 we found a 
close linear relationship between aortic dimensions and the normalized FD. In one of these 
studies, systolic FD was correlated with future ascending aortic growth in patients with 
bicuspid valve anatomy.12 Despite the correlations found in this and other studies, longitudinal 
studies in patients after ASO are needed to assess the causative role of systolic FD for 
progressive neo-aortic root dilatation. Furthermore, the TGA-specific preoperative spatial 
position of the great arteries showed to be a factor for different directionality of the eccentric 
flow profiles in the neo-aortic root. Most likely this is the result of a different angulation 
between the neo-aortic valve and the newly formed STJ, depending on the location from 
where the aorta needs to be transposed on top of the neo-aortic root, stressing the influence 
of geometry on flow deviation within the ascending aorta. Next to this, a cardiac MRI study 
showed that a more acute aortic arch angulation, as is typical in post-ASO aortic geometry, 
is a risk factor for the development of root dilatation and valve regurgitation.28
A comparative computational fluid dynamic (CFD) and in vitro 4D flow MRI phantom 
study on the thoracic aorta from a single TGA case after ASO supports the findings of our 
study.29 In the TGA model (derived from a 15-year-old patient) appreciable less symmetrical 
flow, with a skewed peak of flow velocity in the ascending aorta, was observed compared 
with the aortic model of a healthy subject, in which the higher velocities were clustered 
around the center of the neo-aortic root. In line with the finding of our study, there was 
a flow jet impingement at the top of the TGA anterior root with a higher WSS in the anterior 
ascending aortic wall.
In TGA patients, WSS analysis showed in general a more evenly distributed and regionally 
lower WSS in the dilated root compared with the healthy subjects and clear areas of higher 
WSS at the right and anterior aortic wall regions from the mid-aortic level and above. The 
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displacement of flow away from the aortic centerline and directed more towards the vessel 
wall in the proximal ascending aorta, together with a sudden change in vessel geometry at 
mid-ascending aortic level, most likely causes an increase in velocity with a higher near-wall 
velocity gradient resulting in elevated WSS in the right and anterior wall regions of the distal 
AAo.
The geometric shape of the aorta with its typical appearance after ASO has proved to be 
one of the most influential factors on blood flow and WSS in aortic flow simulations.30 The 
CFD investigation on TGA models after ASO about the influence of geometric changes in 
the thoracic aorta on the blood flow and WSS reported a large curvature near the aortic 
root as a distinctive characteristic of the post-ASO geometry.30 The WSS assessment in the 
TGA aortic models of that study revealed significantly higher maximum WSS values than in 
the healthy aortic model, comparable with the findings in this study. The maximum WSS 
was located in either the ascending aorta or the aortic arch, depending on the degree of 
aortic torsion and curvature of the two assessed TGA models.30 The relationship between 
the degree of aortic diameter reduction at mid-AAo level and WSS in the anterior regions 
of the distal ascending aorta found in our study supports the hypothesis that in TGA patients 
after ASO aortic blood flow physiology (expressed in advanced hemodynamic parameters) 
is altered due to a changed geometry.
Currently, no cases have been documented with aortic rupture or dissection after ASO, 
but in several re-operated patients the anterior wall of the aneurysmatic aorta was observed 
to be paper-thin and fragile.21, 22 These regions correspond to the areas of elevated WSS, as 
found in our study, and the combined CFD and in vitro 4D flow study by Biglino et al.29 
Whether this hemodynamic parameter may add to the prediction of progressive aortic 
dilatation, aortic wall thinning, or imply a higher lifetime risk on adverse aortic events (aortic 
rupture or dissection) at that site is unknown and requires further longitudinal follow-up. 
This is of high importance as, to date, indications for reoperation for neo-aortic root 
dilatation after ASO to prevent rupture, dissection or progressive neo-aortic regurgitation 
are unclear. Moreover, extending knowledge on pathophysiologic mechanisms of altered 
flow hemodynamics on disease progression is necessary, to get better insight and to think 
about alternative surgical techniques solving long-term residual sequelae in patients with 
TGA. In this regard, an alternative surgical technique has been described for TGA which 
preserves a more physiologic spiral anatomy of the great arteries, without applying Lecompte 
maneuver.31 Although not frequently applied worldwide and technically not applicable for 
every TGA patient, results from in vivo 4D flow studies in these patients 20 years after ASO 
reported more physiological aortic blood flow in the great arteries compared with patients 
who underwent a Lecompte procedure during ASO.32 These results, together with the results 
of this study, in which we showed already the presence of abnormal aortic flow 
hemodynamics in young patients after ASO, suggest aortic geometry as an important factor 
for altered flow hemodynamics. Although aortic geometry seems to contribute to altered 
flow hemodynamics, due to the measurements at a single timepoint, it is unknown if the 
altered FD and WSS are the result of progressive aortic dilatation, or if in any way these 
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altered hemodynamics were causative to the dilatation. Additional 4D flow studies evaluating 
the interindividual differences in aortic hemodynamics between TGA patients with different 
anatomy (i.e. with or without VSD, with different spatial position of the great arteries) and 
between TGA patients with different surgical ASO techniques (i.e. with and without Lecompte 
maneuver) need to be performed to optimize management strategies for the best long-term 
outcomes.
The current study is subject to some limitations. Healthy subjects who were used as a 
reference group were older compared with the TGA patients included in this study. This 
might have an impact on the Z-scores that were somewhat larger than expected in the 
healthy subjects group by the use of the MRI-derived normative data with an age range up 
to 20 years.19 While the MRI-derived normative dataset is based on a small population of 
children and uses nongated contrast-enhanced MRA images, there is currently no larger 
combined pediatric and adolescent MRI-specific database and this method of normalization 
is the best available alternative. In addition, the velocity of the aortic flow will decrease with 
increasing age,33 which could have lowered the WSS results in healthy subjects, as WSS is 
closely related to velocity since it is a derivative of velocity.34, 35 However, the relative small 
age difference between the adolescent TGA patient group and the healthy young adult 
subjects is not expected to lead to large differences in mean velocity according to the study 
on the distribution of velocity in the normal aorta over age by Garcia et al.33 Therefore, only 
small differences in WSS are to be expected based on the age difference. These differences 
do not exceed the WSS differences that have been found between younger TGA patients 
and healthy subjects, neither will they explain the WSS asymmetry results in this study. 
Moreover, in healthy adolescents and young adults flow velocity distribution descriptors 
indicating velocity symmetry and shape (i.e. skewness and kurtosis) only started to increase 
significantly beyond the age of 40 years.33 Hence, small differences in age between TGA 
patients and the healthy control group in this study will not have affected normalized FD 
measures.
Because of the limited spatial resolution of 4D flow MRI, WSS is known to be 
underestimated. However, all MR acquisitions in both TGA and healthy subjects were made 
at the same MR scanner with the same imaging parameters, so differences between groups 
remain useful. Moreover, patients were analyzed with the software for which a 3D WSS 
reproducibility analysis study showed robustness of the segmentation and WSS analysis 
method.16 Furthermore, the robustness and reproducibility of 2D WSS analysis in cross-
sectional planes has been previously demonstrated.36 However, WSS determination in the 
neo-aortic root remains a challenge because of the aortic motion and the presence of slow 
and recirculating flow. Although we did perform a time-resolved segmentation method to 
account for aortic motion,16 small border errors may be present for the calculated WSS in 
the neo-aortic root region, implying that it may not actually reflect the stress on the wall.
In conclusion, TGA patients after ASO have more flow asymmetry in the proximal AAo 
evidenced by a higher magnitude and directionality of FD, related to increased proximal 
AAo Z-scores. TGA-specific geometry related to the ASO, with neo-aortic root dilatation and 
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a sudden change in vessel diameter at mid-AAo level, leads to specific WSS distribution 
along the AAo in TGA patients that is different with higher WSS compared with healthy 
subjects. Our observations only start to unravel the interaction between the post-ASO 
geometry and hemodynamics within the ascending aorta and how the hemodynamics may 
be involved in the (progression of) neo-aortic root dilatation. Therefore, longitudinal follow-
up studies are needed for correlation between changes in systolic WSS and progression of 
dilatation and to assess the consequence of the increased WSS and its WSS extent on the 
distal AAo.
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Progressive root dilatation is an important complication in patients with transposition of 
the great arteries (TGA) after arterial switch operation (ASO) that may be caused by altered 
flow dynamics. Aortic wall shear stress (WSS) distribution at rest and under dobutamine 
stress (DS) conditions using 4D flow magnetic resonance imaging (MRI) were investigated 
in relation to thoracic aorta geometry.
Methods
4D flow MRI was performed in sixteen adolescent TGA patients after ASO (rest and DS 
condition) and in ten healthy controls (rest). The primary outcome measure was the WSS 
distribution along the aortic segments and the WSS change with DS in TGA patients. Based 
on the results, we secondary zoomed in on factors (aortic geometry and left ventricular (LV 
function) parameters) that might relate to these WSS distribution differences. Aortic 
diameters, arch angle, LV function parameters (stroke volume, LV ejection fraction, cardiac 
output) and peak systolic aortic WSS were obtained.
Results
TGA patients had significantly larger neo-aortic root and smaller mid-ascending aorta (AAo) 
dimensions and aortic arch angle. At rest, patients had significantly higher WSS in the entire 
thoracic aorta, except for the dilated root. High WSS levels beyond the proximal AAo were 
associated with the diameter decrease from the root to the mid-AAo (correlation coefficient 
r = 0.54-0.59, P = 0.022-0.031), not associated with the aortic arch angle. During DS, WSS 
increased in all aortic segments (P < 0.001), most pronounced in the AAo segments. The 
increase in LV ejection fraction, stroke volume and cardiac output as a result of DS showed 
a moderate linear relationship with the WSS increase in the distal AAo (correlation coefficient 
r = 0.54-0.57, P = 0.002-0.038).
Conclusions
Increased aortic WSS was observed in TGA patients after ASO, related to the ASO-specific 
geometry, which increased with DS. Stress-enhanced elevated WSS may play a role in neo-
aortic root dilatation and anterior aortic wall thinning of the distal AAo.




The arterial switch operation (ASO) is the current treatment for patients with transposition 
of the great arteries (TGA). This surgical intervention restores the ventriculoarterial 
concordance by reconnecting the great arteries to the correct ventricles leaving the 
semilunar valves and the native root in its original position. The relocation of the great 
arteries following ASO results in an altered spatial great artery relationship and geometry 
of the thoracic aorta. With the Lecompte maneuver, the pulmonary artery bifurcation is 
positioned in front of the ascending aorta with the pulmonary artery branches embracing 
the ascending aorta resulting in a more posterior location of the ascending aorta post-ASO. 
Consequently, an acute angulation of the curvature of the aortic arch is often present after 
ASO.1, 2
In the long term, progressive neo-aortic root dilatation occurs accompanied by an 
increasing incidence of neo-aortic valve leakage in these patients.3, 4 Furthermore, 
cardiothoracic surgeons have observed thinning of the anterior wall of the ascending aorta 
in adult post-ASO patients who underwent reoperation for the aneurysmatic neo-aortic root 
dilatation,5, 6 closely related to the location of the pulmonary arteries. It is largely unknown 
what mechanisms contribute to the progression of neo-aortic root dilatation and anterior 
wall thinning, but geometry-driven alterations in aortic flow might have its impact on the 
(neo-)aortic wall. This relationship has been shown in bicuspid aortic valve-related 
aortopathy7 but has not been extensively evaluated in TGA patients post-ASO so far.8
With 4D flow magnetic resonance imaging (MRI), blood flow and hemodynamic 
parameters in large vessels can be visualized and quantified and this imaging modality 
facilitates studying the relation and interaction of aorta geometry and blood flow on the 
aortic wall (i.e. wall shear stress, WSS). Currently, almost all patient studies using 4D flow 
MRI have been performed in rest states. However, it is unknown how aortic blood flow 
hemodynamics behave with an increase in cardiac output (CO) and whether changes in 
stroke volume (SV) may add to changes in hemodynamic parameters. Low-dose dobutamine 
increases heart rate, myocardial contractility and ventricular ejection by stimulating β-1 
receptors on the heart and allows studying aortic hemodynamics under increased SV 
conditions using MRI.
We hypothesize that evaluation of hemodynamics of the thoracic aortic reveals specific 
areas with abnormal WSS that increase under pharmacological-induced stress conditions 
and may help to better understand blood flow interactions on the aortic vessel wall in 
patients with repaired congenital heart diseases with altered aortic geometry. Therefore, 
the aim of this study was to evaluate aortic WSS in the thoracic aorta of patients with TGA 
after ASO with comparative rest and pharmacological stress 4D flow MRI investigations.




The study protocol was approved by the local Medical Ethics Committee and informed 
consent was obtained from all patients and their legal guardians. Sixteen patients with TGA 
and intact ventricular septum or TGA with ventricular septal defect were prospectively 
included in the study between January 2016 and December 2017. Patients from outpatient 
pediatric and congenital cardiology clinics who needed a standard-of-care MRI of the heart 
and large vessels as regular clinical follow-up for early detection of well-known sequelae 
after ASO from the age of 10 years were invited to participate. To ensure morphologic 
homogeneity, exclusion criteria were Taussig-Bing anomaly, prior left ventricular (LV) outflow 
tract obstruction, bicuspid neo-aortic valve, aortic arch obstruction, presence of branch 
pulmonary artery stent(s), moderate-to-severe neo-aortic insufficiency or prior neo-aortic 
valve or root reoperations. All patients underwent aortic 4D flow MRI at rest and during 
dobutamine-induced stress immediately following the standard-of-care MRI assessment. 
The healthy subjects were recruited from a prior 4D flow MRI validation study9 and served 
as a reference group. They underwent the same MRI protocol including 4D flow aortic 
imaging (only at rest).
Magnetic resonance imaging acquisition
All MRI examinations were performed on a 3T scanner (Ingenia, Philips Healthcare, the 
Netherlands). The protocol included ECG-gated two-dimensional cine steady-state free 
precession (SSFP) imaging for ventricular and functional analysis at rest and during 
dobutamine stress. At rest, a three-dimensional (3D) non-contrast-enhanced magnetic 
resonance angiography (NCE-MRA) was performed for the assessment of thoracic aorta 
diameters and aortic arch geometry. 4D flow MRI covering the thoracic aorta was acquired 
at rest and during dobutamine stress condition. MRI acquisitions details are summarized 
in supplementary Table S1. Dobutamine was administered intravenously starting at a dose 
of 5.0 µg/kg/min, and the dose was increased to 7.5 µg/kg/min after 3 min followed by a 
5-10 min observation period waiting for a steady state of patients’ heart rate and blood 
pressure.
Aortic geometry and cardiac function
Left ventricular indices [end-systolic and end-diastolic volume (LVESV and LVEDV)] and LV 
function parameters [SV, LV ejection fraction (LVEF), CO and cardiac index] were obtained 
from short-axis SSFP-images:
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Aortic diameters were measured from NCE-MRA at 6 anatomic landmarks: 1. neo-aortic 
root (Root); 2. sinotubular junction, defined as the aortic level 5-7 mm below the pulmonary 
artery bifurcation; 3. mid-ascending aorta at the level of the pulmonary artery bifurcation 
(mid-AAo); 4. aorta at the origin of the innominate artery; 5. aortic isthmus; 6. mid-descending 
aorta (Figure 1A-B). Aortic dimensions were measured from external-to-external edges from 
a sagittal-axis orientation. Average neo-aortic root diameters (average of three cusp-to-
commissure dimensions) were measured perpendicular to the aortic axis on NCE-MRA 
double oblique transversal angulated multiplanar reconstructions. Diameters were indexed 
to body surface area and converted into Z-scores.10 Aortic diameter ratio between the neo-




Aortic arch geometry was obtained from NCE-MRA. After aortic segmentation using 
Enterprise Suite v6.5 (Vital Images, Minnetonka, USA) and automatic computation of the 
centerline of the aorta segmentations, the aortic arch width (w), maximal height (h, 
perpendicular to the width) and aortic arch angle (α, between mid-AAo, maximal height and 
mid-descending aorta) were quantified (Figure 1C-D) using an in-house developed software 
(Python Software Foundation, Wolfeboro Falls, NH, USA). Width-height (w/h) ratio was 
calculated accordingly.
Figure 1. Workflow aortic geometry and 4D flow analysis.
Non-contrast enhanced magnetic resonance angiography (NCE-MRA) (A) with aortic diameter measurements 
(B). Aortic segmentation from NCE-MRA of a TGA patient (C) and healthy subject (D) with centerline creation, 
aortic width (w), height (h) and aortic arch angle (α) measurement. Raw 4D flow MRI data (E) used to create a 
3D aortic segmentation (F). Visualization of anatomical great artery relation with the peak systolic aortic WSS 
(G). Thoracic aorta subdivision into 5 segments (H).
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Segmental WSS assessment
The software program CAAS MR 4D flow v2.0 (Pie Medical Imaging BV, Maastricht, the 
Netherlands) was used for post-processing of the 4D flow MRI data, for which a 3D WSS 
reproducibility analysis study showed robustness of the segmentation and WSS analysis 
method.9 A summary of the workflow analysis is depicted in Figure 1E-H, and was previously 
described in detail.9 Briefly, from the 4D flow dataset peak systolic thoracic aortic 
segmentations were performed and provided with an aortic centerline (Figure 1E-F). For the 
regional aortic wall shear stress (WSS) assessment, the thoracic aorta was manually 
subdivided into 5 segments based on anatomic landmarks by placing planes perpendicular 
to the aortic centerline (Figure 1G): segment 1: proximal ascending aorta (pAAo, from aortic 
valve level to mid-AAo); segment 2: distal ascending aorta (dAAo, from mid-AAo to innominate 
artery); segment 3: aortic arch (Arch, from the innominate artery until left subclavian artery); 
segment 4: proximal descending aorta (pDAo, beyond the left subclavian artery to the mid-
descending thoracic aorta); and segment 5: distal descending aorta (dDAo, from mid-
descending thoracic aorta to the descending aorta at the level of the aortic valve). For every 
aortic segment, mean 3D systolic WSS (WSSmean) and maximum 3D systolic WSS (WSSmax) 
values were calculated as described previously (Figure 1H).9 Wall shear stress is defined as 
the derivative of the axial velocity u at the vascular wall in the direction perpendicular to 
the vascular wall times the dynamic viscosity µ (WSS =  µ 𝜕𝜕𝜕𝜕
𝜕𝜕𝜕𝜕 
|y=0 (in mPa)). The surface of the 
3D segmented aorta was divided into wall points, and for all wall points, a 3D systolic WSS 
vector was calculated based on a quadratic approximation of the axial velocity profile 
perpendicular to the surface of the 3D segmented aorta.9 WSSmax was then defined as the 
maximum WSS vector of all wall points within the defined aortic segment (in mPa). WSSmean 
was defined as the average of all WSS vectors of all wall points within the defined aortic 
segment (in mPa). Differences in WSS (∆WSS) and percentage WSS changes (%WSS) between 
rest and stress state were calculated for each segment:











Statistical analyses were performed using IBM SPSS Statistics version 23 (IBM, Chicago, IL, 
USA). Variables are presented as mean ± standard deviation or median (interquartile range, 
IQR) depending on the normality of the distribution. The normality of the distribution was 
tested using the Shapiro-Wilk test. The primary outcome measure was the WSS distribution 
along the aortic segments and the WSS change with dobutamine stress in TGA patients. 
Based on the results, we secondary zoomed in on factors (aortic geometry and LV function 
parameters) that might relate to these WSS distribution differences. A power calculation 
was performed to determine the power to detect differences in the WSS values between 
the rest and dobutamine stress measurements (primary outcome measure). Based on the 
WSS magnitude known in the healthy pediatric and adult population, study sample sizes to 
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show a 20% difference (difference of clinical interest; estimated mean difference in WSSmean 
400 Pa; estimated standard deviation 100 Pa) in these variables with a power of 90% and a 
α error of 0.01 (to correct for multiple comparison according to the Bonferroni correction) 
must contain a minimum of 6 TGA patients. The power analysis was performed for the 
paired t-test (because of the unknown shape of the underlying distribution) (Division of 
Biomathematics/Biostatistics, Columbia University Medical Center, New York, USA; http://
biomath.info/power). Using the rule of thumb because of using a non-parametric test, we 
added 15% to the sample size required for a parametric test, resulting in a study sample 
size of at least 7 to 8 patients.
A chi-square test was performed to investigate differences in sex distribution between 
TGA patients and healthy subjects. Differences between groups were compared using the 
independent sample t-test or a Mann Whitney test based on the normality of the distribution. 
Differences in cardiac parameters between rest and dobutamine stress were tested by a 
paired t-test; in case of non-normality, the Wilcoxon signed-rank test was performed. A 
Friedman test was performed to test for differences in the percentage increase in WSS from 
rest to stress state between the 5 aortic segments. A Bonferroni correction was performed 
to adjust for the multiple comparisons for the WSS analysis along aortic segments between 
groups, between rest and dobutamine stress in TGA patients and for the percentage WSS 
increase from rest to stress between the 5 aortic segments. Correlation between aortic 
geometry measures (root/mid-AAo diameter ratio, arch angle and w/h ratio) and segmental 
aortic WSS were calculated using Spearman rank correlation. Correlation between 
percentage WSSmean increase and percentage increase in LV function parameters (EF, SV, 




Patient characteristics are shown in Table 1. Indexed neo-aortic root and sinotubular junction 
dimensions (Z-scores) were significantly larger in TGA patients compared to healthy subjects. 
Neo-aortic root and sinotubular junction were dilated (Z-score >2.0) in 94% and 81% of the 
TGA patients respectively. Patients without aortic Z-score >2.0 had also large indexed neo-
aortic root and sinotubular junction dimensions with Z-scores ≥1.7, except for one patient. 
The mid-AAo diameter was significantly smaller in TGA patients. Other thoracic aortic 
dimensions were within the normal range compared with the MRI-based healthy reference 
population (Z-score <2.0). Aortic arch geometry descriptors showed that the aortic arch 
height was comparable between TGA patients and healthy subjects. The aortic arch angle, 
aortic width and w/h ratio were significantly smaller in TGA patients.
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Table 1. Baseline characteristics and MRI measurements





Patient and surgical characteristics
Male, n (%) 11 (68.8) 5 (50.0) 0.339
Age, yearsa 16.5 [14.4-18.8] 27.3 [24.9-28.4] <0.001
Weight, kg 63.8 ± 14.0 68.3 ± 12.7 0.419
Height, cm 173.4 ± 12.7 175.6 ± 6.6 0.571
BSA, m2 1.75 ± 0.25 1.8 ± 0.20 0.452
Transposition type, n (%)
TGA-IVS 12 (75.0)
TGA-VSD 4 (25.0)
Coronary artery anatomy, n (%)*
1LCx-2R 11 (68.8)
1L-2CxR 2 (12.5)
1L-2R, no Cx 2 (12.5)
1RL-2Cx 1 (6.3)
Surgical variables
Age at ASO, days (range) 8 (1-70)
Previous surgery prior to ASO, n (%) 1 (6.3)
Lecompte maneuver, n (%) 16 (100)
Coronary artery transfer technique, n (%)
   Double button 6 (37.5)
   Single button, single trapdoor 7 (43.8)
   Double trapdoor 3 (18.8)
Aortic diameters (mm/BSA0.5)
Neo-aortic root sagittal 21.4 ± 3.2 17.0 ± 1.5 0.001
Neo-aortic root short-axis, mean 21.7 ± 3.0 16.7 ± 0.9 <0.001
Sinotubular junction 16.9 ± 3.0 14.1 ± 1.6 0.013
Mid ascending aortaa 12.7 [12.0-14.9] 15.1 [13.6-16.3] 0.035
Origin of brachiocephalic trunk 13.0 ± 1.6 13.2 ± 1.2 0.755
Aortic isthmus 12.6 ± 1.6 11.1 ± 1.1 0.018
Mid descending aorta 10.0 ± 1.3 10.2 ± 0.6 0.526
Aortic Z-scores
Neo-aortic root short-axis, mean 4.8 ± 1.6 1.5 ± 0.7 <0.001
Sinotubular junction 3.6 ± 2.3 1.4 ± 1.3 0.011
Mid-ascending aortaa -0.3 [-1.0-0.3] 1.8 [0.2-2.7] 0.005
Origin of brachiocephalic trunk -0.5 ± 1.5 0.2 ± 1.3 0.217
Aortic isthmus 2.2 ± 1.2 0.8 ± 1.4 0.013
Mid-descending aorta -0.3 ± 0.9 0.2 ± 0.6 0.197
Aortic arch geometry
Arch width 41.3 ± 5.1 58.4 ± 7.4 <0.001
Arch height 31.0 ± 5.5 34.0 ± 3.3 0.132
Arch angle (°) 66.6 ± 8.2 80.1 ± 7.4 <0.001
Width/Height ratio 1.4 ± 0.2 1.7 ± 0.2 0.001
a Data are presented as median [Interquartile range]. * Coronary artery anatomy description according to the 
Leiden Convention coronary coding system. BSA, body surface area; IVS, intact ventricular septum; TGA, 
transposition of the great arteries; VSD, ventricular septal defect.
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Figure 2. Aortic wall shear stress assessment at rest and during dobutamine stress.
WSSmean (A) and WSSmax (B) values (mean ± standard error of the mean) along the thoracic aortic segments 
in TGA patients (rest and stress) and compared with healthy subjects (rest). Adjusted P values (Bonferroni 
correction) of the corresponding lines represent the results of the WSS comparison with the TGA patients at 
rest (only significant P values are depicted). Percentage WSS increase between rest and dobutamine stress for 
each of the thoracic aortic segments (C). Differences in %WSS increase between the 5 segments for WSSmax: 
P = 0.19; for WSSmean: P < 0.001 (Friedman test). Brackets with adjusted P values (Dunn’s pairwise post hoc 
test with Bonferroni correction) are depicted to indicate statistical significance for differences in %WSSmean 
increase between the aortic segments.
dAAo, distal ascending aorta; dDAo, distal descending aorta; pAAo, proximal ascending aorta; pDAo, proximal 
descending aorta; TGA, transposition of the great arteries; WSS, wall shear stress.
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Thoracic aortic WSS at rest and correlation with geometry
Figure 2A-B illustrates the aortic WSS along the entire thoracic aortic segments and shows 
the regional differences in WSSmean and WSSmax between TGA patients and healthy 
subjects. At rest, TGA patients showed significantly higher WSS in almost all thoracic aortic 
segments (P < 0.001 - P = 0.015), except for the pAAo segment (for WSSmean and WSSmax) 
and pDAo (for WSSmean) (Figure 2A-B). In TGA patients, WSS magnitude (WSSmean and 
WSSmax) was lowest in the dilated pAAo while the highest WSSmax levels were found in 
the dAAo segment. Along the thoracic aorta, the trend (i.e. increase or decrease) of the 
WSSmean and WSSmax between the aortic segments also differed between TGA patients 
and healthy subjects. In the healthy subjects, there was a WSS decrease from the pAAo 
segment to the aortic arch segment, with a WSS increase beyond the aortic arch (Figure 
2A-B). In TGA patients, there was a significant WSS increase from the pAAo to the dAAo 
segment (P < 0.001 for WSSmean; P = 0.003 for WSSmax) with a concomitant WSS decrease 
in the aortic arch segment compared with the dAAo segment (Figure 2A-B). Beyond the 
aortic arch, in the descending thoracic aorta, there was overall an increase in WSSmean and 
WSSmax between the consecutive segments comparable to the trend found in healthy 
subjects, but on a higher WSS level.
At rest, WSSmean in the dAAo segment, but also in the descending aortic segments, 
showed a moderate linear relationship with the change in aortic dimension between the 
neo-aortic root and mid-AAo, as expressed as the root/mid-AAo ratio (Figure 3). A higher 
systolic WSSmean was detected in the patients with relatively small mid-AAo diameters 
compared with the neo-aortic root dimensions. In general, the aortic arch geometry 
descriptors, arch angle and w/h ratio, did not show a relationship with the WSS parameters 
from the aortic arch and descending aortic segments (supplementary Table S2). Only for 
WSSmax in the distal DAo segment, an association was observed with the arch geometry 
(angle: correlation coefficient r = 0.58, P = 0.020 and w/h ratio: correlation coefficient r = 
0.54, P = 0.032).
Dobutamine-stress induced changes in LV function parameters
At rest, no significant differences between TGA patients and healthy subjects were observed 
in cardiac parameters, except for heart rate and cardiac index (supplementary Table S3). 
All patients received maximum dobutamine dosage (7.5 µg/kg/min) without any adverse 
effects. In the entire TGA group, heart rate, blood pressure and the LV functional parameters 
derived from MRI, SV and CO, significantly increased from rest to stress state (supplementary 
Table S3). Fourteen TGA patients had a normal systolic LV function (EF ≥55%) and two 
patients slightly below normal (EF 51% and 54%) without regional wall motion abnormalities. 
No significant neo-aortic regurgitation was present in the patients. All healthy subjects had 
an EF ≥55%.
Stress-induced changes in aortic WSS and correlation with LV function parameters
During dobutamine stress, the trend in WSS between the aortic segments remained similar 
but with significantly higher WSS in all aortic segments compared with the levels at rest 
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state (P < 0.001 - P = 0.009, for WSSmax and WSSmean) (Figure 2A-B). The highest absolute 
WSSmean and WSSmax values were detected in the dAAo segment. The percentage WSS 
increase from rest to stress state was highest for the ascending aortic segments (pAAo and 
dAAo) with a WSS increase between 56-78% (Figure 2C). The percentage WSS increase was 
the most pronounced for WSSmax and high but to a lesser extend present for WSSmean 
(for pAAo and dAAo: WSSmax 78% and 76%; WSSmean 58% and 56%, respectively). The 
dobutamine-induced percentage WSS increase diminished for the consecutive aortic 
segments beyond the ascending aortic segments (Figure 2C).
All TGA patients showed more or less similar WSS patterns with an increased WSS area 
at the anterior wall of the dAAo segment, on top of the anterior root. This area of high WSS 
was present at rest and during dobutamine stress and the area of high WSS also extended 
over the anterior wall of the dAAo (Figure 4, example of single patient). The WSS distribution 
in the dAAo segments was asymmetric and more expressed on the anterior wall, and more 
symmetrically distributed over the aortic wall of descending aortic segments as suggested 
by the lower magnitude of WSSmax and the higher magnitude of WSSmean in the descending 
aortic segments as compared with the ascending aortic segments (Figure 2A-B).
The percentage increase of peak systolic WSSmean in the dAAo segment with stress 
showed a moderate positive linear relationship with the percentage increase in parameters 
EF, SV and CO as a result of dobutamine (Figure 5). Cardiac output and EF showed the best 
association with the percentage increase in WSSmean (correlation coefficient r = 0.59, P = 
0.016 and correlation coefficient r = 0.70, P = 0.002, respectively). Arch geometric descriptors 
did not show significant associations with WSS in aortic segments during dobutamine stress 
(supplementary Table S2).
Figure 3. Relationship between ascending aortic diameter change and WSSmean at rest along the thoracic aorta.
Spearman correlation coefficient (r).
AAo, ascending aorta; DAo, descending aorta; WSS, wall shear stress.
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Discussion
This study evaluated the thoracic aortic WSS in TGA patients after ASO. The effect of 
pharmacological-derived stress on aortic WSS was studied in vivo and was compared with 
the rest state. The main findings of this study demonstrate that patients after ASO have a 
significantly higher WSS magnitude in the entire thoracic aorta compared with healthy 
subjects at rest, except for the dilated proximal AAo. The regions of high peak systolic WSS 
were most pronounced in the distal AAo and located at the anterior aortic wall of that 
segment. The specific ascending aortic geometry post-ASO, reflected by the size discrepancy 
Figure 4. Peak systolic 3D wall shear stress visualization (anterior aortic view) in single a TGA case - rest vs stress
Figure 5. Correlation between increase in WSSmean in the distal AAo and ejection fraction, stroke volume, and 
cardiac output under dobutamine infusion.
Pearson correlation coefficient (r).
AAo, ascending aorta; CO, cardiac output; EF, ejection fraction; SV, stroke volume; WSS, wall shear stress.
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between the dilated neo-aortic root and the smaller mid-AAo diameter, was associated with 
higher WSS levels in the aortic segments downstream this caliber change: the larger the 
size discrepancy, the higher the WSS levels in the distal AAo, but also in the descending 
aortic segments. In addition to this association, the geometry of the aortic arch did not 
further contribute to the high WSS levels in the aortic arch and the descending aortic 
segments. Dobutamine-induced cardiac stress did increase WSS magnitude significantly 
along all thoracic aortic segments, the most prominent in the AAo. The highest peak systolic 
WSS was present in the distal AAo segment during both rest and stress, but for stress, this 
was even more pronounced. The peak systolic WSS increase by dobutamine in that segment 
showed a positive correlation with the increase in the LVEF, SV and CO.
The results of this study extend the findings reported previously.8 In addition to the 
increased WSS in the distal AAo segment, significantly higher WSS values at rest were 
observed in the aortic segments beyond the distal AAo (the arch and descending aortic 
segments), segments of the aorta remote from the dilated neo-aortic root and not directly 
affected by the surgical repair. The increased WSS in these descending aortic segments is 
most likely a perpetuation of the elevated WSS found in the distal AAo segment owing to 
the eccentric aortic outflow8 and the abnormal ascending aortic geometry. This is supported 
by the observed relationship between the ascending aortic geometry and WSS in the 
descending thoracic aortic segments in this study. Local geometric changes of the aorta (i.e. 
changes in diameter, arch curvature, vessel torsion) are known to have effect on downstream 
hemodynamics.11 In accordance with existing literature,1, 2 TGA patients in this study showed 
a more acute aortic arch angulation. However, the aortic arch geometry descriptors (angle 
and w/h ratio) were not associated with the high WSS magnitude in the aortic arch and 
descending aortic segments, on top of the aforementioned association with the ascending 
aortic geometry. This could also be related to the lack of power due to the relatively small 
sample size of TGA patients.
Impaired aortic bioelastic aortic wall properties have been described after ASO for TGA12 
and may also affect the blood flow propagation in the thoracic aorta (i.e. higher velocity), 
but these factors were not investigated in this study. In thoracic aortas of healthy volunteers, 
it has been reported that there is a significant slowing of blood flow velocity in the aortic 
arch compared with the velocity in the ascending aorta followed by an increase to higher 
velocities in the descending aorta due to vessel diameter reduction.13 As WSS is a derivative 
of velocity, these observations are in accordance to the findings of the WSS trend along the 
thoracic aorta in the healthy subjects from this study, where WSS initially starts high in the 
proximal AAo, significantly diminishes in the aortic arch segment and subsequently increases 
in the descending aortic segments. This trend of WSS increase from the arch to the 
descending aortic segments was also observed in the TGA patients.
Aortic WSS during dobutamine stress
Low-dose dobutamine administration resulted in a normal cardiac hemodynamic response 
in the TGA patients. Similar to previous findings from echocardiographic and MRI studies 
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in healthy subjects,14, 15 a significant increase in SV and LVEF, a decrease in end-systolic 
volume and no changes in end-diastolic volume were observed.
The dobutamine-induced increase in SV, EF, and CO enhanced the geometry-driven 
effects on WSS distribution. The SV in patients after ASO accumulates in the dilated aortic 
root and under stress may play a role in root dilatation negatively influenced by the smaller 
mid-AAo segment (vessel narrowing) on top of the dilated root. Notably, highest percentages 
of WSS increase under stress were found in the proximal and distal AAo segments. The 
increased WSS findings might introduce a risk with important clinical consequences in the 
long run as increased WSS is associated with elastic fiber alteration (thinning and 
degeneration) and dysregulation of the extracellular matrix in the aortic wall.7, 16 In healthy 
subjects, regular exercise-induced increases in blood flow and shear stress have been 
observed to enhance vascular function and structure.17 However, in diseased aortas with 
altered flow phenomena and elevated regional WSS aggravated by increased SV, this may 
have negative effects on cardiovascular remodeling. In the arterial roots of unoperated TGA 
patients, already structural vessel wall abnormalities characterized by a diminished amount 
and altered distribution of collagen and a dedifferentiating of smooth muscle cells with 
increasing age have been observed,18 making the neo-aortic root theoretically more 
vulnerable for altered WSS. So far, no reports have been described on histopathological 
changes in the distal AAo in TGA patients after ASO. However, cardiothoracic surgeons who 
performed reoperations on adult post-ASO patients have observed a thinner and more 
fragile anterior wall of the ascending aorta just behind the pulmonary artery bifurcation.5, 
6 These anterior aortic regions clinically correlate with the regions of abnormal increased 
WSS in the distal AAo as found in this study.
Clinical implications of the altered WSS distribution over the aorta and the changes during 
stress are preliminary and consequences unknown, as we did not evaluate the effect of it 
on the aortic wall tissue itself. Correlation studies between 4D flow MR-derived aortic WSS 
and aortic vessel specimen after neo-aortic root and/or ascending aortic replacement are 
important next steps to consider. Furthermore, serial 4D flow MR evaluations are essential 
to assess the predictive value of hemodynamic parameters such as WSS on the progression 
of aortic dilatation, wall thinning or the development of adverse aortic events (aortic 
dissection or rupture). Ultimately, comparative hemodynamic studies between TGA patients 
after ASO performed with different techniques (i.e. conventional ASO with versus without 
Lecompte maneuver and conventional ASO versus spiral ASO technique) may provide 
insights for the optimization of surgical strategies for patients with different anatomy. 
Currently, based on our study, clinical recommendations related to these issues are not yet 
possible.
Limitations
The study is limited by the small sample size but represents randomly selected TGA patients 
from the outpatient clinic that required MR investigation as part of their regular lifelong 
follow-up. Furthermore, healthy subjects in this study were older compared with the TGA 
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patients. As the velocity of aortic blood flow is known to decrease with increasing age,19 
older age could have lowered the WSS results in healthy subjects since it is a derivative of 
velocity. However, no large differences in mean velocity and thus in WSS are to be expected 
based on the small differences in age range between the groups based on a study on the 
velocity distribution in the normal aorta over age.19 The comparison of the effect of 
pharmacological-induced stress on the aortic WSS could not be performed other than within 
the TGA group.
Conclusion
In conclusion, increased aortic WSS was found in the distal ascending aortic segment and 
in the aortic segments beyond and was primary related to the ASO-specific geometry of the 
ascending aorta, not related to the steeper arch geometry. Dobutamine-induced stress 
further increased abnormal segmental WSS and showed a moderate positive correlation 
with the increase in left ventricular cardiac output parameters. Pharmacological-induced 
stress evaluations of aortic blood flow may better reflect location and expansion of vascular 
wall areas exposed to abnormal WSS with subsequent risks for vascular remodeling. Stress 
might play a role in neo-aortic root dilatation in TGA patients after ASO given the significant 
stress-induced WSS increase in the neo-aortic root, acting on root tissue with structural 
vessel wall abnormalities.
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Supplementary material
Supplementary Table S1. NCE-MRA and 4D flow MRI acquisition details 
MR scanner, field strength Ingenia - Philips Medical Systems, 3Tesla
Coil Combination of FlexCoverage Posterior coil (table top) 




Respiratory compensation Navigator gating
Cardiac gating Prospective, to end diastole
Spatial resolution (mm) 1.6 x 1.6 x 3.2
Temporal resolution (ms) 31.4 ± 1.6
TE (ms) 2.3
TR (ms) 3.6-3.9
Field-of-view (mm) 300 x 300 x 99
Reconstructed voxel size (mm) 0.8 x 0.8 x 1.6
Aortic 4D flow MRI
Sequence Segmented fast-spoiled echo pulse
Respiratory compensation Navigator gating
Cardiac gating retrospective, 24-36 phases
Spatial resolution (mm) 2.5 x 2.5 x 2.5
Temporal resolution (ms) 34-36 (rest)
33-34 (stress)
Flip angle (°) 10
TE (ms) 2.4-2.6 (rest)
2.2-2.4 (stress)
TR (ms) 4.2-4.5 (rest)
4.1-4.3 (stress)
VENC (cm/s) 200 (range 200-300) (rest)
3000 (range 250-350) (stress)
Scan duration (minutes) 10-12
Acceleration methods SENSE factor 2.5, AP direction; TFE factor 2
Gradient correction Yes*
Phase offset correction Yes*
Acquisition time ~ 12 minutes
* from standard available scanner software.
AP, anterior-posterior; ms, milliseconds; NCE-MRA, non-contrast enhanced magnetic resonance angiography; 
SENSE, sensitivity encoding; TE, echo time; TFE, turbo field echo; TR, repetition time; VENC, velocity encoding.
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Supplementary Table S2. Relationship between the aortic arch geometry and aortic WSS in TGA patients from 
the arch and beyond
Arch angle (°) w/h ratio
r P value r P value
Rest state
Arch WSSmean 0.01 0.97 -0.08 0.76
WSSmax 0.11 0.69 0.03 0.91
pDAo WSSmean 0.24 0.36 0.19 0.49
WSSmax 0.35 0.19 0.25 0.34
dDAo WSSmean 0.13 0.64 0.13 0.63
WSSmax* 0.58 0.02 0.54 0.03
Stress state
Arch WSSmean -0.01 0.96 -0.08 0.77
WSSmax 0.24 0.38 0.27 0.31
pDAo WSSmean 0.004 0.99 -0.01 0.96
WSSmax -0.02 0.95 0.02 0.94
dDAo WSSmean -0.35 0.19 -0.25 0.35
WSSmax 0.28 0.30 0.32 0.23
Spearman correlation coefficient (r). * statistically significant.
dDAo, distal descending aorta; pDAo, proximal descending aorta; WSSmax, maximum 3D systolic wall shear 
stress; WSSmean, mean 3D systolic wall shear stress.

















































































































































































































































































































































































































































































































































































































































































































































































































































Altered aortic 3D hemodynamics and geometry in 
pediatric Marfan syndrome patients
Journal of Cardiovascular Magnetic Resonance. 2017;19:30-41
CHAPTER 9




Blood flow dynamics make it possible to better understand the development of aortopathy 
and cardiovascular events in patients with Marfan syndrome (MFS). Aortic 3D blood flow 
characteristics were investigated in relation to aortic geometry in children and adolescents 
with MFS.
Methods
25 MFS patients (age 15.6 ± 4.0 years; 11 females) and 21 healthy controls (age 16.0 ± 2.6 
years; 12 females) underwent magnetic resonance angiography and 4D flow CMR for 
assessment of thoracic aortic size and 3D blood flow velocities. Data analysis included 
calculation of aortic diameter and BSA-indexed aortic dimensions (Z-score) along the thoracic 
aorta, 3D mean systolic wall shear stress (WSSmean) in 10 aortic segments and assessment 
of aortic blood flow patterns.
Results
Aortic root (root), ascending (AAo) and descending (DAo) aortic size was significantly larger 
in MFS patients than healthy controls (Root Z-score: 3.56 ± 1.45 vs 0.49 ± 0.78, P < 0.001; 
AAo Z-score 0.21 ± 0.95 vs -0.54 ± 0.64, P = 0.004; proximal DAo Z-score 2.02 ± 1.60 vs 0.56 
± 0.66, P < 0.001). A regional variation in prevalence and severity of flow patterns (vortex 
and helix flow patterns) was observed, with the aortic root and the proximal DAo (pDAo) 
being more frequently affected in MFS. MFS patients had significantly reduced WSSmean in 
the proximal AAo (pAAo) outer segment (0.65 ± 0.12 vs 0.73 ± 0.14 Pa, P = 0.029) and pDAo 
inner segment (0.74 ± 0.17 vs 0.87 ± 0.21 Pa, P = 0.021), as well as higher WSSmean in the inner 
segment of the distal AAo (0.94 ± 0.14 vs 0.84 ± 0.15 Pa, P = 0.036) compared to healthy 
subjects. An inverse relationship existed between pDAo WSSmean and both pDAo diameter 
(r = -0.53, P < 0.001) and % diameter change along the pDAo segment (r = -0.64, P < 0.001).
Conclusions
MFS children and young adults have altered aortic flow patterns and differences in aortic 
WSS that were most pronounced in the pAAo and pDAo, segments where aortic dissection 
or rupture often originate. The presence of vortex flow patterns and abnormal WSS 
correlated with regional size of the pDAo and are potentially valuable additional markers 
of disease severity.




Marfan syndrome (MFS) is an inherited autosomal dominant connective tissue disease, 
mostly related to mutations in the fibrillin-1 (FBN1) gene. Many organ systems can be 
involved, but most life-threatening complications are related to the cardiovascular system 
and include aortic dissection and aortic rupture. Although the entire aorta may dilate in 
MFS, specific aortic regions are prone for progressive dilation and dissection and represent 
the aortic root and the proximal descending aorta (pDAo).1-3 Before the implementation of 
preventive surgical management strategies, two-thirds of dissections and ruptures occurred 
in the ascending aorta (AAo) while one-third occurred in the descending aorta (DAo). 
Recently, this ratio has shifted towards proportionally more DAo complications.4, 5 Thus, 
pathology of the aorta distal to the aortic root remains a cause of concern.
In the current guidelines, absolute aortic diameters and identification of changes in aortic 
dimension play an important role in risk stratification and decision making for preventive 
surgery.6 However, it is known that aortic dissection may occur in only moderately dilated 
aortas, and recent literature has shown that only about 50% of MFS patients with pDAo 
dissections had pDAo diameters larger than the upper limit of normal.5 These findings 
indicate that aortic dimension alone may not capture the predictive risk for adverse 
cardiovascular events.
It is not well known how aortic hemodynamics interact with the altered vascular structure 
of the aorta in MFS. Independent associations between hemodynamic markers and 
aortopathy have been presented in cardiovascular magnetic resonance (CMR) imaging 
studies.7-10 These studies employed time-resolved 3D phase-contrast CMR with three-
directional velocity encoding (4D flow CMR) to enable a comprehensive, non-invasive in-vivo 
investigation of cardiac and aortic hemodynamics. The technique allows for quantitative 
analysis of advanced hemodynamic parameters11-14 such as wall shear stress (WSS), which 
is defined as the tangential force exerted by blood flow on the aortic wall. WSS has recently 
been correlated with evidence of molecular and architectural medial wall dysfunction in 
bicuspid aortic valve-related aortopathy.15 WSS may also be a useful parameter to identify 
focal regions with wall dysfunction in MFS patients. The aim of the study was to investigate 
regional aortic WSS, flow patterns and aortic dimensions in a pediatric MFS cohort compared 
to a healthy age appropriate control cohort by using a novel 3D WSS technique.
Methods
Study population
Twenty-five patients with MFS (mean age 15.6 ± 4.0 years, 11 females) were included in this 
Institutional Review Board (IRB) approved and HIPAA compliant study. All patients underwent 
4D flow CMR immediately following a clinically ordered standard-of-care CMR assessment 
of the entire aorta. The diagnosis of MFS was based on clinical criteria according to the 
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international standards derived from the 2010 Revised Ghent Criteria.16 In addition to the 
clinical criteria, conventional genetic testing for FBN1 mutation was performed in 23 MFS 
patients; in 22 of them a FBN1 mutation was proven. Patients with a bicuspid aortic valve 
or prior aortic surgery were excluded. Twenty-one healthy pediatric subjects (mean age 16.0 
± 2.6 years, 12 females) with a tricuspid aortic valve without history of cardiovascular disease 
and normal cardiac and aortic valve function, who underwent 4D flow CMR following a 
standard-of-care CMR examination, were collected from a retrospective chart review as 
approved by the IRB and were used as a healthy control group. The majority of these 
subjects underwent CMR for atypical chest pain after the inability of echocardiography to 
detect the origins of coronary arteries. The CMR revealed no morphological and functional 
cardiac or large vessel abnormalities in any of the healthy subjects. Written informed consent 
was obtained from all participants or their legal guardians for the addition of the 4D flow 
CMR to the standard-of-care CMR protocol.
Magnetic Resonance Imaging
CMR examinations were performed on 1.5T systems (MAGNETOM Avanto or Area, Siemens, 
Germany). All patients and healthy subjects underwent a standard-of-care CMR exam that 
included dynamic ECG gated two-dimensional (2D) cine steady state free precession (SSFP) 
imaging, for the evaluation of cardiac anatomy and function, as well as ECG gated and 
navigator triggered time-resolved contrast-enhanced MR angiography (CE-MRA) after 
administration of blood pool contrast media (gadofosveset trisodium, ABLAVAR, 0.03 mmol/
kg, Lantheus, N. Billerica, MA), for evaluation of aortic morphology and dimensions. Sequence 
parameters for CE-MRA: spatial resolution 1.3-1.5 x 1.3-1.5 x 1.3-1.7 mm3, echo time/
repetition time: 1.2-1.6 ms/3.2-3.6 ms, flip angle: 18°. For assessment of aortic blood flow, 
4D flow CMR was acquired during free breathing using respiratory navigator and prospective 
ECG-gating, with full volumetric coverage of the thoracic aorta in an oblique sagittal 
orientation. Standardized 4D flow sequence parameters were used throughout the study 
for age categories: 6-12 years and >12 years of age. Average 4D flow scan parameters were 
as follows: spatial resolution: 2.3-3.8 x 1.6-2.0 x 1.8-3.0 mm3, temporal resolution: 38.4-41.6 
ms, echo time/repetition time: 2.4-2.7 ms/5.0-5.1 ms, flip angle: 15°, field of view: 250-320 
x 141-250 mm2, matrix size: 160 x 70-130 and velocity sensitivity: 120-200 cm/s.
Data analysis
Thoracic aortic size
Thoracic aortic diameters were determined from the CE-MRA exams using a 3D workstation 
with multiplanar reformatting capabilities (Vitrea, Vital Images, Minneapolis, MN). According 
to the international guidelines,17 maximum orthogonal aortic diameters were measured 
along the aorta from inner-edge to inner-edge at the following levels: STJ: sinotubular 
junction; midAAo: mid-ascending aorta, at the level of the right pulmonary artery; dAAo: 
distal ascending aorta, prior to innominate artery; distal aortic arch, between left carotid 
artery and left subclavian artery; aortic isthmus, at the level direct beyond the left subclavian 
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artery; pDAo: proximal descending aorta, at the level of the ductal ampulla; midDAo: mid-
descending aorta, at the level of the left atrium; dDAo: distal descending aorta, at the level 
of the diaphragm (Figure 1B).
Maximum aortic root (Root) diameter was measured on a short-axis cine SSFP plane 
across the aortic root at peak systole.18, 19 Change in aortic diameter along aortic segments 
was calculated and expressed as percentage change for the segments aortic root to midAAo 
and aortic isthmus to pDAo:
!
|𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴	𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 −𝑚𝑚𝐴𝐴𝑚𝑚𝐴𝐴𝐴𝐴𝐴𝐴|
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴	𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 - ∗ 100					and			 !
|𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴	𝐴𝐴𝑖𝑖𝐴𝐴ℎ𝑚𝑚𝑚𝑚𝑖𝑖 − 𝑝𝑝𝑝𝑝𝐴𝐴𝐴𝐴|
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴	𝐴𝐴𝑖𝑖𝐴𝐴ℎ𝑚𝑚𝑚𝑚𝑖𝑖 - ∗ 100                                                   and  !
|𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 	𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 −𝑚𝑚𝐴𝐴𝑚𝑚𝐴𝐴𝐴𝐴𝐴𝐴|
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 	𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 - ∗ 100					a 			 !
|𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 	𝐴𝐴𝑖𝑖𝐴𝐴ℎ𝑚𝑚𝑚𝑚𝑖𝑖 − 𝑝𝑝𝑝𝑝𝐴𝐴𝐴𝐴|
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 	𝐴𝐴𝑖𝑖𝐴𝐴ℎ𝑚𝑚𝑚𝑚𝑖𝑖 - ∗ 100 .
To account for the range of patient age and body size, aortic Z-scores were calculated 
for each patient from the CMR aortic measurements (AAo through pDAo) and the body 
surface area (BSA; determined according to the method of Mosteller),20 using EchoIMS 
(Merge Healthcare, Chicago, IL). The Z-score is a nomogram-based metric for assessing 
aortic dilatation in pediatric patients in which a Z-score between -2 and +2 is considered 
normal.21 While EchoIMS provides ultrasound derived normative data, there is currently no 
CMR-specific database, and as such, this method of normalization is the best available 
alternative and supported by previous studies.22, 23 Particularly, Z-scores of the pDAo were 
calculated from the data on the aortic isthmus region of EchoIMS data. An aortic Z-score 
≥2.0 indicates that the aortic diameter at that level is outside the upper normal range (≥2 
standard deviations from the mean). Based on pDAo Z-scores, MFS patients were divided 
into subgroups for additional analysis: group 1: MFS Z-score pDAo ≥2.0; group 2: MFS Z-score 
pDAo <2.0.
Figure 1. Aortic 4D flow data processing and analysis.
4D flow raw data including anatomical and flow data (A). Volumetric aorta segmentation; levels of aortic 
diameter measurements (B). Calculation of systolic 3D WSS vector maps (C). Regional WSS analysis in 10 aortic 
regions (D). Arch, aortic arch; dAAo, distal ascending aorta; pAAo, proximal ascending aorta; dDAo, distal 
descending aorta; pDAo, proximal descending aorta.
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4D flow data processing and 3D blood flow visualization
All 4D flow CMR data (Figure 1A) were corrected for noise, velocity aliasing, Maxwell terms 
and eddy currents using Matlab-based in-house software (MathWorks, Natick, MA) as 
described previously.24 A 3D phase-contrast MR angiogram was created from the corrected 
4D flow CMR data and was used to semi-automatically define a 3D segmentation of the 
thoracic aorta (Mimics, Materialise, Leuven, Belgium) (Figure 1B). The 3D segmentation was 
used to mask the velocity field for the generation of time-resolved 3D pathlines to visualize 
aortic 3D blood flow (Ensight, CEI, Apex, NC). Semiquantitative aortic flow pattern analysis 
using pathline movies was performed in MFS patients and healthy subjects in a blinded 
fashion and random order by two observers (CR and JR). A helical flow pattern was defined 
as rotational fluid motion around an axis parallel to the bulk fluid motion (i.e. along the 
longitudinal axis of the vessel). Vortical flow patterns were defined as revolving particles 
around a point within the vessel with a rotation direction deviating by >90° from the 
physiological flow direction. Vortex and helix flow pattern grading was assessed in three 
aortic segments (AAo, Arch and DAo) on a 3-point ordinal scale: 0: no vortex/helix patterns; 
1: flow rotation <360°; 2: flow rotation >360° (Examples in Figure 2).
Figure 2. Aortic 3D blood flow characteristics (systolic streamlines).
Panel B represents systolic streamline visualization of a normal aorta from a healthy control. Panels A, C and D 
illustrate typical secondary flow patterns in Marfan syndrome patients during systole, like a helix flow pattern 
from the aortic root into the pAAo (A, grade 2) and vortex and helix flow patterns in the pDAo (C, grade 2). 
Prominent vortex flow patterns in the aortic root (D). Arch, aortic arch; dAAo, distal ascending aorta; pAAo, 
proximal ascending aorta; dDAo, distal descending aorta; pDAo, proximal descending aorta.
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Regional wall shear stress assessment
Based on the 3D segmentation, 3D mean systolic wall shear stress (WSSmean) along the entire 
aortic vessel wall was calculated from 4D flow velocity data (Figure 1C) using a previously 
described algorithm, which was shown to provide good reproducibility.25, 26 Briefly, WSS 
vector was estimated for each wall point on the aortic surface based on the 3D velocity 
spatial gradient perpendicular to the vessel wall. Systolic WSS vector magnitude was defined 
as the average over five cardiac time frames centered on the peak systolic time frame (i.e., 
peak systolic phase ± 2 phases). WSSmean was calculated within 10 aortic regions that were 
manually drawn based on anatomic landmarks (Figure 1D): 1) inner and outer proximal 
ascending aorta (pAAo, from STJ to midAAo); 2) inner and outer distal ascending aorta (dAAo, 
from midAAo to the origin of the innominate artery); 3) inner and outer aortic arch (from 
origin innominate artery until left subclavian artery); 4) inner and outer proximal descending 
aorta (pDAo, beyond the left subclavian artery to mid-descending thoracic aorta); 5) inner 
and outer distal descending aorta (dDAo, from mid-descending thoracic aorta to the level 
of the aortic valve). Of note, the supra-aortic arch branches were excluded from the regional 
WSS measurements.
Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics 20.0 (SPSS Inc., Chicago, IL, USA). 
Baseline characteristics are provided as mean ± standard deviation for continuous variables 
and percentage for discrete variables. Shapiro-Wilk tests were performed to test for equal 
distribution of continuous variables. A chi-square test was used to investigate differences 
in gender distribution between the MFS and healthy subject groups. A non-paired t-test was 
performed to study differences in continuous variables from baseline characteristics 
between the two cohorts. For comparison of differences between aortic Z-scores as well as 
regional aortic WSS between the two cohorts a Mann Whitney test was used. A Kruskal-Wallis 
test was used to evaluate differences in aortic Z-score, size change and regional WSS 
between the two MFS subgroups, as well as between the MFS subgroup with a pDAo Z-score 
≥2.0 and healthy subjects. The relationships between aortic dimensions and hemodynamic 
parameters were investigated using correlation analysis based on linear regression. A P 
value <0.05 was considered statistically significant for all statistical tests. Inter-observer 
agreement on qualitative assessment of helix and vortex flow formation between two 
observers was calculated using Cohen’s κ statistics. A κ value of 0.61-0.80 corresponded to 
substantial interobserver agreement; values of 0.41-0.60 corresponded to moderate 
agreement.
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Results
Patient characteristics are summarized in Table 1. As expected, MFS patients were typically 
taller than healthy subjects. All patients and healthy subjects had normal systolic biventricular 
function and no significant regurgitation of the mitral valve or aortic valve, except for one 
MFS patient who showed moderate mitral valve regurgitation.
Thoracic aorta dimensions
As summarized in Table 1, the aortic diameter Z-scores were significantly greater in MFS 
patients compared to healthy subjects at all thoracic aorta levels (P ≤ 0.05), except for the 
distal aortic arch (P = 0.155). Aortic dilatation in the MFS population was most prominent in 
the aortic root and pDAo, with Z-scores of 3.56 ± 1.45 and 2.02 ± 1.60, respectively. Using a 
Z-score ≥2.0 to define aortic dilatation, n = 21 (84%) MFS patients had aortic root dilatation 
and n = 10 (40%) had dilatation of the STJ. Seven MFS patients (28%) had a pDAo Z-score ≥2.0.
Aortic flow patterns
There was moderate to substantial inter-observer agreement for grading of flow patterns 
within the AAo (Kappa 0.54) and DAo (Kappa 0.84) between the two observers. Examples 
of 3D blood flow patterns found in MFS patients are depicted in Figure 2 (Panels A, C and 
D) and online supplementary Video 1. Marked vortex flow patterns were noted in the pDAo 
region of 14 MFS patients and in only two healthy subjects (56% vs 9.5% of total subjects, P 
= 0.002), with an average pDAo vortex grading significantly higher in MFS patients than 
healthy subjects (0.82 ± 0.83 vs 0.14 ± 0.39, P < 0.001). These vortex flow patterns were most 
pronounced in MFS patients with a dilated pDAo (6 out of 7) (Figure 3; and online 
supplementary Video 1). Physiological vortex patterns in the sinuses of the aortic root were 
more often visible in MFS patients compared to healthy subjects (76.0% vs 23.8%, P < 0.001; 
Figure 2, Panel D; and online supplementary Video 1 and 2). Non-physiological helical flow 
patterns with high strength (grade 2) originating from the aortic root were observed in 16% 
of the MFS patients and were not present in any of the healthy subjects (P < 0.05, Figure 2, 
Panel A). Finally, throughout the AAo, no difference in presence or strength of major flow 
patterns was observed between the MFS patients and healthy subjects (MFS vs healthy 
subjects: prevalence 76.0% vs 57.1%, P = 0.17; average helix grading 1.18 ± 0.71 vs 0.86 ± 
0.76, P = 0.14). No helix or vortex flow patterns were present in the aortic arch for both MFS 
patients and healthy subjects.
Segmental aortic WSS & correlations with diameter
Figure 4A illustrates regional differences in WSSmean between MFS patients and healthy 
subjects. MFS patients showed reduced WSSmean in the pAAo outer segment (0.65 ± 0.12 vs 
0.73 ± 0.14 Pa, P = 0.029) and pDAo inner segment (0.74 ± 0.17 vs 0.87 ± 0.21 Pa, P = 0.021) 
compared to healthy subjects (Figure 4A). There was a higher WSSmean in the inner segment 
of the dAAo in MFS patients (0.94 ± 0.14 vs 0.84 ± 0.15 Pa, P = 0.036). Moreover, in the entire 
Altered aortic 3D hemodynamics and geometry in pediatric Marfan syndrome patients
185
9
study cohort (MFS and healthy subjects), WSSmean showed a strong inverse relationship with 
aortic dimensions, as well as with diameter changes along aortic segments. The most 
prominent association was found between the WSSmean of the pDAo inner segment and both 
the pDAo Z-score (r = -0.53, P < 0.001) and the diameter change along the corresponding 
segment (r = -0.64, P < 0.001; Figure 5).
Table 1. Baseline characteristics
Marfan Healthy controls P value
N (females) 25 (11) 21 (12) 0.375
Age (y) 15.6 ± 4.0 16.0 ± 2.6 0.720
Height (cm) 178.6 ± 17.3 161.2 ± 11.2 <0.001*
Weight (kg) 65.6 ± 20.2 58.8 ± 15.1 0.208
BSA (m2) 1.78 ± 0.36 1.61 ± 0.25 0.082
BMI (kg/m2) 20.1 ± 4.5 22.4 ± 4.0 0.081
LV ejection fraction (%) 55.7 ± 6.5 58.1 ± 3.7 0.243
Bilateral ectopia lentis (n, %) 5 (20) 0
Genetic mutation (n)
FBN1 gene 22 -
Unknown 3 -
Cardiac medication (n, %) 20 (80) 0
1. Beta-blocker 15 (60) -
2. AT II-receptor antagonist 7 (28) -
3. ACE inhibitor 3 (12) -
4. Combination 1+2 4 (16) -
5. Combination 1+3 1 (4) -
Thoracic aortic size (Z-score)
Aortic Root 3.56 ± 1.45 0.49 ± 0.78 <0.001*
ST-junction 1.70 ± 1.28 -0.34 ± 0.77 <0.001*
Ascending aorta 0.21 ± 0.95 -0.54 ± 0.64 0.004*
Distal aortic arch 0.14 ± 0.90 -0.23 ± 0.66 0.155
Aortic isthmus 0.96 ± 0.94 0.43 ± 0.49 0.039*
Proximal descending aorta 2.02 ± 1.60 0.56 ± 0.66 <0.001*
The P value stems from non-paired t-test, for sex from chi-square test and for thoracic aorta dimensions from 
the Mann Whitney test. *P < 0.05. 
ACE, angiotensin converting enzyme; AT, angiotensin; BMI, body mass index; BSA, body surface area; FBN1, 
fibrillin-1; LV, left ventricular; ST, sinotubular.
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Subgroup analysis according to proximal DAo dilatation
Based on pDAo Z-scores, MFS patients were divided into subgroups for additional analysis. 
Seven MFS patients had a Z-score pDAo ≥2.0 (group 1), whereas 18 MFS patients had a Z-score 
pDAo <2.0 (group 2). Age, gender and BSA were comparable between the MFS subgroups 
with dilated pDAo (Z-score ≥2.0) and healthy subjects (Table 2). Differences in aortic diameter 
and segmental WSS between healthy subjects and MFS subgroups as well as between the 2 
MFS subgroups are summarized in Table 2. Dimensions of the entire thoracic aorta in the 
MFS subgroup with dilated pDAo showed significantly greater Z-scores compared to both 
other groups, except for the aortic root (Table 2). MFS patients with a dilated pDAo showed 
significantly lower WSSmean in the inner pDAo aortic segment (P < 0.05) compared to both the 
MFS patients with pDAo Z-score <2.0 and the group of healthy subjects (Figure 4B-C and 
Table 2). Furthermore, MFS patients with dilated pDAo also showed lower WSSmean at the 
inner pAAo segment (P < 0.05) and outer dDAo (P < 0.05) compared to healthy subjects.
Discussion
The findings of this study demonstrate that pediatric MFS patients have significantly lower 
WSSmean in the pAAo and pDAo than age-matched healthy controls. These regions in the 
aorta correspond to the locations where aortic dissection and aortic rupture often originate.2, 
4, 5 The subgroup of MFS patients with already dilated pDAo showed more prominent local 
vortex flow patterns and markedly lower WSSmean in the dilated pDAo region, when compared 
to non-dilated pDAo MFS patients and healthy controls. Furthermore, an inverse relationship 
between regional aortic diameter and WSSmean was observed in the entire study group.
Figure 4. Comparison of mean systolic wall shear stress in the ten aortic regions between groups.
Entire MFS cohort (n = 25) vs healthy subjects (n = 21) (A). MFS with a pDAo Z-score ≥2.0 (n = 7) vs MFS with a 
pDAo Z-score <2.0 (n = 18) (B). MFS with pDAo Z-score ≥2.0 (n = 7) vs healthy subjects (n = 21) (C). 
pDAo, proximal descending aorta.
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Aortic dilatation in MFS patients may start in early childhood, warranting close clinical 
follow up of the diameters in the entire thoracic aorta from the time of diagnosis. The 
average aortic size and the heterogeneous involvement of the pDAo regarding dilatation 
found in this study are in concordance with previous studies.27, 28 Although MFS is known to 
be prone to ascending aortic complications, a substantial part of the aortic dissections in 
MFS occur in the pDAo before reaching surgical cut-off levels. European studies reported 
the pDAo to be the site of the first aortic complications in 16-18% of the MFS patients.2, 29 
This proportion will increase after elective surgery of the AAo.4, 5 Changes in WSS in the aorta 
caused by changes in flow may be the key to better understand aortic disease development 
in MFS.
Aortic flow patterns and wall shear stress
Mechanisms leading to progressive aortic dilatation and elongation are not fully understood. 
Recently, aortic flow and derived hemodynamic factors derived from CMR, including WSS, 
have been associated with focal evidence of molecular and architectural tissue dysfunction 
in patients with bicuspid aortic valve and aortopathy.15 This study confirms that children 
and adolescent MFS patients already have disturbed aortic flow patterns in the thoracic 
aorta. The regions of prominent flow alterations were the aortic root and pDAo, with a 
significantly higher prevalence and strength of vortex flow patterns found in the pDAo in 
MFS compared to healthy subjects. Although it is known that small vortex flow patterns in 
Figure 5. Relationship between size change and inner wall shear stress in the proximal descending aortic 
segment.
Inverse relation between diameter change between aortic isthmus and pDAo segment (in % of isthmus 
diameter) and WSSmean of the pDAo segment in MFS patients and healthy subjects. pDAo, proximal descending 
aorta; WSSmean, mean systolic wall shear stress.
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the pDAo sometimes occur in normal aortas with an aortic spindle (i.e. a normal variation 
in the aortic contour not to be confused with an aneurysm),30 the high prevalence and 
extensive nature found in these young MFS patients in this study is remarkable and 
consistent with observations by two previous CMR studies in MFS, with prevalence rates 
ranging from 54-70%.8, 31 Local aortic geometry seems to be related to the formation of these 
flow phenomena as the MFS subjects with most dilated pDAo segments (Z-score >2.0) 
showed the most extensive focal vortex flow patterns in this study.
Table 2. Comparison of aortic dimension and WSS between MFS groups and healthy subjects
Group 1
MFS - pDAo Z ≥2.0
(n = 7)
Group 2 





Age (y) 15.6 ± 4.5 15.6 ± 4.0 16.0 ± 2.6
Females (n) 3 8 12
BSA (m2) 1.6 ± 0.4 1.8 ± 0.3 1.6 ± 0.3
Thoracic aortic size (Z-score) 
Z-score Aortic Root** 4.4 ± 1.3 3.2 ± 1.4 0.5 ± 0.8
Z-score STJ** 3.0 ± 0.9 1.2 ± 1.0 -0.3 ± 0.8
Z-score AAo** 1.1 ± 0.7 -0.1 ± 0.8 -0.5 ± 0.6
Z-score distal Arch* 0.8 ± 0.7 -0.1 ± 0.9 -0.2 ± 0.7
Z-score Isthmus** 2.0 ± 0.7 0.6 ± 0.7 0.4 ± 0.5
Z-score proximal DAo** 4.2 ± 1.1 1.2 ± 0.6 0.6 ± 0.7
Δ diameter Root-AAo (%)** 30.9 ± 4.0 33.8 ± 7.0 19.0 ± 7.0
Δ diameter Isthmus-pDAo (%)** 27.9 ± 9.1 10.4 ± 10.1 1.9 ± 5.7
WSSmean (Pa)
1. Inner pAAo* 0.69 ± 0.18 0.81 ± 0.09 0.86 ± 0.16
2. Outer pAAo 0.59 ± 0.11 0.67 ± 0.11 0.73 ± 0.14
3. Inner dAAo* 0.85 ± 0.18 0.97 ± 0.11 0.85 ± 0.15
4. Outer dAAo 0.75 ± 0.14 0.87 ± 0.11 0.83 ± 0.14
5. Inner Arch 0.83 ± 0.13 0.99 ± 0.13 0.91 ± 0.16
6. Outer Arch 0.71 ± 0.09 0.80 ± 0.11 0.79 ± 0.14
7. Inner pDAo* 0.58 ± 0.13 0.80 ± 0.14 0.87 ± 0.21
8. Outer pDAo 0.76 ± 0.13 0.89 ± 0.10 0.86 ± 0.12
9. Inner dDAo 0.75 ± 0.09 0.89 ± 0.16 0.89 ± 0.17
10. Outer dDAo* 0.78 ± 0.05 0.99 ± 0.18 0.97 ± 0.16
Significant across subgroups using a Kruskal-Wallis test. *P < 0.05, **P < 0.001.
Arch, aortic arch; dAAo, distal ascending aorta; pAAo, proximal ascending aorta; dDAo, distal descending aorta; 
pDAo, proximal descending aorta.
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Several studies previously demonstrated that visibly pathologic flow patterns could lead 
to measurable alterations in WSS.32, 33 Interestingly, the observed vortex flow patterns in the 
pDAo in MFS patients in this study corresponded to the reduced WSSmean observed in the 
same segment. A similar relationship has been described in a longitudinal follow-up study 
of MFS patients after root replacement where vortex flow disturbances within the pDAo 
segment together with reduced local WSS measures developed.34 In addition to the lower 
WSSmean in the pDAo segment, considerable differences in WSSmean were observed in the 
pAAo outer segment of the MFS patients compared to healthy subjects. However, no obvious 
flow pattern differences in the AAo were detected between MFS patients and the controls, 
except for local helix formation originating from the aortic root into the proximal AAo in 4 
MFS patients. The significant difference in AAo size between the MFS and healthy controls 
could have contributed to this reduced regional WSSmean.
Few studies have investigated aortic WSS in MFS disease cohorts so far9, 10 and comparable 
investigations on aortic WSS were conducted in similar patients groups with dilative 
aortopathy of unknown origin (i.e. non-bicuspid valve related diseases).32, 35 As in MFS 
patients, these patients have in common that the AAo is more or less dilated and these 
studies revealed similar aortic WSS results. In general, lower systolic WSS values were found 
along the dilated thoracic aorta in both these patient groups, as provided by 2D planar WSS 
quantification methods.9, 32, 35 Similar to our findings, the specific locations of reduced systolic 
WSS were found at the outer curvature of the pAAo in most of these studies.9, 35 Contrary 
to our results, one of the WSS studies in pediatric MFS patients showed inhomogeneous 
but relatively higher peak systolic WSS values at focal points on the vessel lumen 
circumference in the AAo compared to a healthy control group.10 Although this is inconsistent 
to our findings, the higher WSS found in that study might be explained by the fact that the 
MFS patients were younger and had similar or even significantly smaller indexed aortic 
dimensions compared to the older healthy control group. Indeed, both factors (i.e. younger 
age and smaller vessel dimensions) have been proven to be associated with relatively higher 
WSS measures.36, 37 The pDAo WSS in the MFS cohorts from these 4D flow CMR studies was 
equal or lower in MFS, but statistically similar compared to the WSS of healthy controls.9, 10 
It should be noted that the aortic WSS measurements in these comparative studies were 
all based on 2D planar WSS quantification methods, which means that WSS measurements 
are derived from single 2D cross-sectional planes along the thoracic aorta.
In this study, we used a novel approach providing 3D WSS along the entire aortic wall 
that was recently developed.25, 26 The major advantage of this 3D WSS approach is that the 
entire aorta is included rather than sampling only a fraction of the vessel wall, thus reducing 
the chance of missing important regional variations in WSS. Moreover, it allows regional 
comparison to control references and no manual placement of 2D cross-sectional planes 
is needed, which is more subject to observer variability. In addition, the estimation of 3D 
WSS over a certain regional vessel surface enables to study relationships between regional 
hemodynamics and geometric measures, for instance aortic diameter or diameter changes 
between vessel segments.
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Aortic WSS and diameter
The findings of our study revealed a close interaction between altered aortic diameter and 
regional WSSmean in MFS patients and healthy subjects. First, an inverse relationship between 
WSSmean and aortic diameter was observed, which is congruent with existing literature.
35, 36, 
38 The most obvious correlation was found for the pDAo segment, where both diameter and 
diameter change between the aortic isthmus and the largest pDAo dimension were inversely 
proportional to WSSmean. Furthermore, subgroup analysis of MFS patients with a dilated 
pDAo showed the lowest WSSmean in the corresponding region. Second, the dilation of the 
aortic root and STJ in MFS patients may have resulted in reduced WSSmean values in the pAAo 
segment and might explain the WSSmean asymmetry between the inner and outer pAAo 
segments. Such WSS asymmetry was also observed in the pAAo segment in another 4D flow 
CMR study on MFS patients.9 Moreover, an in-vitro computational fluid dynamic (CFD) 
investigation about the effect of morphological changes in the aortic root on flow 
hemodynamics supports these findings. That CFD study, which was conducted with MFS-
specific aortic root models of increasing size, showed that progressive root dilatation 
resulted in a different orientation of the blood stream jet in the aortic root and pAAo.39 It is 
conceivable that a flow displacement from the sinus-side towards the commissure side has 
resulted in the altered distribution of WSSmean that was observed in the pAAo in the MFS 
patients of this study.
Clinical perspectives
Current management strategies for preventive aortic replacement in MFS are based on aortic 
diameters or rate of dilatation. However, this strategy remains imperfect and has led to a 
search for additional markers of disease severity and predictors of adverse vascular events, 
such as hemodynamic parameters. The results of this study showed already hemodynamic 
differences in young MFS patients compared to age-appropriate healthy subjects and 
determined close relationships between regional aortic geometry, flow patterns and 3D WSS 
over certain vessel regions. This relationship was most evident for the pDAo. Whether these 
hemodynamic parameters (i.e. flow and WSS) may add in the prediction of progressive 
dilatation, adverse events or optimization of management strategies in future in addition to 
the current diameter measurements is unknown and requires further longitudinal follow-up. 
In this regard and in line with our findings, a recent longitudinal 4D flow follow-up study on 
MFS patients after preventive valve-sparing aortic root replacement reported the occurrence 
of helical and vortex flow pattern formation along the inner curvature of the pDAo in 50% 
of the patients.34 Additionally, in that report, a single case was described with newly derived 
regional vortex formation in the pDAo and altered WSS in that region prior to the development 
of an intramural hematoma with subsequent aortic dissection type B in the pDAo. This 
occurred 5 years after root replacement and the changes in flow and WSS parameters are 
noteworthy and suggest that these factors may play a role in the onset of the adverse event.34 
Together with our results, these observations show the clinical potential and future 
perspectives of comprehensive aortic flow hemodynamics assessments and monitoring of 
longitudinal changes by 4D flow imaging for optimization of preventive decision making. 
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Based on these and our data, one might speculate that at least the MFS patients with pDAo 
Z-score ≥2.0, abnormal vortex flow patterns and decreased local WSSmean, are at higher risk 
for adverse cardiovascular events. Additional longitudinal studies in are warranted to further 
elucidate the diagnostic value of inter-individual differences in MFS hemodynamics and the 
applicability of 4D flow parameters in prediction models.
Study Limitations
The current study is subject to several limitations. In this observational study there might 
be some selection bias. Although MFS patients underwent CMR as a regular part of their 
lifelong clinical follow-up according to the MFS imaging guidelines, we cannot completely 
exclude the possibility that some of them received MR imaging based on previously 
abnormal findings on echocardiographic imaging. These results therefore may not be 
generalizable. However, it is known that the MFS patients individually can show a large 
heterogeneity in the involvement of heart and cardiovascular problems, e.g. the onset and 
the progression of disease over time.
To account for patient age and body size for aortic dimensions comparison in children, 
aortic Z-scores were calculated using EchoIMS. While EchoIMS provides ultrasound-derived 
normative data, there is currently no large pediatric CMR-specific database and this method 
of normalization is the best available alternative, is used in clinical practice and has been 
applied in previous CMR studies.22, 23
Finally, potential sources of error, including the limited spatial resolution of 4D flow CMR, 
could have resulted in underestimation of 3D WSSmean measurements. However, as both 
patient and healthy control groups underwent MR imaging at the same scanners with similar 
scan parameters, relative differences in WSSmean between the two groups remain useful. 
Furthermore, 3D segmentation of the aorta based on the time-averaged systolic portion of 
the cardiac cycle is a potential source of error in this 4D flow study. However, averaging 
WSS over five systolic phases of the cardiac cycle with our algorithm, and using a well-defined 
segmentation protocol have been proven to produce low variability.26
Conclusions
MFS children and young adults have altered aortic flow patterns and differences in WSS 
that were most pronounced in the pAAo and pDAo, which correspond to the locations where 
aortic dissection and aortic rupture often originate in these patients. Furthermore, close 
relationships between the regional aortic size and the presence of abnormal flow patterns 
and WSS were demonstrated and were more evident in the pDAo segment. These findings 
indicate that hemodynamic parameters may be discriminative and potentially valuable 
additional markers of disease severity. Additional longitudinal studies correlating changes 
in hemodynamic parameters (aortic flow profiles and WSS) with aortopathy are needed to 
establish the role of these parameters in disease progression and risk prediction of adverse 
events in MFS patients.




1. Alpendurada F, Mohiaddin R. Prevalence of cardiovascular manifestations in patients with Marfan 
syndrome: a cardiovascular magnetic resonance stud. J Cardiovasc Magn Reson. 2008;10(Suppl 1)A164.
2. Engelfriet PM, Boersma E, Tijssen JG, Bouma BJ, Mulder BJ. Beyond the root: dilatation of the distal aorta 
in Marfan’s syndrome. Heart. 2006;92(9):1238-43.
3. Mariucci EM, Lovato L, Rosati M, Palena LM, Bonvicini M, Fattori R. Dilation of peripheral vessels in Marfan 
syndrome: importance of thoracoabdominal MR angiography. Int J Cardiol. 2013;167(6):2928-31.
4. Mimoun L, Detaint D, Hamroun D, Arnoult F, Delorme G, Gautier M, Milleron O, Meuleman C, Raoux F, 
Boileau C, et al. Dissection in Marfan syndrome: the importance of the descending aorta. Eur Heart J. 
2011;32(4):443-9.
5. den Hartog AW, Franken R, Zwinderman AH, Timmermans J, Scholte AJ, van den Berg MP, de Waard V, 
Pals G, Mulder BJ, Groenink M. The risk for type B aortic dissection in Marfan syndrome. J Am Coll Cardiol. 
2015;65(3):246-54.
6. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, 
Gaemperli O, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document 
covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task 
Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur 
Heart J. 2014;35(41):2873-926.
7. van Ooij P, Potters WV, Collins J, Carr M, Carr J, Malaisrie SC, Fedak PW, McCarthy PM, Markl M, Barker 
AJ. Characterization of abnormal wall shear stress using 4D flow MRI in human bicuspid aortopathy. Ann 
Biomed Eng. 2015;43(6):1385-97.
8. Geiger J, Markl M, Herzer L, Hirtler D, Loeffelbein F, Stiller B, Langer M, Arnold R. Aortic flow patterns in 
patients with Marfan syndrome assessed by flow-sensitive four-dimensional MRI. J Magn Reson Imaging. 
2012;35(3):594-600.
9. Wang HH, Chiu HH, Tseng WY, Peng HH. Does altered aortic flow in marfan syndrome relate to aortic root 
dilatation? J Magn Reson Imaging. 2016;44(2):500-8.
10. Geiger J, Arnold R, Herzer L, Hirtler D, Stankovic Z, Russe M, Langer M, Markl M. Aortic wall shear stress in 
Marfan syndrome. Magn Reson Med. 2013;70(4):1137-44.
11. Wigstrom L, Ebbers T, Fyrenius A, Karlsson M, Engvall J, Wranne B, Bolger AF. Particle trace visualization 
of intracardiac flow using time-resolved 3D phase contrast MRI. Magn Reson Med. 1999;41(4):793-9.
12. Buonocore MH. Visualizing blood flow patterns using streamlines, arrows, and particle paths. Magn Reson 
Med. 1998;40(2):210-26.
13. Markl M, Frydrychowicz A, Kozerke S, Hope M, Wieben O. 4D flow MRI. J Magn Reson Imaging. 
2012;36(5):1015-36.
14. Markl M, Schnell S, Wu C, Bollache E, Jarvis K, Barker AJ, Robinson JD, Rigsby CK. Advanced flow MRI: 
emerging techniques and applications. Clin Radiol. 2016;71(8):779-95.
15. Guzzardi DG, Barker AJ, van Ooij P, Malaisrie SC, Puthumana JJ, Belke DD, Mewhort HE, Svystonyuk DA, 
Kang S, Verma S, et al. Valve-Related Hemodynamics Mediate Human Bicuspid Aortopathy: Insights From 
Wall Shear Stress Mapping. J Am Coll Cardiol. 2015;66(8):892-900.
16. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau 
G, Faivre L, Milewicz DM, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 
2010;47(7):476-85.
17. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE, Jr., Eagle KA, Hermann LK, Isselbacher 
EM, Kazerooni EA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the 
diagnosis and management of patients with thoracic aortic disease. A Report of the American College 
of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American 
Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society 
PART II  |  Chapter 9
194
of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society 
of Interventional Radiology, Society of Thoracic Surgeons,and Society for Vascular Medicine. J Am Coll 
Cardiol. 2010;55(14):e27-e129.
18. Burman ED, Keegan J, Kilner PJ. Aortic root measurement by cardiovascular magnetic resonance: 
specification of planes and lines of measurement and corresponding normal values. Circ Cardiovasc 
Imaging. 2008;1(2):104-13.
19. Nejatian A, Yu J, Geva T, White MT, Prakash A. Aortic Measurements in Patients with Aortopathy are 
Larger and More Reproducible by Cardiac Magnetic Resonance Compared with Echocardiography. 
Pediatr Cardiol. 2015;36(8):1761-73.
20. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317(17):1098.
21. Chubb H, Simpson JM. The use of Z-scores in paediatric cardiology. Ann Pediatr Cardiol. 2012;5(2):179-84.
22. Johnson RK, Premraj S, Patel SS, Wahle A, Stolpen A, Sonka M, Scholz TD. Quantitative assessment of the 
entire thoracic aorta from magnetic resonance images. Cardiol Young. 2011;21(2):170-7.
23. Allen BD, van Ooij P, Barker AJ, Carr M, Gabbour M, Schnell S, Jarvis KB, Carr JC, Markl M, Rigsby C, et al. 
Thoracic aorta 3D hemodynamics in pediatric and young adult patients with bicuspid aortic valve. J Magn 
Reson Imaging. 2015;42(4):954-63.
24. Bock J, Kreher B, Henning J, Markl M. Optimized pre-processing of time-resolved 2D and 3D phase 
contrast MRI data. Proceedings of the 15th Annual Meeting of ISMRM, Berlin, Germany. 2007; Abstract 3138.
25. Potters WV, van Ooij P, Marquering H, vanBavel E, Nederveen AJ. Volumetric arterial wall shear stress 
calculation based on cine phase contrast MRI. J Magn Reson Imaging. 2015;41(2):505-16.
26. van Ooij P, Powell AL, Potters WV, Carr JC, Markl M, Barker AA. Reproducibility and interobserver variability 
of systolic blood flow velocity and 3D wall shear stress derived from 4D flow MRI in the healthy aorta. J 
Magn Reson Imaging. 2016;43(1):236-48.
27. Faivre L, Masurel-Paulet A, Collod-Beroud G, Callewaert BL, Child AH, Stheneur C, Binquet C, Gautier 
E, Chevallier B, Huet F, et al. Clinical and molecular study of 320 children with Marfan syndrome and 
related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations. Pediatrics. 
2009;123(1):391-8.
28. van Karnebeek CD, Naeff MS, Mulder BJ, Hennekam RC, Offringa M. Natural history of cardiovascular 
manifestations in Marfan syndrome. Arch Dis Child. 2001;84(2):129-37.
29. Finkbohner R, Johnston D, Crawford ES, Coselli J, Milewicz DM. Marfan syndrome. Long-term survival and 
complications after aortic aneurysm repair. Circulation. 1995;91(3):728-33.
30. Fisher RG, Sanchez-Torres M, Whigham CJ, Thomas JW. “Lumps” and “bumps” that mimic acute aortic and 
brachiocephalic vessel injury. Radiographics. 1997;17(4):825-34.
31. Picher A, Cassar TE, Suttie J, Francis JM, Leeson P, Blair E, Wordsworth BP, Forfar JC, Myerson SG, Markl M, 
et al. Visualisation of aortic flow disturbance in Marfan syndrome by 4D phase-contrast CMR. J Cardiovasc 
Magn Reson. 2011;13(Suppl 1):P201.
32. Bieging ET, Frydrychowicz A, Wentland A, Landgraf BR, Johnson KM, Wieben O, Francois CJ. In vivo 
three-dimensional MR wall shear stress estimation in ascending aortic dilatation. J Magn Reson Imaging. 
2011;33(3):589-97.
33. Frydrychowicz A, Arnold R, Hirtler D, Schlensak C, Stalder AF, Hennig J, Langer M, Markl M. Multidirectional 
flow analysis by cardiovascular magnetic resonance in aneurysm development following repair of aortic 
coarctation. J Cardiovasc Magn Reson. 2008;10:30.
34. Hope TA, Kvitting JP, Hope MD, Miller DC, Markl M, Herfkens RJ. Evaluation of Marfan patients status post 
valve-sparing aortic root replacement with 4D flow. Magn Reson Imaging. 2013;31(9):1479-84.
35. Burk J, Blanke P, Stankovic Z, Barker A, Russe M, Geiger J, Frydrychowicz A, Langer M, Markl M. Evaluation 
of 3D blood flow patterns and wall shear stress in the normal and dilated thoracic aorta using flow-
sensitive 4D CMR. J Cardiovasc Magn Reson. 2012;14:84.
36. Truong U, Fonseca B, Dunning J, Burgett S, Lanning C, Ivy DD, Shandas R, Hunter K, Barker AJ. Wall shear 
Altered aortic 3D hemodynamics and geometry in pediatric Marfan syndrome patients
195
9
stress measured by phase contrast cardiovascular magnetic resonance in children and adolescents with 
pulmonary arterial hypertension. J Cardiovasc Magn Reson. 2013;15:81.
37. van Ooij P, Garcia J, Potters WV, Malaisrie SC, Collins JD, Carr JC, Markl M, Barker AJ. Age-related changes 
in aortic 3D blood flow velocities and wall shear stress: Implications for the identification of altered 
hemodynamics in patients with aortic valve disease. J Magn Reson Imaging. 2016;43(5):1239-49.
38. Allen BD, Markl M, Barker AJ, van Ooij P, Carr JC, Malaisrie SC, McCarthy P, Bonow RO, Kansal P. Influence 
of beta-blocker therapy on aortic blood flow in patients with bicuspid aortic valve. Int J Cardiovasc Imaging. 
2016;32(4):621-8.
39. Querzoli G, Fortini S, Espa S, Costantini M, Sorgini F. Fluid dynamics of aortic root dilation in Marfan 
syndrome. J Biomech. 2014;47(12):3120-8.
Online supplementary videos 
Video 1. Pathline visualization from a MFS patient’s aorta with local vortex flow pattern in 
the proximal descending aorta during systole and early diastole. Note the prominent vortex 
flow patterns in the sinuses of the aortic root.
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The aim of this thesis was to investigate the prevalence and evolution of neo-aortic root 
pathology and surgical cardiovascular outcomes in patients after arterial switch operation 
(ASO) for transposition of the great arteries (TGA). Furthermore, thoracic aortic blood flow 
hemodynamics were investigated in relation to post-ASO geometry and root pathology with 
advanced non-invasive 4D flow cardiovascular magnetic resonance imaging (MRI) techniques.
A brief introduction about the Leiden surgical history for TGA was given in Chapter 1, 
together with a description of the neo-aortic complications (i.e. neo-aortic root dilatation 
and neo-aortic valve regurgitation) patients may face during follow-up after ASO. The first 
ASO was successfully performed in 1975 and this approach has become the surgical 
procedure of choice for TGA worldwide since mid-eighties.1 Cardiovascular imaging 
modalities such as echocardiography and cardiovascular MRI play an important role in the 
diagnosis of TGA and in monitoring and management of the neo-aortic root postoperatively. 
In the studies described in this thesis, echo and 4D flow MRI techniques were used to gain 
new insights into the progression of neo-aortic root pathology and on the aortic blood flow 
hemodynamics in TGA patients after ASO.
Part I
The neo-aorta in TGA – outcome after arterial switch operation
Chapter 2 summarizes the long-term surgical cardiovascular outcomes of the TGA cohort 
after 43 years of experience with the ASO in the Center for Congenital Heart Disease 
Amsterdam-Leiden (1977-2020). Patients with TGA with intact septum or TGA with ventricular 
septal defect (TGA-VSD) and double outlet right ventricle with subpulmonary VSD (Taussig- 
Bing anomaly) were included. The entire cohort consisted of 490 patients who underwent 
ASO. Of them, 43 patients died in the first postoperative month and 34 overseas patients 
(surviving ASO) were lost to follow-up, leaving 413 early ASO survivors with known follow-up 
for the evaluation of long-term outcome. Median follow-up was 15.6 (IQR 7.0-22.4) years 
post-ASO. Hospital mortality rates decreased rapidly over decades to 3.3% for the last two 
decades. Late mortality was low with 12 out of 413 patients (2.9%) who died after hospital 
discharge post-ASO, at a median age of 10.6 (0.9-21.9) years post-ASO. Late mortality was 
not related to acute coronary artery problems in 5 patients with identified causes of death; 
in 7 patients the exact cause of death could not be retrieved retrospectively. During follow-
up the need for one or more reoperations and one or more catheter interventions was 
20.1% and 13.1% respectively. Most reoperations and interventions were performed for 
right ventricular outflow tract problems. Coronary artery reoperations or interventions were 
required in only nine patients (2.2%), suggesting that coronary problems do not frequently 
occur during follow-up. The neo-aortic root pathology however significantly impacts long-
term outcome given that the incidence of neo-aortic root and aortic valve redo surgery 
increases over decades. Twenty-one surgical procedures and one catheter procedure for 
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neo-aortic valve insufficiency and/or root dilatation were performed in 15 patients (3.6%), 
approximately 20% of the total amount of reoperations. In two-third of the reoperated 
patients surgery was performed in the last decade (2009-2020). Between 1977 and 2009, 
only 5 patients needed reoperation for neo-aortic pathology of the 302 early survivors after 
ASO (1.7%). Although the total amount of reoperations for neo-aortic valve/root problems 
is still low and comparable to international surgical centers,2 with longer follow-up times it 
is likely that the need for surgery for late neo-aortic root complications will further increase. 
Independent risk factors for the need of any reoperation or intervention were: a more 
complex TGA morphology (TGA-VSD), aortic arch repair associated to ASO and a non-usual 
coronary artery anatomy.
Chapter 3 describes the natural growth of the native aortic valve and the pulmonary valve 
in fetuses with TGA from 20 weeks’ gestation till birth. This growth was compared with 
normal fetal semilunar valve growth from reference data of fetuses without congenital heart 
defects.3, 4 In TGA fetuses, semilunar valves (i.e. both the pulmonary and the aortic valve) 
were larger compared with fetuses with normal hearts. Pulmonary valve annular diameters 
were larger than controls from 27 weeks’ gestation, especially when a VSD was present, and 
were also significantly larger than control aortic valve annular diameters from 23 weeks’ 
gestation. These observations suggest that other factors besides flow play a role in the 
growth of the semilunar valve annuli in fetal TGA. The indexed size of the pulmonary valve 
annulus (i.e. indexed to body surface area and expressed as Z-score) at 26 to 30 weeks 
correlated with the indexed size of the neo-aortic root at last follow-up visit post-ASO. 
However, this correlation was not strong enough and the postoperative follow-up relatively 
short to be clinically useful for a prenatal prediction of neo-aortic root dilatation (dilatation 
defined as Z-score >2.0) post-ASO. Findings from this study adds to our understanding of 
the pathophysiology of fetal semilunar growth. Furthermore, it provides insight in the origin 
of the differences between the morphological subtypes of TGA as starting point for the 
further course of neo-aortic valve and root growth in the years beyond the ASO.
Chapter 4 reports the results of a retrospective longitudinal follow-up study on neo-aortic 
growth, neo-aortic valve function and reoperations for neo-aortic valve and/or root pathology 
from birth up to 39 years post-ASO for the various morphological subtypes of TGA. This 
study demonstrated that neo-aortic root dilatation is progressive over time and does not 
stabilize in adulthood. The neo-aortic annulus, root and the sinotubular junction all showed 
similar growth patterns: a rapid disproportional increase in the first year after ASO exceeding 
upper limits of normal dimensions (indexed to body surface area with on average Z-scores 
>2.0), followed by a nearly linear increase of neo-aortic dimensions in childhood comparable 
to normal somatic growth, with an ongoing progressive growth in adulthood. Complex 
morphological TGA subtype (TGA-VSD and Taussig-Bing anomaly) and male gender were 
found to be independent risk factors for neo-aortic root dilatation.
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Furthermore, neo-aortic valve regurgitation continued to develop over time: freedom 
from moderate or more regurgitation during first 25 years post-ASO was 69%. Importantly, 
this study showed that the progression of neo-aortic root dilatation is a critical factor for 
impairment of the neo-aortic valve function: per millimeter increase in neo-aortic root 
dimension over time there was an average 9% increase in the hazard of moderate or more 
neo-aortic valve regurgitation. These data suggest that in this group of patients an important 
underlying mechanism for regurgitation is impaired leaflet coaptation due to progression 
of the neo-aortic root and valve dimensions. Bicuspid pulmonary valve morphology was 
not associated with a higher risk of regurgitation which endorses that a preoperative 
competent bicuspid valve itself is not a contraindication for ASO with regard to long-term 
valve function. The incidence of neo-aortic reoperations in this study was low and concerned 
3% of the cohort. However, already 14% of the study cohort developed a neo-aortic root 
diameter ≥40mm, with at least moderate neo-aortic valve regurgitation in 26% of them. Of 
note, one-quarter of these patients have not even reached adulthood. The ongoing neo-
aortic dilatation also during adulthood, progression of neo-aortic valve regurgitation and 
its mutual relationship as demonstrated in this study is of concern and may imply an 
increased need of root and valve reoperations in the near future.
Chapter 5 presents an extension of the results on the effect of changing neo-aortic 
dimensions over time on the risk of neo-aortic valve regurgitation as reported in Chapter 
4. A reanalysis on the data was performed by a more comprehensive statistical analysis 
approach for the evaluation of longitudinal data with time-to-event data by means of joint 
modeling. From this approach, it was confirmed that the neo-aortic root dimensions showed 
a positive significant association with at least moderate neo-aortic valve regurgitation, but 
the association was much stronger than was previously determined (Chapter 4). Furthermore, 
with joint modeling the neo-aortic root dimension was also shown to be an independent 
risk factor for the development of at least mild neo-aortic valve regurgitation where 
previously no association was found. Moreover, also the neo-aortic annulus dimension was 
an independent risk factor for the development of both at least mild neo-aortic valve 
regurgitation and at least moderate neo-aortic valve regurgitation. Apart from this, neo-
aortic annular growth rate as well as the neo-aortic root growth rate, in addition to the 
annular and root dimensions, were independently associated with the development of at 
least mild neo-aortic valve regurgitation. This means that a faster growth of the neo-aortic 
annulus and neo-aortic root, on top of the neo-aortic dimensions, was associated with a 
higher risk of neo-aortic valve regurgitation.




Aortic 4D flow MR imaging - the arterial switch operation for TGA 
and beyond
Recently, 4D flow MRI has been introduced as a novel non-invasive imaging method that 
can be used for comprehensive in vivo assessment of blood flow in the large vessels.5, 6 It 
provides information about the spatial and temporal distribution of vascular blood flow and 
enables the quantification of flow-related hemodynamic parameters. Therefore, 4D flow 
MRI is used to better understand cardiovascular physiology and pathophysiology and has 
led to improved knowledge of disease progression in patients with congenital heart disease-
related aortopathy.6-10 Advanced hemodynamic parameters such as wall shear stress (WSS) 
and flow displacement can be derived from 4D flow MRI. Several studies have shown that 
increased flow displacement, defined as the displacement of peak systolic flow from the 
aortic center, is related to aortic valve morphology and is correlated with future ascending 
aortic growth in bicuspid valve-related dilated aortopathy.9, 11 The parameter WSS represents 
the viscous shear force of flowing blood acting tangentially to the vessel wall. Areas of high 
WSS have been associated with marked histological changes in the ascending aortic vessel 
wall in patients with bicuspid aortic valves.12 In addition, abnormal WSS has been suggested 
to have potentially contributing effects on vessel dilatation and aneurysm formation; for 
example, on the thoracic aorta and on intracranial aneurysms.13, 14
The application of aortic 4D flow MRI can therefore be of great value for the evaluation 
of aortopathy in patients after ASO for TGA. However, validation of the applied 4D flow 
techniques and knowledge on the reproducibility and consistency of its output parameter(s) 
are necessary to interpret differences between patient groups and between longitudinal 
patient data. For that reason, a scan-rescan reproducibility and observer variability study 
for 3D systolic WSS in the thoracic aorta was performed in healthy subjects and summarized 
in Chapter 6. For the WSS analysis, the thoracic aorta was divided into 5 segments: proximal 
and distal ascending aortic segment, aortic arch and proximal and distal descending aortic 
segment. Consequently, the maximum peak systolic WSS (WSSmax) and the mean peak 
systolic WSS (WSSmean) in each of the segments were calculated. Scan–rescan reproducibility 
was good for WSSmean in all thoracic aortic regions but scan–rescan reproducibility for 
WSSmax was moderate with higher variability in the proximal ascending aorta. The 
intraobserver and interobserver reproducibility for segmental systolic WSS analysis of 
WSSmax and WSSmean was good to excellent. In general, the ascending aortic segments 
showed more variability in WSSmax and WSSmean measurements compared to aortic arch 
or descending aortic segments for scan–rescan, intraobserver and interobserver comparison. 
These WSS variations should be considered in patient studies and comparative rest–stress 
studies to avoid misinterpretation of data.
In Chapter 7, we investigated the ascending aortic hemodynamics in simple TGA patients 
after ASO compared to healthy subjects using 4D flow MRI. In these patients, neo-aortic 
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root dilatation is present and progressive over time and has been shown to be a critical 
factor in deterioration of the neo-aortic valve function (as stated in Chapter 4 and 5). Aortic 
dimensions from the ascending aorta and two quantitative hemodynamic parameters were 
assessed: normalized flow displacement (FD) and WSS. TGA patients after ASO showed more 
eccentric flow in the proximal ascending aorta (i.e. neo-aortic root) evidenced by a higher 
magnitude and directionality of FD, which was linearly related with local indexed aortic 
dimensions of the neo-aortic root and sinotubular junction (i.e. indexed by body surface 
area and expressed as Z-scores). Directionality of the eccentric flow profiles in the neo-aortic 
root were significantly different between patients with different TGA-specific preoperative 
position of the great arteries: a right-anterior or right-sided position of the aorta related to 
the pulmonary artery showed more FD to the right-side of the ascending aorta, whereas a 
left-anterior or anterior position of the aorta resulted in more FD to the left-side of the aortic 
wall at the level of the neo-aortic root. Furthermore, TGA patients showed abnormal regional 
WSS in the proximal ascending aorta: lower WSS compared to healthy subjects; in the distal 
ascending aorta: higher WSS compared to healthy subjects, with a focal increased WSS 
hotspot on the anterior-right anterior wall of the distal ascending aorta. The ASO-specific 
aortic geometry consisted of neo-aortic root dilatation and a sudden change in vessel 
diameter at the mid-ascending aortic level, the level of anterior aortic compression by the 
pulmonary trunk due to Lecompte maneuver as part of the ASO. This sudden change in 
aortic diameter was associated with increased and asymmetric peak systolic WSS distribution 
along the distal ascending aorta, most pronounced in the right and anterior aortic wall 
regions. The larger the size discrepancy between the neo-aortic root and mid-ascending 
aorta, the higher the WSS levels in the distal ascending aorta.
 The regions of the abnormal increased WSS clinically correlate with the location of the 
paper-thin and fragile anterior wall of the ascending aorta that has been found in ASO 
patients during root reoperations, as described earlier by our center.15 The flow displacement 
direction from root to mid-ascending aorta also corresponded to the peak systolic WSS 
distribution in the mid-ascending aorta, but the contribution of FD on WSS distribution more 
upstream in the distal ascending aorta was less compared with the effect of vessel tapering. 
The observations from this study start to unravel the interaction between the post-ASO 
geometry and hemodynamics within the ascending aorta and how the hemodynamics may 
be involved in the (progression of) neo-aortic root dilatation and/or anterior aortic wall 
thinning of the distal ascending aorta.
In Chapter 8, aortic WSS distribution was evaluated in the entire thoracic aorta of TGA 
patients after ASO compared to healthy subjects and was related to geometric thoracic 
aortic alterations post-ASO. Furthermore, the effects of dobutamine-induced stress on aortic 
WSS were studied in vivo in TGA patients and were compared with the rest state. The 
investigations were conducted to assess whether geometry-driven or pharmacological 
stress-induced alterations in aortic flow might have its impact on the aortic wall in patients 
with increased risk on progressive neo-aortic root dilatation over time. This is important 
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since progressive neo-aortic root dilatation has been proven to be a major factor for the 
impairment of neo-aortic valve function in these patients (as stated in Chapter 4 and 5). In 
concordance with literature,16-18 specific geometric alterations of the thoracic aorta after 
ASO were observed and consisted of a large size discrepancy between the dilated neo-aortic 
root and the mid-ascending aortic diameter due the anterior aortic position and compression 
by the pulmonary artery branches after ASO with Lecompte maneuver. Furthermore, a more 
acute angulation of the curvature of the aortic arch was determined. From the 4D flow 
analysis, pediatric and adolescent patients after ASO showed significantly higher WSS 
magnitude in the entire thoracic aorta compared with healthy subjects at rest, except for 
the dilated proximal ascending aorta. In agreement with the findings in Chapter 7, the 
regions of high peak systolic WSS were most pronounced in the distal ascending aorta and 
located at the anterior aortic wall of that segment. The specific ascending aortic geometry 
post-ASO, reflected by the size discrepancy between the dilated neo-aortic root and the 
smaller mid-ascending aorta diameter, was associated with higher WSS levels in all the aortic 
segments downstream this caliber change: the larger the size discrepancy, the higher the 
WSS levels in the distal ascending aorta, but also in the descending aortic segments. The 
geometry of the aortic arch, reflected by the sharper aortic arch angulation in TGA patients 
after ASO compared to healthy subjects, did not further contribute to the high WSS levels 
in the aortic arch and the descending aortic segments.
Dobutamine-induced cardiac stress did increase WSS magnitude significantly along all 
thoracic aortic segments, the most prominent in the ascending aortic segments. The highest 
peak systolic WSS was present in the distal ascending aortic segment during both rest and 
stress, but for stress, this was even more pronounced. The peak systolic WSS increase by 
dobutamine in that segment showed a positive correlation with the increase in the LV 
ejection fraction, stroke volume, and cardiac output. Based on the results from this study 
we concluded that pharmacological-induced stress evaluations of aortic blood flow might 
better reflect location and expansion of vascular wall areas exposed to abnormal WSS with 
subsequent risks for vascular remodeling. Stress might play a role in neo-aortic root 
dilatation in TGA patients after ASO given the significant stress-induced WSS increase in the 
neo-aortic root, acting on root tissue with structural vessel wall abnormalities.19, 20
Knowledge on the extend of the distribution and magnitude of aortic WSS is not only of 
interest in postoperative congenital heart disease patients such as in patients after ASO, 
but also in patients with inherited connective tissue disease such as Marfan syndrome. 
These patient groups have progressive root dilatation in common, but Marfan patients have 
proven to be at risk for aortic dissection and aortic rupture.21, 22 In TGA patients after ASO 
root dilatation and valve insufficiency are well documented but aortic dissections have not 
been reported in literature so far. To learn from patients with aortopathy being more at risk 
for adverse cardiovascular events, we also performed a 4D flow MRI study in pediatric 
patients with Marfan syndrome. This study was performed in collaboration with the Lurie 
Children’s Hospital of Chicago and the Northwestern University Feinberg School of Medicine, 
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Chicago, Illinois, USA and is summarized in Chapter 9. Thoracic aorta hemodynamics such 
as blood flow patterns, regional aortic WSS, and aortic dimensions were assessed in a 
pediatric Marfan syndrome cohort and were compared to a healthy age-appropriate control 
cohort. A substantial part of the children with Marfan syndrome showed altered aortic flow 
patterns, consisting of marked vortex flow in the proximal descending aorta and non-
physiological helical flow patterns with high strength originating from the aortic root into 
the ascending aorta. Moreover, significant differences in aortic WSS were found in Marfan 
patients compared to the aged matched healthy subjects. These flow alterations and the 
detected lower WSS magnitude were most pronounced in the proximal ascending aorta 
and proximal descending aorta, segments where aortic dissection or rupture often originate. 
The presence of vortex flow patterns and abnormal WSS correlated with regional size of 
the proximal descending aorta and are potentially valuable additional markers of disease 
severity. Long-term follow-up of these patients will indicate the prognostication of these 4D 
flow imaging parameters on the progression of aortic dilatation and/or the occurrence of 
adverse aortic events at these predilection sites.
Conclusions
In this thesis multiple aspects of aortopathy in patients with transposition of the great 
arteries were studied, both in fetal life and after the arterial switch operation, with a key 
role for aortic imaging and longitudinal follow-up. The development of the neo-aortic valve 
and root dimensions and the fate of the neo-aortic valve over time were investigated and 
showed progressive root dilatation without stabilization in adult life with the root diameter 
as critical factor for the impairment of neo-aortic valve function. Based on these findings, 
along with observations of an increased incidence of reoperations on the neo-aortic valve 
and/or root over the past decade, the need for surgery for late neo-aortic root complications 
is expected to further increase with longer follow-up times.
The pathophysiology of progressive root dilatation remains incompletely understood 
and is most likely multifactorial. In this thesis, it was demonstrated that more complex 
morphological TGA subtype (TGA-VSD and Taussig-Bing anomaly) and male gender were 
independent risk factors for neo-aortic root dilatation. Furthermore, insights from the 
present 4D flow studies suggest a contributing factor of flow hemodynamics associated 
with the ASO-specific thoracic aortic geometry. These insights from comprehensive aortic 
blood flow imaging may contribute in further understanding the mechanisms involved in 
the neo-aortic root dilation and, ultimately, provide valuable information to guide 
personalized management of neo-aortic disease in TGA patients after ASO within the next 
decade.
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Recommendations and future prospects – personalized management
Three important areas of research impacting patient care for TGA patients after ASO in 
the near future should focus on personalized cardiovascular management to improve 
outcome.
1.  Surveillance of valve and root complications – risk stratification models from serial 
data
Noninvasive imaging modalities are used for detection and surveillance of root dilatation 
and valve insufficiency. Longitudinal long-term follow-up data from standardized imaging 
protocols enables the assessment of risk factors for certain outcomes, as shown for the 
occurrence of neo-aortic valve leakage in this thesis. In addition, these data will also allow 
to predict outcome of adverse events or disease progression on an individualized basis. 
Development of such prediction models and risk stratification tools for physicians can 
serve for scientifically-based individual patient management. Using this information to 
direct care, identifies the right level of care for each patient, maximizes efficiency and 
may improve outcome at population level.
New statistical methodologies (e.g. joint modeling) can simultaneous model a 
longitudinal marker (neo-aortic root dilatation) with time-to-event data (the occurrence 
of certain degree of neo-aortic valve regurgitation). These models give more insight in 
patients: how they ‘behave’ compared to their peers. In addition, they have the potential 
to reduce costs, time and to better prognosticate. Since survival into adulthood is 
expected for almost all congenital heart diseases and prognostication is requested by 
patients and their parents, central registration of outcome data and longitudinal 
measures for residual abnormalities in large (local, national or even European controlled) 
databases is a recommended next step. We have the framework, but we have to critically 
choose patient categories for this investment and implement this in daily practice.
2.  4D flow imaging – surgical considerations (ASO technique & TGA morphology)
Extending knowledge on pathophysiologic mechanisms of altered flow hemodynamics 
on disease progression is necessary in TGA patients after ASO, to get better insight and 
to think about surgical techniques solving long-term residual sequelae in patients with 
TGA. Some surgical centers advocate for the preservation of the spiral relationship of 
the large arteries by the use of a direct spiral ASO instead of the application of the 
Lecompte maneuver with the neonatal ASO.23, 24 Although it needs to be proved that 
direct spiral ASO has its advantages in functional outcome over the ASO with Lecompte 
maneuver in the long run, from semiquantitative evaluation of aortic flow patterns by 
4D flow MR imaging in these patients with 20 year postoperative follow-up it is reported 
that more physiologically aortic blood flow profiles with less blood flow alterations (i.e. 
less vortex formation and lower relative helicity magnitude) are present using that 
technique.24 These results, together with the results from the aortic 4D flow studies 
PART II  |  Chapter 10
206
reported in this thesis (Chapter 7 and 8) in which we showed already abnormal ascending 
aortic flow hemodynamics in young patients after ASO, suggest aortic geometry as an 
important factor for altered ascending aortic flow hemodynamics. The clinical relevance 
of these differences in blood flow profiles between the surgical ASO approaches for TGA 
patients later in life remains to be evaluated. Since all 4D flow studies in TGA patients 
after ASO have been performed at one single timepoint without serial follow-up, it is 
unknown whether the altered hemodynamics are either the result of progressive aortic 
dilatation, or whether the altered hemodynamics are in any way causative to the 
dilatation. Longitudinal 4D flow studies in these patients are necessary to gain more 
insight in these mechanisms. Moreover, additional 4D flow studies evaluating the 
interindividual differences in aortic hemodynamics between TGA patients with different 
ASO techniques (i.e. with and without the application of Lecompte maneuver) and 
between TGA patients with different anatomy (i.e. with or without VSD and TGA subgroups 
with different spatial position of the great arteries) need to be performed to ultimately 
optimize individual surgical management strategies for the best long-term outcomes.
3.  4D flow imaging – a guide for interventions
Risk factors for neo-aortic root dilatation in TGA patients are most likely multifactorial, 
but insights from the present 4D flow studies suggest a contributing factor of flow 
hemodynamics related to the ASO-specific geometry of the thoracic aorta. Ultimately, 
advanced hemodynamic imaging parameters derived from 4D flow can serve in the 
prediction of aortic complications (root dilatation, aortic rupture or aortic dissection) and 
may aid in timing of interventions to optimize clinical outcome for dilative aortopathies 
as current management strategies are imperfect and based on just absolute diameters.25 
Therefore, efforts should be made to incorporate 4D flow MRI as standard follow-up 
examination in TGA patients after ASO, but also in other aortopathies like Marfan 
syndrome and after reconstructive aortic arch repair, to put the value of these novel 
imaging markers in clinical perspective. Moreover, 4D flow studies in all patients 
necessitating root replacement are required for the comparison of MR-derived 
biomarkers and histopathological aortic wall alterations to investigate flow-mediated 
wall changes contributing to root dilatation and anterior aortic wall thinning. Multi-
institutional collaboration should be encouraged to move forward on this topic given the 
challenge of data collection with the relative low incidence of root replacements in single 
institutions.
Another potentially essential role for 4D flow imaging is its use in the preoperative 
planning for root and ascending aortic replacements. The integration of 4D flow-derived 
data from individual TGA-specific aortas in computational fluid dynamics enables the 
evaluation of the most optimal surgical approach for an intervention, by predicting the 
hemodynamic response and determining the best personalized aortic conduit fit (size, 
curvature and length) for implantation. Preoperative personalized surgical planning in a 
virtual platform with integrated computational fluid dynamic modeling of personalized 
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in vivo aortic 4D flow data will be the future, to tailor conduit characteristics, conduit 
production and implantation (i.e. model-based personalized management). It is expected 
that this application will not only become important for patients with aortopathy, but 
may also be relevant for a larger spectrum of growing patients with (repaired) congenital 
heart defects.
Technical advances in cardiovascular imaging are essential to promote cardiovascular 
science and medical management. However, one note has to be made. The rapidly 
advancing technology is striking, but validation of these new applications is essential 
before the implementation in daily clinical practice, and should not be underestimated. 
If proven to be robust (precise and reproducible), these techniques will ultimately change 
clinical practice and improve outcome for patients with TGA and other congenital heart 
diseases.
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Nederlandse samenvatting 
Transpositie van de grote vaten (TGA) is een ernstige aangeboren hartafwijking waarbij 
in de aanleg van het hart de grote slagaders zijn verwisseld: de aorta komt uit de 
rechterkamer; de longslagader uit de linkerkamer. In Europa komt deze aandoening voor 
bij 3-4 op 10000 levend geboren kinderen. Operatief ingrijpen kort na geboorte is 
noodzakelijk anders overlijdt de patiënt. De huidige chirurgische behandeling van deze 
hartafwijking is de arteriële switch operatie (ASO). Deze operatie werd in 1975 voor het 
eerst succesvol uitgevoerd en sinds midden jaren ‘80 heeft het wereldwijd de daarvoor 
gebruikelijke operatieve techniek nagenoeg volledig vervangen. Tijdens de ASO worden 
de grote slagaders boven het niveau van de hartkleppen omgedraaid, zodat de grote 
bloedvaten weer op de juiste hartkamers aangesloten zijn. Tevens worden de 
kransslagaders omgezet. De longslagaderklep, aortaklep en het eerste deel van de 
slagaders blijven op hun oorspronkelijke plaats zitten. Hoewel deze nieuwe operatieve 
techniek de korte- en langetermijnoverleving voor kinderen met deze aandoening sterk 
heeft verbeterd, worden er in het beloop belangrijke restafwijkingen gevonden. Een van 
deze afwijkingen is een toenemende verwijding (dilatatie) van het eerste deel van de aorta 
(na ASO neo-aortawortel genoemd). Dilatatie van de neo-aortawortel komt bij het 
merendeel van de patiënten na ASO voor.
Dit proefschrift beschrijft de ontwikkeling van de neo-aortawortelproblematiek en de lange 
termijn cardiovasculaire uitkomsten bij patiënten na een ASO als behandeling voor TGA. 
Daarnaast worden de hemodynamische aspecten van de bloedstroom in de thoracale aorta 
in deze patiënten onderzocht in relatie met de aortageometrie en de neo-
aortawortelpathologie door middel van geavanceerde cardiovasculaire beeldvormende 
techniek: vierdimensionale flow magnetische resonantie imaging (4D flow MRI).
Hoofdstuk 1 geeft een korte introductie over de Leidse chirurgische geschiedenis van de 
behandeling van patiënten met TGA en de ontwikkeling van de ASO. De ASO werd voor het 
eerst succesvol uitgevoerd door dr. Jatene in 1975 en al in 1977 in het academisch ziekenhuis 
Leiden toegepast. Vanaf midden jaren ‘80 werd de ASO wereldwijd de beoogde operatieve 
techniek voor patiënten met TGA.1 De belangrijkste aortacomplicaties die op termijn na ASO 
kunnen optreden zijn dilatatie van de neo-aortawortel en neo-aortakleplekkage. 
Echocardiografie en cardiale MRI spelen een essentiële rol bij het diagnosticeren van deze 
hartaandoeningen en bij de monitoring en timing van de behandeling van neo-
aortawortelproblemen na ASO. In de beschreven studies in dit proefschrift zijn 
echocardiografie en 4D flow MRI gebruikt om nieuwe inzichten te verkrijgen in zowel de 






De aorta in TGA – foetale groei & resultaten na de arteriële switch 
operatie
Het eerste deel van dit proefschrift richt zich op de resultaten na ASO met focus op de aorta, 
alsmede op de groei van de aorta in patiënten met TGA, zowel tijdens de zwangerschap als 
na ASO. In Hoofdstuk 2 worden de langetermijnuitkomsten beschreven van het cohort 
TGA-patiënten geopereerd in het Centrum voor Aangeboren Hartafwijkingen Amsterdam-
Leiden tussen 1977 en 2020. Dit cohort omvat 490 patiënten na ASO en bestaat uit TGA-
patiënten met eenvoudiger anatomie, zoals TGA met intact ventrikel septum (TGA-IVS) en 
TGA met ventrikel septum defect (TGA-VSD), alsook uit patiënten met een complexere TGA-
variant zoals double outlet rechterventrikel met subpulmonaal VSD (Taussig-Bing anomalie). 
Drieënveertig patiënten zijn direct of kort (<30 dagen) na de ASO overleden en van 34 
patiënten is er geen follow-up omdat zij terugkeerden naar het land van verwijzing. Hierdoor 
is de langetermijnuitkomst van 413 patiënten beoordeeld met een mediane follow-up van 
15.6 (interkwartielafstand, IQR 7.0-22.4) jaar na ASO. De ziekenhuissterfte (overlijden in het 
ziekenhuis na hartoperatie) daalde snel na implementatie van de ASO tot 3.3% over de 
afgelopen twintig jaar. Twaalf van de 413 patiënten zijn gedurende follow-up (na ontslag 
uit het ziekenhuis na ASO) overleden, gemiddeld op een leeftijd van 10.6 (IQR 0.9-21.9) jaar 
na ASO. Voor 5 van de 12 patiënten kon de oorzaak van het overlijden worden achterhaald; 
geen van deze patiënten overleed door een probleem aan de kransslagaderen.
Het percentage van de patiënten dat in het beloop na ASO een nieuwe operatieve ingreep 
(heroperatie) of katheterinterventie heeft ondergaan is respectievelijk 20.1% en 13.1%. De 
meeste heroperaties betreffen operaties voor het herstellen van problemen in de 
rechterkamer uitstroombaan. Heroperaties of katheterinterventies aan kransslagaderen 
waren noodzakelijk in slechts 9 patiënten (2.2%), wat suggereert dat problemen aan 
kransslagaderen in het beloop niet veel voorkomen. Neo-aortaklep en/of neo-
aortawortelpathologie lijkt een belangrijker probleem te worden op de lange termijn, gezien 
de toenemende incidentie van heroperaties voor deze problematiek. Eenentwintig 
chirurgische procedures en één katheterinterventie waren noodzakelijk bij 15 patiënten 
(3.6%) voor de behandeling van belangrijke neo-aortakleplekkage en/of neo-
aortaworteldilatatie. Dit betreft 20% van het totaal aantal heroperaties. Bij twee derde van 
deze patiënten werd de operatie in de afgelopen 11 jaar uitgevoerd (2009-2020). Tussen 
1977 en 2009 was slechts bij 5 van de 302 patiënten na ASO (1.7%) een heroperatie 
noodzakelijk voor neo-aortaproblematiek. Hoewel het totaal aantal heroperaties voor neo-
aortapathologie nu nog laag is en vergelijkbaar met internationale centra voor 
kinderhartchirurgie,2 is het te verwachten dat dit aantal zal toenemen bij langere follow-up. 
Onafhankelijke risicofactoren voor heroperatie of interventie, ongeacht de indicatie, zijn: 1. 
een meer complexe TGA-morfologie (TGA-VSD en Taussig-Bing anomalie), 2. een status na 
eerder chirurgisch herstel van de aortaboog en 3. een minder gebruikelijke kransslagader 
anatomie (anders dan 1LCx-2R, 1L-2CxR of 1L-2R,Cx afwezig).
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In Hoofdstuk 3 wordt de intra-uteriene groei van de aortaklep en de longslagaderklep (ook 
wel semilunair kleppen genoemd) bij foetussen met een TGA beschreven (vanaf 20 weken 
zwangerschapstermijn tot aan de geboorte). Deze groei wordt vergeleken met de intra-
uteriene groei van de semilunair kleppen bij foetussen zonder hartafwijking.3, 4 Gedurende 
deze periode is zowel de afmeting van de longslagaderklep als die van de aortaklep 
gemiddeld groter in foetussen met TGA dan in foetussen zonder deze hartafwijking. Vanaf 
een zwangerschapstermijn van 27 weken is de longslagaderklep in een TGA foetus gemiddeld 
groter dan de longslagaderklep in de controle groep, met name in aanwezigheid van een 
VSD. Bovendien is de longslagaderklep gemiddeld groter in vergelijking met de aortaklep 
in de controle groep vanaf een zwangerschapstermijn van 23 weken. Deze uitkomsten 
suggereren dat er naast de factor van een preferentiële bloedstroming (flow) ook andere 
factoren een rol spelen bij de groei van de semilunair kleppen in foetussen met TGA. De 
longslagaderklep tussen 26 en 30 weken zwangerschapstermijn (afmeting geïndexeerd voor 
lichaamsoppervlak en uitgedrukt als Z-score) correleerde met de geïndexeerde neo-
aortawortel diameter na ASO gemeten bij het laatste kindercardiologische bezoek. Deze 
correlatie is relatief zwak en ook de follow-up van de patiënten in deze studie is relatief kort 
waardoor de longslagaderklep afmeting bij de foetus niet kan worden gebruikt als 
voorspeller van neo-aortaworteldilatatie na ASO. De bevindingen uit deze studie dragen bij 
aan het begrip van de pathofysiologie van foetale groei van de semilunair kleppen en geven 
bovendien inzicht in het ontstaan van de verschillen in semilunair klep afmetingen tussen 
TGA-patiënten met diverse morfologie.
In Hoofdstuk 4 worden de resultaten beschreven van een retrospectieve longitudinale 
studie naar de groei en functie van de neo-aortaklep en neo-aortawortel in 345 patiënten 
vanaf ASO tot 39 jaar nadien. Tevens worden de heroperaties voor neo-aortawortel en 
kleppathologie geëvalueerd. Dit onderzoek toont aan dat de dilatatie van de neo-aortawortel 
progressief is en zich voortzet op volwassen leeftijd zonder tekenen van stabilisatie in 
tegenstelling tot de aortawortel van gezonde volwassenen die nauwelijks in diameter 
toeneemt met de leeftijd. De neo-aortaklep, neo-aortawortel en sinotubulaire junctie laten 
een identiek groeipatroon zien: er is een snelle disproportionele toename in het eerste jaar 
na ASO resulterend in geïndexeerde afmetingen boven de bovengrenzen van normaal 
(geïndexeerd voor lichaamsoppervlak met groepsgemiddelde Z-scores >2.0). De neo-aorta 
afmetingen op kinderleeftijd (1-18 jaar) laten een nagenoeg lineaire toename zien 
vergelijkbaar met de somatische groei in die periode, maar worden gevolgd door een 
progressieve groei op volwassen leeftijd. Onafhankelijke risicofactoren voor neo-
aortadilatatie (dilatatie gedefinieerd als Z-score >2.0) zijn: mannelijk geslacht en een meer 
complexe TGA-morfologie (TGA-VSD en Taussig-Bing anomalie). De neo-aortakleplekkage 
toont eveneens een progressief beloop in de tijd: de kans op ontwikkelen van tenminste 
matige neo-aortakleplekkage 25 jaar na ASO is 31%. De progressie van neo-
aortaworteldilatatie blijkt een kritische factor te zijn voor verslechtering van de neo-




neo-aortawortel is er een 9% toename in kans (hazard) op het ontwikkelen van tenminste 
matige neo-aortakleplekkage. Dit is een belangrijke bevinding en impliceert een verminderde 
coaptatie van de klepbladen door een toename van de neo-aortawortel en neo-
aortaklepafmetingen als belangrijk onderliggend mechanisme voor het ontstaan van 
kleplekkage. Een bicuspide (tweeslippige in plaats van een meer gebruikelijke drieslippige) 
neo-aortaklep is niet geassocieerd met een hoger risico op kleplekkage. Op basis van deze 
resultaten kunnen we concluderen dat een competente bicuspide longslagaderklep bij een 
TGA-patiënt geen contra-indicatie is voor het verrichten van een ASO.
Het percentage patiënten met heroperaties aan de neo-aortaklep of neo-aortawortel in 
de studiegroep was laag, gemiddeld 3%. Echter, van de totale onderzoeksgroep heeft al 
14% van de patiënten een neo-aortaworteldiameter ≥40 mm, waarbij in 26% van de gevallen 
tenminste een matige neo-aortakleplekkage is vastgesteld. Een kwart van de patiënten met 
een worteldiameter ≥40 mm is minderjarig (<18 jaar). Deze resultaten, samen met de 
voortgaande neo-aortadilatatie en neo-aortakleplekkage op volwassen leeftijd, en hun sterke 
onderlinge samenhang zoals aangetoond in dit onderzoek, zijn zorgwekkend en impliceren 
een te verwachten stijging van het aantal heroperaties voor neo-aortaklep en/of neo-
aortawortelpathologie in de nabije toekomst.
Hoofdstuk 5 toont het resultaat van de aanvullende analyse naar het effect van verander-
ende aortadimensies in de tijd op het ontstaan van neo-aorta regurgitatie, zoals 
gerapporteerd in Hoofdstuk 4. Met een uitgebreidere statistische analyse (joint modeling) 
werd de sterke relatie tussen de neo-aortawortel afmeting en neo-aortakleplekkage 
bevestigd, maar deze was veel sterker dan eerder vastgesteld. Ook voor het ontwikkelen 
van tenminste milde neo-aortakleplekkage werd zowel de neo-aortaklep als neo-
aortaworteldiameter als onafhankelijke risicofactor gekenmerkt. Bovendien werd gevonden 
dat naast de diameter ook de groeisnelheid van de neo-aortaklep en neo-aortawortel een 
onafhankelijke kritische factor is voor het ontwikkelen van tenminste milde neo-aortaklep-
lekkage. Dit betekent dat een snellere groei van de neo-aortaklep en de neo-aortawortel, 
bovenop de neo-aortaklep en -wortelafmeting, een hoger risico op neo-aortakleplekkage 
geeft.
Deel II
Aorta 4D flow imaging in TGA patiënten na de ASO en daarbuiten
4D flow MRI is onlangs geïntroduceerd als een nieuwe niet-invasieve beeldvormingsmethode 
die wordt gebruikt voor beoordeling van de hemodynamische aspecten van de bloedstroom 
in de grote bloedvaten.5, 6 Het geeft informatie over het verloop van de bloedstroom binnen 
het bloedvat gedurende de hartcyclus (visualisatie van bloedstroom in 3 loodrechte 
richtingen in de ruimte (3D) als functie van de tijd (4D)) en maakt kwantificatie van flow-
gerelateerde hemodynamische parameters mogelijk.
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Om die reden wordt 4D flow MRI gebruikt om de cardiovasculaire fysiologie en 
pathofysiologie beter te begrijpen, wat heeft geleid tot een betere kennis van de progressie 
van aortaproblematiek in patiënten met aangeboren hartafwijkingen.6-10 Hemodynamische 
parameters zoals ‘wall shear stress’ (WSS) en ‘flow displacement’ kunnen worden afgeleid 
van 4D flow MRI. Genormaliseerde flow displacement (FD) is een kwantitatieve maat voor 
de excentriciteit van de bloedstroom en is gedefinieerd als de afstand tussen het centrum 
van het bloedvat en het ‘snelheidscentrum’ van het golffront van de bloedstroom, 
genormaliseerd voor de diameter van het bloedvat. Door verschillende studies is aangetoond 
dat een toename in FD verband houdt met de morfologie van de aortaklep en gecorreleerd 
is met de mate van groei van de aorta in patiënten met een bicuspide aortaklep.9, 11 De 
parameter WSS, vrij vertaald wandschuifspanning, vertegenwoordigt de kracht van de 
bloedstroom die tangentieel (in de lengterichting van het verloop van het bloedvat) op de 
vaatwand inwerkt. Gebieden van de aorta blootgesteld aan hoge WSS zijn geassocieerd met 
kenmerkende histologische veranderingen in de aortavaatwand in patiënten met een 
bicuspide aortaklep.12 Bovendien is beschreven dat een abnormale WSS een potentieel 
bijdragend effect heeft op vaatdilatatie en aneurysma vorming, bijvoorbeeld in de thoracale 
aorta en bij intracraniële aneurysmata.13, 14
De toepassing van aorta 4D flow MRI kan daarom van belangrijke waarde zijn voor de 
evaluatie van aortaproblematiek bij TGA-patiënten na ASO. Validatie van de toegepaste 4D 
flow MRI-techniek door kennis over de reproduceerbaarheid en consistentie van de uitkomst 
parameter(s) is echter noodzakelijk om verschillen tussen patiëntgroepen en tussen 
longitudinale patiëntdata te kunnen interpreteren. Om die reden is een onderzoek ter 
beoordeling van de scan-rescan reproduceerbaarheid en beoordelaarsbetrouwbaarheid 
voor de hemodynamische parameter 3D WSS in de thoracale aorta uitgevoerd bij gezonde 
vrijwilligers. Hiervoor is er van de gezonde vrijwilligers tweemaal eenzelfde MRI-scan van 
het hart en de grote bloedvaten gemaakt met 10 minuten pauze tussen de twee scans 
(scan-rescan). De resultaten hiervan zijn samengevat in Hoofdstuk 6. Voor de beoordeling 
van de WSS is de thoracale aorta opgedeeld in vijf gelijke segmenten: proximale aorta 
ascendens, distale aorta ascendens, aortaboog, proximale aorta descendens en distale 
aorta descendens. De maximale pieksystolische WSS (WSSmax) en de gemiddelde 
pieksystolische WSS (WSSmean) is in elk van de segmenten berekend. De scan-rescan 
reproduceerbaarheid was goed voor WSSmean in alle thoracale aorta segmenten; de scan-
rescan reproduceerbaarheid voor WSSmax was matig met een hogere variabiliteit in de 
proximale aorta ascendens. De reproduceerbaarheid van een identieke beoordelaar 
(intraobserver) en van twee onafhankelijke beoordelaars (interobserver) voor segmentale 
beoordeling van WSSmax en WSSmean was goed tot uitstekend. De segmenten van de 
ascenderende aorta tonen in het algemeen meer variabiliteit in WSSmax en WSSmean in 
vergelijking met de segmenten van de aorta descendens en aortaboog voor zowel de scan-
rescan, intraobserver als interobserver beoordelingen. Met deze WSS-variaties moet 
rekening gehouden worden bij de interpretatie van onderzoeksresultaten tussen 




In Hoofdstuk 7 zijn de resultaten van het 4D flow MRI-onderzoek naar de bloedstroom 
hemodynamica in de aorta ascendens in patiënten met TGA na ASO gerapporteerd. Deze 
resultaten zijn vergeleken met gezonde vrijwilligers. Naast de afmetingen van de aorta 
ascendens zijn er twee van 4D flow afgeleide hemodynamische parameters beoordeeld: FD 
en WSS. Patiënten na ASO tonen een meer excentrische bloedstroom in de proximale aorta 
ascendens (inclusief neo-aortawortel) zich uitend in een hogere FD en verschillende FD-
richting. De mate van FD laat hierbij een lineair verband zien met geïndexeerde 
aortadimensies van de neo-aortawortel en de sinotubulaire overgang (dimensies 
geïndexeerd voor lichaamsoppervlak en uitgedrukt als Z-score). De richting van de 
excentrische flowprofielen in de neo-aortawortel is significant verschillend tussen de 
patiënten met verschillende TGA-specifieke preoperatieve positie van de grote vaten: in de 
groep TGA-patiënten met de aorta rechts of rechts-anterior gepositioneerd ten opzichte 
van de longslagader is de FD-richting meer gericht naar de rechterzijde in de aorta 
ascendens, terwijl een aorta positie links-anterior of anterior ten opzichte van de 
longslagader resulteert in een FD meer naar de linkerzijde van de aortawand van de aorta 
ascendens gericht ter hoogte van de neo-aortawortel. Daarnaast hebben TGA-patiënten 
een abnormale regionale WSS in het proximale segment aorta ascendens (lager in 
vergelijking met gezonde vrijwilligers) en in het distale segment van de aorta ascendens 
(hoger in vergelijking met gezonde vrijwilligers), met een lokaal gebied van maximaal 
verhoogde WSS aan de (rechter) voorzijde van de distale aorta ascendens. De geometrie 
van de aorta na ASO is erg specifiek en bestaat uit neo-aortaworteldilatatie en een vrij 
plotselinge overgang naar een smallere aortadiameter ter hoogte van het middendeel van 
de aorta ascendens (mid-aorta ascendens). Deze overgang is exact gelegen op het niveau 
van aortacompressie door de voorgelegen longslagaderstam als gevolg van de Lecompte 
manoeuvre als onderdeel van de ASO. De verandering in aortadiameter, uitgedrukt als ratio, 
is geassocieerd met een verhoogde WSS en een asymmetrische WSS-verdeling in het distale 
segment van de aorta ascendens. De relatie was lineair: hoe groter de discrepantie tussen 
de diameter van de neo-aortawortel en mid-aorta ascendens, des te hoger de WSS in het 
distale segment van de aorta ascendens.
Het gebied van de abnormaal verhoogde WSS correleert klinisch met de locatie van een 
papierdunne en fragiele voorwand van de aorta ascendens, een bevinding die frequent 
wordt gezien tijdens heroperaties aan de aorta in patiënten na ASO zoals eerder beschreven 
door ons centrum.15 De richting van de FD vanaf de neo-aortawortel naar de mid-aorta 
ascendens komt ook overeen met de WSS-verdeling in de mid-aorta ascendens. De bijdrage 
van FD aan de WSS-distributie meer stroomopwaarts in de distale aorta ascendens is minder 
sterk vergeleken met de bijdrage van de tapering van het bloedvat hieraan. De observaties 
uit dit onderzoek zijn het begin van een verdere ontrafeling van de interactie tussen de 
aortageometrie na ASO en de hemodynamica en geven meer inzicht hoe de bloedstroom 
hemodynamica betrokken kan zijn bij de (progressie van) neo-aortaworteldilatatie en/of 
het dunner worden van de voorzijde van de aortavaatwand van het distale aorta ascendens 
segment.
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Hoofdstuk 8 beschrijft de bevindingen van de 4D flow MRI-studie naar de hemodynamische 
parameter WSS in de gehele thoracale aorta in TGA-patiënten na ASO. Deze WSS-analyse 
is uitgevoerd volgens de methode die is toegepast in het reproduceerbaarheidsonderzoek 
zoals beschreven in Hoofdstuk 6. TGA-patiënten zijn vergeleken met gezonde vrijwilligers 
en segmentale WSS-analyses zijn gerelateerd aan de geometrie van de thoracale aorta na 
de ASO. Daarnaast is het effect van dobutamine geïnduceerde stress op de WSS in de gehele 
thoracale aorta onderzocht.
Specifieke geometrische veranderingen van de thoracale aorta na ASO worden 
waargenomen conform de beschrijvingen in de literatuur.16-18 De specifieke geometrie 
bestaat uit een grote diameter discrepantie tussen de verwijde neo-aortawortel en de relatief 
smallere mid-aorta ascendens, als gevolg van de anterieure positie van de longslagader en 
compressie van de longslagaderstam en -takken op de aorta na ASO met Lecompte 
manoeuvre. Daarnaast wordt in TGA-patiënten een scherpere hoek (angulatie) gezien van 
de aortaboog. Gebaseerd op de 4D flow analyse tonen zowel kinderen als jonge volwassenen 
na ASO significant hogere WSS-waarden in de gehele thoracale aorta vergeleken met de 
gezonde vrijwilligers, met uitzondering van de gedilateerde proximale aorta ascendens. In 
overeenstemming met de bevindingen in Hoofdstuk 7, worden de aorta regio’s met hoge 
piek systolische WSS gevonden in het distale deel van de aorta ascendens, gelegen op de 
voorwand van dat segment. De specifieke geometrie van de aorta ascendens na ASO, 
uitgedrukt in een diameter discrepantie tussen de gedilateerde neo-aortawortel en het 
smallere mid-aorta ascendens deel, is geassocieerd met hogere WSS-waarden in alle 
aortasegmenten stroomafwaarts van deze kaliberverandering: hoe groter de 
diameterdiscrepantie, des te hoger de WSS-waarden zowel in de distale aorta ascendens 
als in beide segmenten van de aorta descendens. De geometrie van de aortaboog, 
gekenmerkt door de meer acute aortaboog angulatie in TGA-patiënten na ASO in vergelijking 
met gezonde vrijwilligers, heeft geen additionele bijdrage aan de hoge WSS-waarden 
gevonden in zowel de aortaboog, het proximale en het distale segment van de aorta 
descendens boven op de WSS-verandering gerelateerd aan de ascendensgeometrie.
Dobutamine geïnduceerde cardiale stress verhoogt de WSS-waarden significant in alle 
segmenten van de thoracale aorta, met de hoogste procentuele WSS-stijging in de segmenten 
van de aorta ascendens. De hoogste pieksystolische WSS-waarde in de thoracale aorta is 
gelegen in het distale aorta ascendens segment, zowel in rust als tijdens dobutamine-stress, 
maar tijdens stress was dit nog meer uitgesproken. De dobutamine geïnduceerde WSS-stijging 
in dat segment toont een significante lineaire correlatie met de toename van de linkerkamer 
ejectiefractie, het slagvolume en het hartminuutvolume (cardiac output). Gebaseerd op de 
resultaten van dit onderzoek kunnen we concluderen dat een beoordeling van aortale 
bloedflow tijdens dobutamine-stress mogelijk beter de locatie en uitgebreidheid van de 
vaatwand(en) blootgesteld aan abnormale WSS kan weergegeven; de gebieden die hierdoor 
meer risico lopen voor vasculaire modellering. Gezien de significante dobutamine-stress 
geïnduceerde toename van WSS in de neo-aortawortel, die een tangentiele kracht uitoefent 
op het neo-aorta weefsel met reeds structurele vaatwandafwijkingen,19, 20 is het voor te stellen 




Kennis van de uitgebreidheid en verdeling van WSS in de aorta is niet alleen van belang 
voor patiënten met postoperatieve congenitale hartaandoeningen zoals patiënten na ASO, 
maar ook voor patiënten met erfelijke bindweefselziekten zoals het Marfan syndroom. Beide 
patiëntengroepen hebben een progressieve worteldilatatie als overeenkomstig kenmerk, 
maar het is bewezen dat Marfan patiënten risico lopen op het ontstaan van een dissectie 
en/of ruptuur van de aorta.21, 22 In TGA-patiënten zijn neo-aortaworteldilatatie en kleplekkage 
bekend, maar aortadissecties zijn tot dusver niet in de literatuur gerapporteerd. Om te leren 
van patiënten met een aortopathie met verhoogd risico op ernstige cardiovasculaire events, 
hebben we ook een 4D flow MRI-onderzoek uitgevoerd bij pediatrische patiënten met het 
Marfan syndroom. Deze studie is uitgevoerd in samenwerking met het Amerikaanse Lurie 
Children’s Hospital en de Northwestern University Feinberg School of Medicine uit Chicago 
en de resultaten zijn samengevat in Hoofdstuk 9. Zowel hemodynamische parameters 
afgeleid van 4D flow, semi-kwantitatieve karakterisering van bloedstroompatronen en 
segmentale WSS-analyse in de thoracale aorta, als de dimensies van de aorta zijn beoordeeld 
bij kinderen met het Marfan syndroom en zijn vergeleken met een voor de leeftijd geschikte 
controle groep. Een substantieel deel van de kinderen met het Marfan syndroom heeft 
opvallend andere aorta bloedstroom patronen in vergelijking met gezonde controles, 
bestaande uit opvallende vortices (vortexfenomenen) in de proximale aorta descendens en 
niet-fysiologische helix-vormige bloedstroom fenomenen, afkomstig van de aortawortel 
zich voortzettend naar de aorta ascendens. Deze veranderde bloedstroom patronen en de 
gedetecteerde lagere WSS-waarden zijn het meest uitgesproken in de proximale aorta 
ascendens en de proximale aorta descendens, segmenten waar aortadissecties of 
aortarupturen doorgaans ontstaan. De vortex patronen en abnormale WSS correleren met 
de regionale afmetingen van de proximale aorta descendens en zijn mogelijk waardevolle 
aanvullende hemodynamische markers voor de ernst van de ziekte. Langdurige follow-up 
van deze patiënten zal het onderscheidend vermogen van deze van 4D flow MRI-afkomstige 
parameters aangeven voor de progressie van aortadilatatie en/of het optreden van ernstige 
aortacomplicaties op deze voorkeurs locaties.
Conclusie
In dit proefschrift zijn meerdere aspecten van de aortaproblematiek bij patiënten met TGA 
bestudeerd. Neo-aorta-afmetingen en de neo-aortaklepfunctie tonen in de loop van de tijd 
een progressieve neo-aortaworteldilatatie zonder stabilisatie op volwassen leeftijd waarbij 
de neo-aortaworteldiameter de kritische factor blijkt te zijn voor verdere achteruitgang in 
neo-aortaklepfunctie. Deze bevindingen, samen met de aangetoonde verhoogde incidentie 
van heroperatieve chirurgie aan de neo-aortaklep en/of de neo-aortawortel in het afgelopen 
decennium, impliceren dat het aantal heroperaties voor late neo-aortawortelcomplicaties 
verder zal toenemen met langere follow-up.
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 De pathofysiologie van de progressieve worteldilatatie is onvolledig begrepen en meest 
waarschijnlijk multifactorieel. In dit proefschrift wordt aangetoond dat een mannelijk 
geslacht en een meer complexe TGA-morfologie (TGA-VSD en Taussig-Bing anomalie) 
onafhankelijke risicofactoren zijn voor dilatatie van de neo-aorta. De inzichten uit de huidige 
4D flow MRI-studies suggereren ook een bijdrage van hemodynamische factoren welke 
geassocieerd zijn met de ASO-specifieke thoracale aortageometrie.
Perspectief voor de toekomst
Belangrijke onderzoeksgebieden die de patiëntenzorg na ASO in de nabije toekomst 
beïnvloeden moeten worden gericht op gepersonaliseerde cardiovasculaire behandeling 
ter optimalisatie van de langetermijnuitkomsten. Op basis van de inzichten verkregen uit 
dit proefschrift bieden de volgende gebieden perspectief voor verdere ontwikkeling met 
klinische relevantie:
• De ontwikkeling van predictie en risicostratificatie modellen op basis van seriële data 
door gestandaardiseerde imaging protocollen en het vastleggen van event data, zoals 
het volgen van aorta dimensies en het optreden van neo-aortakleplekkage in dit 
proefschrift. Deze kunnen dienen voor een wetenschappelijk onderbouwd individueel 
patiënt follow-up schema met adequaat zorgniveau voor elke patiënt, maximalisatie van 
efficiëntie en verbetering van het resultaat op populatieniveau.
• Inzetten op longitudinaal en aanvullend 4D flow MRI-onderzoek voor TGA-patiënten na 
ASO, door deze op te nemen als standaard onderzoek gedurende follow-up.
- Hiermee kunnen vraagstukken rondom de interindividuele verschillen in 
aortahemodynamica tussen TGA-patiënten geopereerd met verschillende ASO-
technieken (bijvoorbeeld met en zonder de toepassing van Lecompte manoeuvre) en 
tussen TGA-patiënten met verschillende anatomie (bijvoorbeeld met of zonder VSD 
en TGA-subgroepen met verschillende ruimtelijke positie van de grote slagaders) 
verder worden opgelost om uiteindelijk individuele chirurgische management 
strategieën te optimaliseren voor de beste langetermijnresultaten.
- Daarnaast kan longitudinaal aorta 4D flow MRI-onderzoek helpen bij het voorspellen 
van aortacomplicaties (worteldilatatie, aortadissectie of aortaruptuur). Specifieke 
hemodynamische markers kunnen indicatief zijn voor het tijdig timen van interventies 
(wortelvervanging) en kunnen zo het klinische resultaat voor dilaterende aorta’s 
optimaliseren, aangezien de huidige behandelstrategieën voor preventieve 
aortachirurgie onvolmaakt en enkel gebaseerd zijn op absolute aortadiameters.
- Integratie van patiënt-specifieke aorta 4D flow informatie in computergestuurde 
modellen, geijkt op de simulatie van de effecten van bloedvatgeometrie en 
bloedstroom op de vaatwand (genaamd Computational Fluid Dynamics), maken het 
preoperatief mogelijk de hemodynamische respons van een chirurgische (her)ingreep 




een probleem op voorhand worden bepaald. Voor patiënten na ASO kan bijvoorbeeld 
de beste gepersonaliseerde pasvorm van een aorta vaatprothese (grootte, kromming 
en lengte) voor implantatie worden bepaald, ter vervanging van het afwijkende deel 
van het bloedvat, met behoud van de meest optimale flow in en voorbij de 
geïmplanteerde vaatprothese.
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Dit proefschrift is het resultaat van een fijne samenwerking, inzet en steun van enthousiaste 
collega’s, patiënten en vrijwilligers. Allereerst wil ik alle patiënten en vrijwilligers bedanken: 
zonder jullie bereidheid was er geen onderzoek naar de bloedstroom in de aorta mogelijk 
geweest.
Prof. dr. Blom, beste Nico, bedankt voor het vertrouwen dat je me gaf door mij als jonge 
fellow kindercardiologie mee te nemen naar de kinderhartmissie in Suriname en me ruimte 
te geven voor het onderzoeksproject. De start met het bijeenzoeken van echodata uit de 
handgeschreven schriftjes en stoffige videobanden was een evenzo geduldige activiteit als 
het vissen op het Brokopondostuwmeer. Beide onvergetelijk met een mooie vangst als 
resultaat. Jij bent een voorbeeld in vele opzichten, bedankt voor de mogelijkheden die je 
me hebt gegeven binnen de kindercardiologie.
Prof. dr. Hazekamp, beste Mark, hartelijk dank voor de begeleiding rondom het proefschrift. 
Jouw ervaring en input maakt wetenschappelijke papers krachtiger en vernieuwend.
Mijn co-promotor, dr. Roest, beste Arno, als directe begeleider sta jij aan de basis van dit 
proefschrift. Jouw enthousiasme en positivisme werken stimulerend en je snelle beoordeling 
van manuscripten zorgt voor behoud van de juiste flow en klinische twist. Dank daarvoor. 
Je bull-ride was onvergetelijk, evenals vele andere congresmomenten.
Prof. dr. Lamb, beste Hildo, hartelijk dank voor de goede samenwerking met de afdeling 
Radiologie. Jullie rol in het verkrijgen van uniek inzicht in pathologie en pathofysiologie door 
imaging van congenitale hartziekten is essentieel.
Dr. Westenberg, beste Jos, het 4D flow MRI-onderzoek was niet mogelijk geweest zonder 
jouw hulp en betrokkenheid. Je schakelde snel zodat kwantitatieve analyse van geavanceerde 
hemodynamische parameters voor de aorta mogelijk werd. Bedankt voor je ideeën en 
wetenschappelijke adviezen.
Dr. Kroft, beste Lucia, bedankt voor het uitwerken van MRI-data en je waardevolle bijdrage 
aan het schrijven van de artikelen.
Pieter van den Boogaard, veel dank ben ik jou verschuldigd voor het scannen van de 
patiënten en vrijwilligers. Niemand is meer toegewijd dan jij om de kindercardiologische 
patiënt door de MRI-scansessies te begeleiden. Gelukkig vond jij de real time control errors 
tijdens de 4D flow acquisities even vervelend als ik.
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Dr. Clur, beste Sally, jouw bevlogenheid voor de foetale cardiologie is inspirerend en 
resulteerde in twee papers samen, waarvan een te vinden in dit proefschrift. Veel dank 
hiervoor.
Dr. Kuipers, beste Irene, jouw tomeloze enthousiasme en inzet zorgden voor state-of-the-art 
echocardiografie. Dank voor je steun tijdens fasen van geluk en verdriet.
Dr. van Geloven, dr. Tsonaka en dr. Baart, beste Nan, Roula en Sara, jullie inzicht en bijdrage 
aan de statistische analyses mag niet onderschat worden. Bedankt voor de prettige 
samenwerking.
Mijn kindercardiologie roots liggen in meerdere centra: Veldhoven, Nijmegen, Utrecht, 
Amsterdam en Leiden. Dank aan diegenen die mij vanuit die basis gevormd hebben.
Kindercardiologen, kinderhartchirurgen, fellows, PA’s, echocardiografisten en betrokkenen 
uit het Centrum voor Aangeboren Hartafwijkingen Amsterdam-Leiden (CAHAL), de 
academische zorg die we dagelijks leveren aan de patiënten is een teamprestatie en is het 
belangrijkste in ons werk. Ik ben trots om van deze groep deel te mogen uitmaken. Speciale 
dank aan de Leidse kindercardiologen, voor de gelegenheid die ik heb gekregen dit 
proefschrift af te ronden.
Researchers of the Northwestern Cardiovascular MR Imaging Group and Lurie Children’s 
Hospital of Chicago. Prof. dr. Markl, dear Michael, thank you for having me, for educating 
me, and making me part of such an impressive research program and team during my stay. 
Dear Alex, Cynthia, Joshua, Julio, Emilie, Susanne, Michael Rose and (former associate) Pim, 
the way in which you are engaged in developing novel advanced imaging (analysis) 
techniques to better understand complex congenital cardiovascular diseases is outstanding. 
I felt right at home and you introduced me to beautiful Chicago. Many thanks for the great 
time and for the paper we wrote together.
Mijn waardering gaat ook uit naar voorgaande en huidige promovendi. Joe, voor de 
geometrische analyse van de aortaboog. Friso, voor je hulp bij het creëren van de cover 
afbeelding. Vivian, Ineke, Lisette en Covadonga, voor jullie photoshop kunsten, koffie, 
zoetigheid en congresgezelligheid.
Gabriella, I am grateful for your drawings for the Introduction of this thesis.
Mijn paranimfen, Ingmar Knobbe en Sander Cretier: Ingmar, een interessante discussie over 
verhoogde rechterkamerdruk als eerste kennismaking leidde later tot een overlappend 
fellowship kindercardiologie. Geweldig was dat, met hoogtepunten als het poolbiljart in 




het CAHAL en werden we in die tijd beide trotse vader. Sander, kindergeneeskunde en 
beeldvorming zijn de kernwoorden die brachten waar we beide nu staan. Dank voor alle 
steun en gezelligheid, veelal onder culinair genot. Medical imaging is key to patient 
understanding, keep up the good clinical work. Dank dat jullie mijn paranimf zijn.
Vrienden van het academische jaar 2000. Na het volbrengen van de studie Geneeskunde 
werd de Rotterdamse hunkering door velen van jullie (tijdelijk of permanent) geruild voor 
een buitenlands avontuur of een tintje Amsterdamse bravoure. Zo ook voor mij als 
zuiderling. Dank voor de vele gezellige momenten samen.
Lieve familie, schoonfamilie en vrienden, ik prijs mij enorm gelukkig met jullie. Ook al wonen 
we niet bij elkaar om de hoek, jullie zijn immer geïnteresseerd en staan altijd voor me klaar.
Mijn allerliefste ouders en broer Mark, dank voor jullie onvoorwaardelijke liefde en steun, 
voor alles wat jullie voor me doen en gedaan hebben. Woorden kunnen niet genoeg 
uitdrukken hoeveel jullie voor me betekenen. Mam, je mag dit helaas niet meer meemaken, 
maar wat zou je trots zijn.
Lieve Linda, bedankt voor jouw liefde, steun en Brabantse nuchterheid, voor onze prachtige 
kinderen Rein en Sophie en voor onze derde spruit die we oktober dit jaar verwachten. Niets 
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